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1. Abstract (English) 
Stress is a vital response of all organisms to the demands of life. By adjusting to stimuli from 
the outside world, and stimuli arising from its internal organs, the body is continually at work to 
ensure its proper function under a widely variable range of conditions. Thus, acute and 
adequate responses to such stimuli (stressors) are essential. However, when these responses 
are either insufficient or excessive, the well-being of the organism is at risk. Furthermore, if 
stress becomes chronic and the cost of continual adjustment rises, a plethora of illnesses can 
result. This phenomenon has grown into epidemic proportions, particularly in Western societies, 
with the physical and mental health of millions severely affected. Despite much research, the 
mechanisms underlying responses to stressors are still incompletely understood. 
The biological substrate of stress responses in mammals, including humans, is known 
to comprise several compartments, which are connected in neuroendocrine circuits. Different 
neuroendocrine circuits mediate responses to different stressors, although important central 
and peripheral components of these circuits are shared. For example, the paraventricular 
nucleus of the hypothalamus (PVN), a central integrator of stressor-induced signaling, controls 
activity of the hypothalamic-pituitary-adrenocortical axis (HPA axis) as well as the autonomic 
nervous system (ANS). Through endocrine (pituitary hormones) and neural (sympathetic 
nerves) mechanisms, stressor-induced signaling converges on the adrenal glands, whose 
cortex and medulla produce the main effector molecules of the HPA axis and ANS, namely 
glucocorticoids and catecholamines, respectively. 
Over the past decades, peptides have been established as crucial regulators of stress 
responses. The classical and most important examples include corticotropin-releasing hormone 
(CRH, hypothalamus) and adrenocorticotropic hormone (ACTH, pituitary) of the HPA axis. 
More recently, an exciting new candidate emerged, namely pituitary adenylate cyclase-
activating polypeptide (PACAP). Proof for the concept that PACAP is a transmitter of the ANS 
during stress came with the description of PACAP-deficient mice, which are unable to 
adequately activate synthesis and release of catecholamines in response to insulin-induced 
hypoglycemia. Thus, under conditions of profound metabolic stress, PACAP-mediated signaling 
within the ANS is a matter of life and death. Early experiments with these PACAP-deficient 
mice indicated that their HPA axis is intact. However, recent data strongly suggested that 
PACAP plays an excitatory role during responses of the HPA axis to stressor exposure. The 
present work therefore focused on both the ANS and HPA axis, using PACAP-deficient 
compared to wild-type mice as models for stressor-induced responses in vivo. 
 Our experiments show that PACAP is required for normal responses to acute stressor 
exposure. Expanding previous results from our laboratory, evidence is provided for PACAP-
dependent regulation of the catecholaminergic system in the adrenal medulla during responses 
of the ANS. By inducing the expression of enzymes required for epinephrine biosynthesis 
(tyrosine hydroxylase, phenylethanolamine N-methyltransferase), as well as neuropeptides 
involved in modulation of adrenal secretory activity (galanin, Tac1, VIP), PACAP appears to 
 7
provide a mechanism for plasticity during periods of high demand. Our data suggest that this 
PACAP-dependent stimulus-transcription coupling may proceed via stressor-specific 
mechanisms, as the induction of a number of transcription factors which are putatively 
responsible for the regulation of enzymes and neuropeptides (e.g. Egr1, Fos, Nur77) is 
PACAP-dependent in response to restraint, but not hypoglycemia. Furthermore, PACAP 
controls upregulation of transcripts encoding potential cytoprotectants (Ier3, Stc1) in the 
adrenal glands, in response to hypoglycemia and restraint. 
Most importantly, our present work is the first to show that the endogenous 
PACAPergic system is required for activation of the HPA axis in response to stressor exposure. 
This appears to be mediated at the central level, via PACAP-dependent stimulation of 
hypophysiotropic neurons, as restraint-induced upregulation of CRH mRNA in the PVN is 
completely abolished in PACAP-deficient mice. Consequently, restraint-induced secretion of 
ACTH and corticosterone is blunted, particularly when stressor exposure is prolonged, while 
serum concentrations of both hormones in untreated mice are equivalent to those in wild-types. 
These PACAP-dependent effects seem to involve PACAP-dependent stimulus-transcription 
coupling throughout the HPA axis, and possibly rely on inducible transcription factors from the 
Nr4a family of orphan nuclear receptors. Thus, rapid regulation of Nur77 (Nr4a1), Nurr1 
(Nr4a2) and Nor1 (Nr4a3) in the PVN, pituitary gland and adrenal cortex occurs in a PACAP-
dependent pattern. The fact that stressor-induced upregulation of transcripts encoding 
steroidogenic acute regulatory protein (StAR) and steroidogenic factor 1 (SF-1) is significantly 
attenuated in adrenal glands from PACAP-deficient mice provides a link between PACAP-
dependent central control of the HPA axis and peripheral corticosterone production. 
Beyond the acute regulation of responses to stressor exposure, our results have 
implications for the understanding, and potentially the treatment, of disease states associated 
with chronic stress. In this regard, a crucial finding from the present work concerns stressor-
induced corticosterone secretion. The initial phase is largely intact in PACAP-deficient animals, 
while more sustained secretion during prolonged stressor exposure becomes increasingly 
blunted. This suggests that chronic hypersecretion of glucocorticoids, such as during certain 
psychiatric illnesses, could be targeted by blockade of the PACAPergic system, without 
compromising acute HPA responses that are necessary for survival and health. 
As mentioned, our experiments suggest that PACAP is a central regulator of the HPA 
axis, controlling activation in response to stressors at the level of the hypothalamic PVN. Future 
work will address the exact signaling mechanisms employed during PACAP-dependent stress 
responses, in order to reveal potential avenues for therapeutic intervention. To further clarify 
the involvement of this neuropeptide in chronic stress-related diseases, the PACAP-deficient 
mouse model will continue to be used as a valuable tool in experiments concerning the 





2. Abstract (German) 
Stress ist eine notwendige Reaktion aller Organismen auf die Anforderungen des Lebens. 
Durch ständige Anpassung an Reize aus der Aussenwelt und seinen inneren Organen bewirkt 
der Körper, dass seine normale Funktion unter stark variierenden Bedingungen aufrecht 
erhalten werden kann. Akute und adäquate Reaktionen auf derartige Reize (Stressoren) sind 
daher lebenswichtig, während zu schwache oder exzessive Reaktionen ein Risiko für die 
Gesundheit darstellen. Wenn Stress zudem chronisch wird, die Kosten ständiger Anpassung 
also zu hoch werden, kann dies zu einer Vielzahl an Krankheiten führen. Dieses Phänomen hat 
mittlerweile epidemische Ausmaße erreicht, besonders in westlichen Ländern, in denen 
Millionen von Menschen chronisch an physischen und seelischen Krankheiten leiden. Trotz 
intensiver Forschungsanstrengungen sind die Mechanismen, die Stressreaktionen zugrunde 
liegen, noch nicht vollständig bekannt. 
Die biologische Grundlage, auf der Stressreaktionen in Säugetieren (also auch dem 
Menschen) ablaufen, beinhaltet mehrere Bestandteile, die in neuroendokrinen Schaltkreisen 
organisiert sind. Unterschiedliche Schaltkreise bewirken Reaktionen auf unterschiedliche 
Stressoren, wobei wichtige zentrale und periphere Komponenten allen Schaltkreisen 
gemeinsam sind. Im Hypothalamus beispielsweise fungiert der Nucleus paraventricularis (PVN) 
als zentrale Schaltstelle zur Kontrolle der Hypothalamus-Hypophysen-Nebennierenrinden-
Achse (HPA-Achse) sowie des autonomen Nervensystems (ANS). Mittels endokriner (Hormone 
der Hypophyse) und neuraler (sympathische Nerven) Mechanismen aktivieren Stressor-
induzierte Signale die Nebennieren, deren Rinde und Mark die wichtigsten Wirkstoffe der HPA-
Achse und des ANS herstellen, nämlich die Glucocorticoide und Catecholamine. 
In den letzten Jahrzehnten konnte klar gezeigt werden, dass Peptide wichtige 
Regulatoren von Stressreaktionen sind. Als klassische und wichtigste Beispiele gelten hier 
CRH (corticotropin-releasing hormone, Hypothalamus) und ACTH (adrenocorticotropic 
hormone, Hypophyse) aus der HPA-Achse. Ein neuer, relativ kürzlich entdeckter Kandidat ist 
das Neuropeptid PACAP (pituitary adenylate cyclase-activating polypeptide). Mittels transgener 
Mäuse konnte bewiesen werden, dass PACAP ein bei Stress freigesetzter Botenstoff des ANS 
ist. PACAP-defiziente Mäuse sind nicht in der Lage, in Reaktion auf Insulin-induzierte 
Hypoglykämie die Synthese und Freisetzung von Catecholaminen adäquat zu aktivieren, so 
dass PACAP-abhängige Signale im Falle von metabolischem Stress zwischen Leben und Tod 
entscheiden. Erste Experimente mit diesen PACAP-defizienten Mäusen beschrieben ihre HPA-
Achse als intakt. Neuere Daten jedoch liessen dringend vermuten, dass PACAP 
Stressreaktionen der HPA-Achse als exzitatorischer Botenstoff unterstützt. Die vorliegende 
Arbeit richtete sich daher sowohl auf das ANS als auch die HPA-Achse und nutzte das PACAP-
defiziente Mausmodell, um Stressor-induzierte Reaktionen in vivo zu untersuchen. 
Unsere Experimente zeigen, dass PACAP für den Ablauf akuter Stressreaktionen 
notwendig ist. Aufbauend auf vorherigen Befunden aus unserem Labor liefern wir Hinweise 
darauf, dass das catecholaminerge System des Nebennierenmarks während Stressreaktionen 
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des ANS PACAP-abhängig reguliert wird. Durch Induktion der Enzyme, welche die Biosynthese 
von Adrenalin steuern (Tyrosinhydroxylase, Phenylethanolamine N-methyltransferase), sowie 
von Neuropeptiden, welche die sekretorische Aktivität der Nebennieren modulieren (Galanin, 
Tac1, VIP), scheint PACAP funktionelle Plastizität im Zuge erhöhter Anforderungen zu 
gewährleisten. Diese Kopplung von Stimulus (Stressor) an Genexpression scheint Stressor-
spezifischen Mustern zu folgen, denn Transkriptionsfaktoren, die für die Regulation der 
Enzyme und Neuropeptide in Frage kommen (z.B. Egr1, Fos, Nur77), werden zwar durch 
Immobilisierungsstress induziert, nicht aber durch Hypoglykämie. Desweiteren kontrolliert 
PACAP die Expression potentiell zytoprotektiver Faktoren (Ier3, Stc1) in den Nebennieren, 
sowohl in Reaktion auf Hypoglykämie als auch Immobilisierung. 
Von besonderer Bedeutung ist die Tatsache, dass die vorliegende Arbeit erstmalig 
Beweise dafür liefert, dass endogenes PACAP für Stressor-induzierte Aktivierung der HPA-
Achse notwendig ist. Dies scheint zentral gesteuert zu werden, mittels PACAP-abhängiger 
Stimulation hypophysiotroper Neurone des Hypothalamus, denn die Induktion von CRH mRNA 
im PVN nach Immobilisierungsstress fällt in PACAP-defizienten Mäusen vollständig aus. 
Infolgedessen ist auch die Sekretion von ACTH und Corticosteron vermindert, besonders bei 
länger anhaltendem Stress, wohingegen basale Konzentrationen beider Hormone im 
Blutkreislauf denen normaler Mäuse gleichwertig sind. Diese PACAP-abhängigen Effekte 
scheinen entlang der gesamten HPA-Achse mit PACAP-abhängigen Genexpressionsmustern 
einher zu gehen, wobei induzierbare Transkriptionsfaktoren der Nr4a-Familie (nukleäre 
Rezeptoren) eine Rolle spielen. Unmittelbar nach Stimulation werden Nur77 (Nr4a1), Nurr1 
(Nr4a2) und Nor1 (Nr4a3) PACAP-abhängig im PVN, der Hypophyse und der 
Nebennierenrinde exprimiert. Die Stressor-induzierte Regulation von Transkripten, welche 
StAR (steroidogenic acute regulatory protein) und SF-1 (steroidogenic factor 1) kodieren, ist in 
den Nebennieren PACAP-defizienter Mäuse signifikant verringert. Dies stellt die Verbindung 
dar zwischen zentraler, PACAP-abhängiger Steuerung der HPA-Achse, sowie peripherer, 
PACAP-abhängiger Produktion von Corticosteron.  
Über akute Stressreaktionen hinaus sind unsere Resultate potentiell bedeutsam für 
das Verständnis von Krankheiten, die mit chronischem Stress korrelieren. Diesbezüglich 
besonders wichtig sind unsere Ergebnisse zu PACAP-abhängiger Sekretion von Corticosteron. 
Während nämlich die initiale Phase in PACAP-defizienten Mäusen weitgehend intakt ist, ergibt 
sich im Verlauf anhaltender Stimulation eine deutliche Verminderung der Sekretion. Daher ist 
es denkbar, dass man die chronische Hypersekretion von Glucocorticoiden, die z.B. mit 
bestimmten psychiatrischen Erkrankungen einhergeht, durch Blockade von PACAP behandeln 
könnte, ohne dabei lebenswichtige akute Funktionen der HPA-Achse zu beeinträchtigen. 
Weitere Experimente werden die Mechanismen PACAP-abhängiger Stressreaktionen 
genauer untersuchen, um potentielle neue Therapieansätze zu entdecken. Das PACAP-
defiziente Mausmodell wird dabei auf allen Ebenen von Stress – Verhalten, Physiologie, sowie 
zelluläre und molekulare Mechanismen – weiterhin wertvolle Ergebnisse bezüglich der Rolle 
dieses Neuropeptides liefern. 
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3. Introduction 
Experiences of “stress” or situations that are “stressful” are familiar to almost everyone in 
today’s fast-paced human world. Feelings of being “stressed” can arise from a variety of 
sources, including psychological pressure in the environments of the workplace, family and 
greater society. From a biological and physiological point of view, “stress” encompasses much 
more than those phenomena associated with contemporary use of the term, and the underlying 
scientific concepts have continuously evolved since the fundamental ideas were first 
formulated. 
3.1. Historical definitions of stress 
In his 1865 landmark publication “Introduction à l'étude de la médecine expérimentale” 
(Introduction to the study of experimental medicine), Claude Bernard postulated that all 
complex living organisms maintain a constant environment within themselves that he called “le 
milieu intérieur ou intra-organique” (internal environment). According to Bernard, this internal 
environment comprises the bodily fluids in which cells and organs are bathed while performing 
their normal function, and maintaining relative constancy of its composition is critical for life. He 
also held the belief that “In experiments concerning bodies […] there are at least two milieus to 
consider: the external or extra-organismal and the internal or intra-organismal milieu” (Bernard, 
1865). Thus, he provided a framework for viewing physiological systems, which function under 
constant conditions maintained by the organisms themselves, in the context of the external 
world in which the organisms are embedded. This was further emphasized by Charles Richet, 
who stated that “The living being is stable. It must be in order not to be destroyed, dissolved or 
disintegrated by the colossal forces, often adverse, which surround it” (Richet, 1900). Building 
on and synthesizing these early ideas, Walter Cannon coined the term “homeostasis” in 1926, 
by which he meant “the coordinated physiological reactions which maintain most of the steady 
states in the body” (Cannon, 1929). According to Cannon, different threats to homeostasis, 
such as pain, hunger and strong emotions, could trigger these reactions in a common pattern, 
including increases in blood sugar, heart rate and epinephrine secretion. He interpreted them 
as “biological adaptations to conditions in wild life which are likely to involve pain and emotional 
excitement, i. e., the necessities of fighting or flight” (Cannon, 1927). In the following years, 
work initiated by Hans Selye provided evidence that, similar to Cannon’s “fight or flight” 
reaction, a “general alarm reaction” could be observed in animals after exposure to different 
noxious agents, leading him to suggest that it represents “a response to damage as such” 
rather than a specific response (Selye, 1936a). Selye was also responsible for introducing the 
term “stress” into the biological vocabulary, and has been credited with popularizing the general 
concept of a unitary stress response (Goldstein and Kopin, 2007).  
The historical importance of the aforementioned researchers comprises three main 
aspects of their contributions. First, in new terms and more completely than their predecessors, 
they established that complex living organisms actively produce and maintain their 
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physiological state (internal environment) through the coordinated action of their organ 
systems. Second, they emphasized that complex organisms are open systems with diverse 
relations to their surroundings, such that maintenance of their physiological state is subject to 
disturbances arising in the outside world (external environment). Lastly, they made fundamental 
observations on the neuroendocrine systems that elaborate responses to these disturbances, 
providing a sound basis for future research into homeostasis and its regulation during stress. 
3.2. Stressors and stressor-responsive pathways – current concepts 
Since the groundbreaking contributions of scientists such as Bernard, Richet, Cannon and 
Selye, extensive research into all aspects of stress has been carried out. Using both tried and 
tested as well as novel and more sophisticated experimental techniques, much has been 
learned about the exact organization of the neuroendocrine pathways that underlie homeostatic 
reactions. While the fundamental facts discovered by the aforementioned scientists persist, 
their theories have been refined and expanded in recent years, leading to a more complete and 
systematic understanding of how stress occurs in the body. 
3.2.1. Processive and systemic – two generalized pathways 
Stimuli that trigger homeostatic reactions are called stressors and can arise from the internal or 
external environment of an organism. Stressors can be separated into a variety of categories, 
as exemplified by Cannon, who listed pain, hunger (starvation) and strong emotions as threats 
to homeostasis (Cannon, 1927). Other examples include injury, blood loss, hypoxia and 
exposure to a cold environment. It has become increasingly evident that the responses 
triggered by different stimuli proceed via different routes, reflecting the nature of the stressors 
and their potential impact on survival, and current concepts propose that two generalized 
pathways govern all stress responses. Psychological stressors, which do not acutely harm the 
organism, are relayed via multiple synaptic connections involving higher brain structures, and 
the corresponding pathway is termed “processive”. Processive stressors obtain physiological 
meaning only after signals from multiple sources have been assembled and interpreted, which 
requires parts of the limbic system (e.g. hippocampus, prefrontal cortex). On the other hand, 
physiological stressors that could immediately cause significant harm or death are more directly 
conveyed to the effector limbs of stress-reactive neuroendocrine circuitry, via the “systemic” 
pathway. Responses to systemic stressors involve simpler circuitry and fewer synaptic 
connections (Herman and Cullinan, 1997).The two pathways were proposed on the basis of 
experiments in which lesions of higher brain structures attenuated or abolished the responses 
to psychological stressors, while responses to physiological disturbances were unaffected 
[reviewed in (Herman and Cullinan, 1997; Herman et al., 2003)]. See Table 1 for common 
synonyms used in describing the processive and systemic pathways, together with the 




Figure 1. Simplified schematic of the two 
generalized pathways comprising stressor-
responsive neuroendocrine circuitry. Both 
pathways share certain elements, such as the 
paraventricular nucleus of the hypothalamus 
(PVN) and the adrenal glands. However, the 
processive pathway involves a larger number 
of synapses and higher degree of connectivity, 
compared to the more direct connections 
underlying the systemic pathway. Note that 
the circuitry is depicted as a highly simplified 
schematic, with many structures omitted for 
clarity. Sympathetic and parasympathetic 
innervation of peripheral targets other than the 
adrenal glands is also not shown. Dotted lines 
indicate connections that proceed via multiple 
relays (not shown), e.g. in the brain stem. See 
the following sections for more detailed 
descriptions of the components and their role 




Pathway       Synonyms     Examples of stressors   
processive     psychological, neurogenic, exteroceptive, anticipatory restraint, fear, novelty, social challenges 
systemic       physiological, metabolic, interoceptive, reactive hypoglycemia, pain, hemorrhage, hypoxia 
 
Table 1. The two generalized pathways that elaborate stress responses, common synonyms used to describe them, 
and examples of the stressors through which they are activated. See Herman et al. for excellent reviews concerning 
these pathways (Herman and Cullinan, 1997; Herman et al., 2003). 
 
3.2.2. Systematic elements and principles of stressor-responsive pathways 
According to current concepts of stress, the wiring schemes underlying stressor-responsive 
pathways contain several systematic elements (Goldstein and Kopin, 2007). Sensors are 
responsible for monitoring variables in the internal or external environment, such as blood 
pressure, blood sugar levels, ambient temperature, and sight or smell of a potential predator. 
Information about these variables is conveyed via afferent neural pathways to structures that 
compare this information with certain setpoints. If a sufficiently large discrepancy arises 
between information about the sensed variables and the corresponding setpoints, effectors are 
activated to counter the discrepancy and to reinstate homeostasis (Goldstein and Kopin, 2007). 
These elements operate in both the processive and systemic pathway. In fact, many of the cell 
groups and anatomical sites which carry out the aforementioned functions are shared by both 
pathways (see following sections). As mentioned earlier, the difference lies in the degree of 
connectivity and the extent to which higher brain centers are involved. In addition, there are 
several principles by which homeostatic systems operate. Among them, negative feedback 
ensures that responses to a stimulus are sufficient, yet not excessive, controlling the activity of 
effectors to provide adequate response magnitude and duration (Goldstein and Kopin, 2007).  
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3.3. Neuroendocrine circuitry underlying responses to stressor exposure 
From an anatomical point of view, the aforementioned pathways can be defined as 
neuroendocrine circuits, based on the tissues, cells and mechanisms they employ. Some of 
these tissues and cells are specific to one pathway, while others are shared. Although they 
have been studied in great detail, revealing much of their functional characteristics, the 
neuroendocrine circuits summarized below and their detailed interactions during stress are still 
an area of active research. Note that, for the purpose of the present work, the collective term 
“stress axis” is used in reference to the sum of all ascending (afferent) and descending 
(efferent) pathways that contribute to stress responses in vivo. 
3.3.1. Hypothalamic-pituitary-adrenocortical axis (HPA axis) 
Signals from peripheral sensors indicating the presence of a stressor are propagated via 
neuronal processes to spinal cord and medulla oblongata. By means of “short circuit” 
communication, immediate reflexes are initiated, or signals are relayed to the brain via “long 
circuit” connections [(Pacak and Palkovits, 2001); see Figure 1 for a simplified schematic]. In 
the paraventricular nucleus of the hypothalamus (PVN), excitatory signals from the brain stem 
and other sources are integrated with inhibitory signals, including those from limbic structures 
such as the hippocampus and prefrontal cortex (Herman et al., 2003). This involves a myriad of 
complex and multidirectional connections, with the “microenvironment” of the PVN (regions 
immediately adjacent to the nucleus) playing a critical role (Herman et al., 2002).  
The PVN of the rat can be divided into several subregions, based on the size, packing 
density, chemical characteristics and projection targets of its neuronal constituents (Armstrong 
et al., 1980; Kiss et al., 1991; Swanson and Kuypers, 1980). A subpopulation of cells in the 
dorsolateral aspect of the medial parvocellular region, which in total comprises roughly 3000 
small-sized neurons in the rat (Kiss et al., 1991), expresses the neuropeptide corticotropin-
releasing hormone (CRH). Most of these CRH-containing neurons send projections to the 
external zone of the median eminence (Swanson et al., 1983), where CRH is released into the 
hypothalamic-hypophyseal portal system. Upon reaching corticotrope cells of the anterior 
pituitary gland, CRH causes secretion of adrenocorticotropic hormone (ACTH), which in turn is 
distributed via the general circulation as an endocrine messenger (Whitnall, 1993). ACTH finally 
stimulates the cortex of the adrenal glands to synthesize and release steroid hormones, among 
which the glucocorticoids (corticosterone in rodents, cortisol in humans) produced in the 
adrenocortical zona fasciculata (Keegan and Hammer, 2002) are the most important factors 
during stress (Herman and Seroogy, 2006). 
Within this neuroendocrine chain of events, CRH-containing hypophysiotropic neurons 
in the PVN are the principal starting point for what is known as the hypothalamic-pituitary-
adrenocortical axis (HPA axis; see hypothalamus, pituitary and adrenal cortex in Figure 1). 
They have been recognized as the central locus at which glucocorticoid secretion is regulated, 
integrating excitatory and inhibitory inputs from a multitude of sources (Herman et al., 2002; 
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Herman et al., 2003). These specialized cells have also been termed “CRH motoneurons” 
(Swanson et al., 1987), reflecting the fact that they drive responses of the HPA axis to 
homeostatic challenge via CRH-stimulated ACTH release, followed by ACTH-dependent 
glucocorticoid secretion. Importantly, in addition to cells in the hippocampus and anterior 
pituitary, these neurons are also crucial targets for glucocorticoid-mediated negative feedback 
within the HPA axis. Thus, via both rapid (independent of transcription, non-genomic) and 
delayed (transcription-dependent, genomic) mechanisms, involving effects at the cell 
membrane and in the nucleus, glucocorticoid action in the nervous system results in a net 
suppression of HPA axis output (Keller-Wood and Dallman, 1984; Prager and Johnson, 2009; 
Tasker et al., 2006), presumably to prevent the system from reacting excessively to stressor 
exposure. 
3.3.2. Autonomic nervous system (ANS) 
The autonomic nervous system (ANS) comprises sympathetic and parasympathetic 
components, with the former being further divided into sympathoadrenal and sympathoneural 
parts (Kvetnansky et al., 2009; Pacak and Palkovits, 2001). In the PVN, a subpopulation of 
parvocellular neurons, distinct from the population of hypophysiotropic neurons (see above), 
projects to targets in the brain stem and spinal cord (Swanson and Kuypers, 1980). These so-
called preautonomic neurons of the ventromedial and dorsal parvocellular PVN are the most 
important cells for integration of excitatory and inhibitory signals impinging on the ANS (Herman 
et al., 2002; Ulrich-Lai and Herman, 2009). Their efferent targets are preganglionic neurons of 
the sympathetic and parasympathetic ANS, residing in the intermediolateral column (IML) of the 
thoracolumbar and craniosacral spinal cord, respectively. Processes of these preganglionic 
neurons extend to form synaptic contacts with second-order neurons in autonomic ganglia, 
from which efferent signals are propagated via postganglionic fibers to finally reach their target 
organs, e.g. in the cardiovascular and digestive system (Ulrich-Lai and Herman, 2009). The 
characteristic feature of the sympathetic ANS is an immediate and fast response to stressors, 
e.g. a drop in blood pressure, allowing regulation of heart rate and blood vessel tone within 
seconds. Such rapid responses, elaborated via the aforementioned synaptic connections, set it 
apart from the relatively sluggish HPA axis, whose more protracted responses take minutes to 
manifest due to the successive action of multiple hormones. Reflex activation of the 
parasympathetic ANS balances sympathetic activity, causing the responses to be short-lived 
(Ulrich-Lai and Herman, 2009).  
 The sympathoadrenal system was defined in early experiments by Walter Cannon and 
others, based on the fact that sympathetic innervation of the adrenal medulla, occurring via the 
splanchnic nerve, is required for the recovery of normal blood sugar levels after insulin-induced 
hypoglycemia (Cannon et al., 1924). According to the architecture of the ANS outlined above, 
the medulla of the adrenal gland can be regarded as a modified sympathetic ganglion. It should 
be noted, however, that activation of the adrenal medulla and other parts of the sympathetic 
ANS do not always occur in parallel or to the same extent. This has prompted leading 
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researchers in the field to propose using a different description, namely “adrenomedullary 
hormonal system” instead of “sympathoadrenal system”, as the latter term implies coordinated 
activity of epinephrine-releasing (adrenal medulla, endocrine response) and norepinephrine-
releasing (sympathetic nerves, neural response) components of the ANS (Goldstein and Kopin, 
2008). With this caveat in mind, we will use the term “sympathoadrenal” when referring to 
functional connections between the sympathetic splanchnic nerve and chromaffin cells of the 
adrenal medulla, the source from which epinephrine is released in response to a variety of 
stressors (Goldstein and Kopin, 2008). 
3.3.3. Interactions between HPA axis and ANS – special role of the adrenal 
glands 
A wealth of evidence accumulated over many decades supports differentiation of stressor-
responsive pathways into an HPA and ANS component, as outlined above. However, it is 
important to recognize that the whole story is more complex. First of all, most stressors activate 
HPA axis and ANS, and both systems share the PVN (central regulator) and adrenal glands 
(peripheral effectors) as crucial components of their functional anatomy. Between both 
systems, there are anatomical and functional interactions at multiple levels (Kvetnansky et al., 
1995). Many of these interactions occur at the level of the adrenal glands, whose activity is 
controlled chiefly via endocrine and neural mechanisms. Given the importance of the main 
adrenal secretory products (cortisol and epinephrine) for a wide variety of stress-related human 
diseases (Chrousos, 2009; Cohen et al., 2007), it is warranted to briefly address some details 
concerning functional anatomy of the glands, especially as it relates to stressor-induced 
activation and cross-talk between HPA axis and ANS. 
The adrenal glands consist of two main compartments, namely an outer cortex and 
inner medulla. In response to stressor exposure, activation of the HPA axis culminates in 
secretion of glucocorticoids from the cortex, and activation of the ANS leads to release of 
epinephrine from the medulla. Glucocorticoid-dependent control of the enzyme that catalyzes 
the final step in epinephrine synthesis constitutes a fundamental mechanism by which the HPA 
axis interacts with the ANS. Thus, classical experiments established that the activity of 
phenylethanolamine N-methyltransferase (PNMT) requires glucocorticoids (Wurtman, 1966), 
and more recent studies using transgenic mice showed adrenomedullary PNMT expression to 
be completely abolished in glucocorticoid receptor-deficient animals (Finotto et al., 1999). 
Although no bona fide portal system exists in the adrenal glands, which had been the subject of 
much controversy, the centripetal blood flow from the cortex to the medulla and the 
ultrastructural features of the adrenal vasculature provide the basis for glucocorticoid-
dependent control of adrenomedullary PNMT (Bassett and West, 1997; Breslow, 1992; 
Coupland and Selby, 1976; Kikuta and Murakami, 1984; Murakami et al., 1989; Sparrow and 
Coupland, 1987; Tokunaga, 1996; Vinson et al., 1985). Based on measurements in the adrenal 
vein and the general circulation, it can be estimated that cells of the adrenal medulla are 
exposed to glucocorticoid concentrations approximately 10-100 times above those encountered 
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by other cells (Mannelli et al., 1982; Padayatty et al., 2007; Stowasser et al., 2001; Sweat, 
1955; Wurtman, 1966). Conversely, autonomic nerves supplying the adrenal glands have been 
demonstrated to affect cortical glucocorticoid secretion (Engeland, 1998; Ulrich-Lai and 
Engeland, 2002), which appears to be at least partly mediated by neuropeptides such as 
PACAP, galanin and VIP (Ehrhart-Bornstein et al., 1998; Holgert et al., 1998; Whitworth et al., 
2003). Furthermore, it is now clear that the zonal distinction of cortex versus medulla is not as 
strict as originally thought, since islands of chromaffin cells can be found in the cortex, and 
markers of cortical cells are expressed in cells of the medulla. Thus, although the centripetal 
organization of blood flow through the adrenals does not allow for endocrine effects, paracrine 
mechanisms are recruited for intraadrenal signaling from medullary cells to the cortex 
(Bornstein et al., 1997; Bornstein et al., 1994; Ehrhart-Bornstein et al., 1998; Whitworth et al., 
2003). 
Taken together, the adrenal glands are not only important peripheral effectors of the 
HPA axis and ANS, but also a locus of interaction between these two stressor-responsive 
systems. Their activity during health and disease is therefore tightly controlled by complex 
mechanisms, involving hormonal and neural pathways. 
3.3.4. Stressor-specific responses of the HPA axis and ANS 
During at least the first half of the twentieth century, responses of the body to stressor exposure 
were thought to follow a stereotypic pattern. Walter Cannon and Hans Selye, two towering 
figures of early stress research, posited that there is a unitary response to a wide variety of 
stimuli, and they respectively emphasized secretory activity of the adrenal medulla and cortex 
as its hallmark (Cannon, 1927; Selye, 1936a). Although their groundbreaking work has lost 
none of its historic impact, we now know that both Cannon’s and Selye’s stories are 
incomplete, and their theories have been refined in recent decades. With respect to what has 
been called Selye’s “doctrine of nonspecificity”, experimental results obtained with different 
stressors and stressor intensities were incompatible with a nonspecific response (Pacak et al., 
1995), and a direct test of the doctrine failed to support it (Pacak et al., 1998). It has become 
quite clear that different stressors induce relatively specific patterns of sympathoadrenal, 
sympathoneural and HPA axis activity, reflected in stressor-specific elevations of circulating 
epinephrine, norepinephrine and ACTH, respectively (Goldstein and Kopin, 2008; Pacak and 
Palkovits, 2001). These patterns are the consequence of stressor-specific activation of 
neuroendocrine circuitry (Pacak and Palkovits, 2001), which corresponds to the generalized 
pathways of processive and systemic stress responses mentioned above (Herman and 
Cullinan, 1997; Herman et al., 2003).    
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3.4. Dysfunction of stressor-responsive systems – chronic stress and 
disease 
The molecules secreted by the HPA axis and ANS affect virtually all bodily functions. Basal 
activity and responsiveness of these systems must therefore be tightly controlled to ensure 
proper conditions at rest and following stressor exposure. According to Chrousos and others, 
homeostatic reactions follow an inverted U-shape dose-response pattern (dose = activity of the 
system; response = homeostatic effect), with “optimal” homeostasis occurring in the middle of 
the curve (Chrousos and Gold, 1992). Such optimal homeostasis is in contrast to insufficient or 
excessive homeostatic reactions (left and right part of the curve), both of which can have 
harmful consequences for the organism (Chrousos, 2009). Chronic disturbances of the HPA 
axis and ANS are now well known to correlate with a myriad of disease states, affecting 
(among others) the immune, gastrointestinal and cardiovascular systems, as well as 
neurological function and mental health (Chrousos, 2009; Cohen et al., 2007; de Kloet et al., 
2005; Herman and Seroogy, 2006). According to one theory, homeostatic responses that were 
originally beneficial have “at this time in evolutionary history […] become maladaptive”, causing 
increased prevalence of complex disorders, especially in Western societies (Chrousos, 2004). 
With respect to the central nervous system, chronic stress and elevated HPA axis activity have 
been implicated as risk factors for the development and progression of anxiety and depression, 
as well as Alzheimer’s and Parkinson’s diseases (Chrousos, 2009; de Kloet et al., 2005; 
Herman and Seroogy, 2006). Thus, the etiology and management of stress have become the 
focus of much preclinical and clinical research. 
3.5. Animal models of stress 
To elucidate the biological underpinnings of stress, it is necessary to study the molecular, 
cellular, physiological, psychological and social mechanisms affecting an organism’s function in 
health and disease. Immense progress has been made in this area thanks to the use of animal 
models. For example, the neuroendocrine pathways mediating the response to low blood 
glucose concentrations (systemic stressor) have been unraveled, such that the brain regions, 
efferent neural routes and peripheral targets are now known. With respect to the contribution of 
the sympathoadrenal system, this was achieved largely by means of physiological experiments, 
using insulin-induced hypoglycemia in mammals as an experimental stressor (Cannon et al., 
1924; Cantu et al., 1968; Cantu et al., 1963; de Vries et al., 2005). In recent decades, 
transgenic mouse models have expanded the scope and refined the methods of stress 
research in vivo, allowing dissection of molecular pathways by targeting specific genes. For 
example, mouse strains under- or overexpressing the glucocorticoid receptor, or harboring 
conditional and region-specific deletions, have greatly contributed to the understanding of 
glucocorticoid signaling pathways in the brain, and how they contribute to the impact of HPA 
axis activity on mental health (Chourbaji et al., 2008; Kolber and Muglia, 2009).  
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Several important aspects of stress-induced effects on brain function are most likely 
unique to the human condition, and thus nearly impossible to reproduce in other species. For 
example, situations of social-evaluative threat, where task performance is under the scrutiny of 
observers, represent powerful stressors in humans (Kudielka and Wust, 2010). Social 
evaluation (processive stressor) increases salivary cortisol concentrations, while task 
performance without evaluation does not, and has been shown to induce feelings of shame or 
lower social self-esteem (Gruenewald et al., 2004). These latter phenomena of human 
experience are beyond the scope of laboratory animal models. Nevertheless, responses of the 
HPA axis and ANS to stressor exposure can be triggered in relatively specific ways, allowing us 
to ask specific questions about the underlying biological mechanisms. 
3.5.1. Insulin-induced hypoglycemia – a systemic stressor 
Injection of insulin causes a rapid drop in blood glucose concentrations. Since glucose is the 
main energy source for the body, and indispensable particularly for the brain, insulin-induced 
hypoglycemia poses an immediate threat to well-being and survival. As such, it elicits a so-
called counterregulatory response that does not require higher brain centers, based on which 
hypoglycemia is classified as a “systemic” stressor (see above). The sympathoadrenal 
component of this counterregulatory response was first described by Cannon and others, who 
showed that epinephrine secretion from the adrenal medulla, mediated via sympathetic outflow 
through the splanchnic nerves, was strongly increased after induction of hypoglycemia (Cannon 
et al., 1924). The source of the splanchnic nerve fibers that stimulate adrenomedullary 
secretion was later determined to be the upper thoracic spinal cord (Cantu et al., 1963). Further 
upstream, the counterregulatory response originates in the central nervous system, specifically 
the ventromedial hypothalamus, where neuronal sensors detect low blood glucose 
concentrations and trigger sympathoadrenal activation (Borg et al., 1995; de Vries et al., 2005). 
In addition to the aforementioned, a number of other neuroendocrine structures are 
activated during hypoglycemia, and the HPA axis is stimulated (Pacak and Palkovits, 2001). In 
a recent study, Goldstein and Kopin performed a meta-analysis of experiments in which activity 
of the HPA axis, sympathoadrenal and sympathoneural systems had been measured 
concurrently, using plasma concentrations of ACTH, epinephrine and norepinephrine as 
indices, respectively. They showed that hypoglycemia induces very pronounced activation of 
the HPA axis, and massive activation of the sympathoadrenal system, while sympathoneural 
activity was only mildly affected (Goldstein and Kopin, 2008). These results are in line with the 
crucial importance of adrenocortical glucocorticoids and adrenomedullary epinephrine for the 
restoration of normal blood sugar concentrations.   
In summary, for the purpose of the experiments described in the present work, insulin-
induced hypoglycemia provides a convenient model to study regulation of ANS and HPA axis 
activity in response to acute stressor exposure. 
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3.5.2. Restraint – a processive stressor 
The inability to move freely or at will can be an extremely threatening experience, for example 
because it increases the likelihood of being preyed on by a predator. Although health and well-
being might not be acutely at risk, physical restraint is therefore a powerful psychological 
stressor. In biomedical research, this was recognized many decades ago and subsequently 
exploited as an experimental approach to the effects of psychological stress on health. For 
example, more than ten years before Walter Cannon formulated his theories concerning the 
sympathoadrenal “fight or flight” reaction, Hirsch and Reinbach found that rabbits responded 
with an increase in blood glucose when tied to a laboratory bench. They termed this 
phenomenon “Fesselungshyperglykämie” (hyperglycemia due to restraint), which we now know 
is caused by sympathoadrenal activation, and pointed out that it was a significant potential 
confounding factor in laboratory studies on sugar metabolism (Hirsch and Reinbach, 1913). 
Hans Selye subsequently introduced restraint as an actual experimental stressor in his studies 
on injury- and toxin-induced physiological reactions. He found that “the mere excitement of an 
animal the free motion of which is interfered with (by tying the legs together or wrapping the 
animal tightly in a towel)” had significant consequences, such as enlargement of the adrenal 
glands (Selye, 1936b). Since then, a number of restraint procedures have been developed and 
adjusted to the specific needs of a wide range of research settings (Buynitsky and Mostofsky, 
2009; Glavin et al., 1994; Pare and Glavin, 1986). Early applications focused on the production 
of gastrointestinal ulcers caused by severe restraint, to screen for pharmacological compounds 
with protective effects (Pare and Glavin, 1986). From there, the focus shifted towards the 
involvement of the central nervous system in peripheral diseases (Glavin et al., 1994), with 
current applications of restraint including a large number of studies on stress-induced 
behavioral changes (Buynitsky and Mostofsky, 2009). Most frequently, rats and mice are used 
as experimental animals. 
It is important to note that the terms “restraint” and “immobilization” are sometimes 
used interchangeably. Both can represent a number of methods, such as wrapping of the 
animal in cloth, wire mesh or plastic, or restricting the size of the home cage (most commonly 
termed restraint). Alternatively, the animal is tied to a laboratory bench, in a prone or supine 
position, with all four limbs extended (most commonly termed immobilization). In the latter case, 
the animals often struggle quite significantly, trying to wrestle their limbs free, while in the 
former case movement is mostly prevented. For these reasons, stress resulting from pain, 
rather than the inability to move per se, has to be considered as a factor influencing 
experimental outcome. It is therefore important to pay close attention to the exact procedure 
used in a particular study. 
Variables used in restraint experiments include duration, repetition (single or repeated 
exposure) and combination with other stressors, such as restraint plus foot shock or water 
immersion (Pare and Glavin, 1986). In contrast to foot shock (lower or higher current) and 
water immersion (lower or higher temperature), as well as pharmacological agents (lower or 
higher doses), it has been argued that restraint / immobilization intensity can not be varied 
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quantitatively within a given procedure (Pacak et al., 1998). However, as outlined above, it is 
quite clear that some procedures entail more or less severe physical impact on the animal. 
Restraint is therefore most appropriately viewed as a mixed psychological / physical stressor. 
The responses triggered by repeated stressor exposure have been the subject of a 
large number of experiments, aimed at elucidating the mechanisms that underlie chronic stress 
in humans. Intriguingly, a single exposure to a severe stressor was found to cause a change in 
reactivity of the HPA axis, such that subsequent exposures to the same (homotypic) stressor 
elicit a reduced response, a phenomenon that is called desensitization or habituation (Armario 
et al., 2004; Girotti et al., 2006). In contrast, exposure to a different (heterotypic) stressor yields 
a more pronounced response, indicating sensitization of the HPA axis. Importantly, habituation 
appears to be specific to the nature of the stressor, occurring after restraint but not 
hypoglycemia (Armario et al., 2004), supporting the notion that processive and systemic 
stressor-responsive pathways (see above) function via partially distinct mechanisms. With 
respect to expression of catecholamine-synthesizing enzymes in the sympathoadrenal system, 
the effects of repeated stressor exposure depend on the tissue (e.g. adrenal medulla versus 
locus coeruleus), the gene (TH, DBH or PNMT) and the stressor (e.g. cold versus 
immobilization). Some effects require repeated exposures while others are maximal after only 
one, some effects habituate while others do not (McMahon et al., 1992; Sabban and Serova, 
2007).  
A single acute exposure to predominantly psychological stressors (such as restraint) 
can have pronounced long-term neuroendocrine, neurochemical, neuroelectrical, 
neuroanatomical and behavioral consequences, some of which take days or weeks to fully 
manifest. Based on this observation, animal models for human posttraumatic stress disorder 
(PTSD) have been developed, aimed at understanding how a single traumatic event can cause 
strong and long-lasting anxiety, fear and emotional disturbance (Armario et al., 2008; Armario 
et al., 2004; Miller and McEwen, 2006; Siegmund and Wotjak, 2006).  
A recent meta-analysis showed that restraint causes very strong activation of the ANS 
and massive activation of the HPA axis (Goldstein and Kopin, 2008). Therefore, taken together 
with the above considerations, restraint is a useful and convenient model to study both acute 
and chronic effects of stress on the function of the peripheral and central nervous system. In 
the present work, experiments were focused on acute aspects of restraint-induced responses. 
3.6. Pituitary adenylate cyclase-activating polypeptide (PACAP) 
Pituitary adenylate cyclase-activating polypeptide (PACAP) was discovered more than 20 years 
ago, during a search for hypothalamic factors that stimulate hormone release from the pituitary 
gland (Miyata et al., 1989). Via functional screening of ovine hypothalamic extracts, Miyata and 
others purified a polypeptide of 38 amino acids that strongly stimulated accumulation of cyclic 
adenosine monophosphate (cAMP) in rat pituitary cells, which they termed PACAP38 (Miyata 
et al., 1989). Subsequently, an additional hypothalamic fraction corresponding to the N-terminal 
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27 amino acids of PACAP38 was isolated, which is now known as PACAP27, the second 
biologically active form of the peptide (Miyata et al., 1990). Furthermore, it was found that 
prepro-PACAP, the precursor from which PACAP38 and PACAP27 are derived, contains an 
additional peptide, termed PACAP-related peptide or PRP (Vaudry et al., 2000). The gene 
encoding PACAP (ADCYAP1 in human, Adcyap1 in mouse) has been cloned, localizing to 
human chromosome 18 and mouse chromosome 17 (Cummings et al., 2002; Hosoya et al., 
1992; Miyata et al., 2000; Yamamoto et al., 1998). Several alternative transcripts exist, which 
have been proposed to be important for specific expression of PACAP in different tissues and 
during development (Cummings et al., 2002), but detailed evidence regarding these 
suggestions is still scarce. Based on sequence homology, PACAP is now recognized as a 
member of the PACAP-VIP-glucagon-GHRH-secretin superfamily of peptides, displaying a 
remarkably high degree of conservation across species, suggesting that it is evolutionarily 
ancient and functionally important (Vaudry et al., 2009; Vaudry et al., 2000).  
In vivo, PACAP38 is far more abundant than PACAP27 (Arimura et al., 1991), and 
throughout the present work, the term PACAP will be used to indicate functions carried out by 
both peptides (unless otherwise indicated). PACAP binds to three G protein-coupled receptors 
(GPCR), namely VPAC1, VPAC2 and PAC1 (Vaudry et al., 2009), of which VPAC1 and VPAC2 
are shared with vasoactive intestinal peptide (VIP) (Laburthe et al., 2002). Just a few years 
after the discovery of PACAP, it was found that PAC1, the PACAP-specific of the three 
receptors, is expressed as a variety of alternatively spliced forms, which allow fine-tuning of 
responses to ligand binding (Spengler et al., 1993). For example, in the third intracellular loop 
of the PAC1 receptor, absence (null) or presence of short cassettes (hip, hop) determines 
coupling of the receptor to downstream intracellular signaling proteins, and it has been shown 
that the PAC1hop variant mediates secretion of catecholamines from adrenomedullary cells 
(Mustafa et al., 2007). Overall, the diversity of coupling and signaling mechanisms available to 
PACAP via its three receptors, which activate effectors such as adenylate cyclase (AC), 
phospholipase C (PLC) and phospholipase D (PLD) (McCulloch et al., 2000), appears to 
underlie the pleiotropic role played by this neuropeptide in a variety of tissues and organ 
systems (Vaudry et al., 2009). With respect to the nervous system, PACAP is known to affect 
development, functional maturation, protection from insult, and regeneration (Somogyvari-Vigh 
and Reglodi, 2004; Waschek, 2002). Among a plethora of other functions, PACAP has 
therefore emerged as an attractive candidate for neuroprotective intervention in conditions such 
as Alzheimer’s disease and stroke (Chen et al., 2006; Dogrukol-Ak et al., 2009). 
3.6.1. Expression of PACAP in stressor-responsive neuroendocrine circuits 
Neuroanatomical studies have shown that PACAP is expressed throughout the rodent nervous 
system, being particularly abundant in the hypothalamus (Hannibal, 2002). In the hypothalamic 
PVN, PACAP has central access to the ANS and HPA axis via preautonomic and 
hypophysiotropic neurons, respectively, indicated by tracing of synaptic connections (Das et al., 
2007; Yi et al., 2010) and the demonstration of PACAPergic nerve terminals innervating CRH-
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containing neurons (Legradi et al., 1998). Furthermore, PACAP is expressed in neurons of the 
hypothalamus and brain stem that project to the intermediolateral column (IML) of the spinal 
cord (Das et al., 2007; Farnham et al., 2008). PACAP is also expressed in the IML itself 
(Hamelink et al., 2002) and in nerve terminals supplying the adrenal glands (Frodin et al., 1995; 
Hamelink et al., 2002; Holgert et al., 1996; Moller and Sundler, 1996). Thus, potential loci of 
PACAPergic effects are found throughout neuroendocrine circuitry of the stress axis, both in 
ascending (afferent) and descending (efferent) pathways. Note that the above examples are of 
PACAPergic structures whose involvement in activation of the ANS and HPA axis has been 
quite clearly demonstrated (see below). Additional potential sites have been omitted from the 
present report in the interest of clarity. 
3.6.2. Expression of PACAP in adrenal glands – some controversial findings 
A number of studies have addressed whether PACAP is expressed in the adrenal glands. Early 
experiments using radioimmunoassay detected PACAP-like material, without asserting whether 
the source would be afferent nerve endings or parenchymal cells (Arimura et al., 1991; Ghatei 
et al., 1993). Subsequently, several groups published immunohistochemical evidence for 
PACAP peptide being contained in adrenal nerve terminals, but not in adrenomedullary 
chromaffin or ganglion cells (Frodin et al., 1995; Hamelink et al., 2002; Holgert et al., 1996; 
Moller and Sundler, 1996), a finding that is contrasted by two papers that report the opposite 
pattern (Shiotani et al., 1995; Tabarin et al., 1994). The transcript encoding PACAP has been 
detected by RT-PCR and Northern blot in independent experiments (Ghatei et al., 1993; 
Mazzocchi et al., 2002; Miyata et al., 2000), with one of the studies indicating that expression is 
restricted to the adrenal medulla (Mazzocchi et al., 2002). Given that PACAP expression in the 
adrenal medulla could provide a paracrine mechanism for modulation of adrenal secretory 
function (Conconi et al., 2006), final proof regarding its presence or absence from parenchymal 
cells is desirable. 
3.6.3. Functional role of PACAP during acute stress responses 
Intracerebroventricular or intrathecal injections of PACAP into the central nervous system 
(CNS) elicit increased sympathetic and decreased parasympathetic nerve activity (Farnham et 
al., 2008; Tanida et al., 2010; Yi et al., 2010), as well as increased corticosterone secretion 
(Agarwal et al., 2005; Yi et al., 2010), clearly indicating the functional relevance of the 
neuroanatomical arrangements mentioned above. Furthermore, behavioral manifestations of 
stress are acutely elicited in rodents when PACAP is injected into the CNS (Agarwal et al., 
2005; Legradi et al., 2007; Norrholm et al., 2005). Our group has provided compelling evidence 
for the involvement of the endogenous PACAPergic system in responses of the ANS and HPA 
axis to stressor exposure, using mice in which the gene encoding PACAP is disrupted. First, we 
showed that PACAP-deficient mice display an insufficient counterregulatory response to 
insulin-induced hypoglycemia, with diminished catecholamine biosynthesis and secretion from 
the adrenal medulla. These results suggested that PACAP release from the sympathoadrenal 
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synapse is required for survival during metabolic stress (Hamelink et al., 2002). Second, we 
recently found that sustained corticosterone secretion from the adrenal cortex, elicited by 
restraint, is impaired in PACAP-deficient mice, which appears to be due to insufficient 
biosynthesis of CRH in the hypothalamus (Stroth and Eiden, 2010). Thus, after exposure to 
acute systemic and processive stressors, an intact PACAPergic system is required for fully 
functional responses of the ANS and HPA axis. 
3.6.4. Effects of PACAP on global gene expression patterns 
As mentioned above, PACAP displays remarkable biological pleiotropy, suggesting that 
PACAP-induced signaling can exert a variety of effects on a given cell type, depending on its 
developmental and functional status. Towards this end, several studies have investigated the 
transcriptome of different cells and tissues in response to PACAP. Studies from our group 
defined two basic categories of genes (including only those whose expression increases) that 
would emerge from experiments in cell culture and in vivo, respectively. First, PACAP-
responsive genes are those whose transcript abundance increases after exposure of cells to 
PACAP. Second, PACAP-dependent genes are those whose transcript abundance increases 
after experimental treatment or insult in wild-type, but not in PACAP-deficient mice (Eiden et al., 
2008; Samal et al., 2007). Using suppression subtractive hybridization and microarray analysis, 
several studies provided evidence that PACAP controls genomic programs underlying cellular 
survival, growth arrest, differentiation and neurite outgrowth, using the PC12 
pheochromocytoma cell line and sympathetic neurons as a model (Braas et al., 2007; Eiden et 
al., 2008; Grumolato et al., 2003; Ishido and Masuo, 2004; Ravni et al., 2006; Vaudry et al., 
2002). Furthermore, transcriptomic responses of the cerebral cortex to ischemia (Chen et al., 
2006), as well as the basal transcriptome of the adrenal glands (Samal et al., 2007), have been 
determined by our laboratory in wild-type versus PACAP-deficient mice. However, no data are 
available to date regarding PACAP-dependent effects of stressor exposure on gene expression 













4. Specific aims of the present work 
As outlined above, PACAP has recently been identified as a mediator of stress responses in 
vivo. Although its function in the counterregulatory response of the ANS to insulin-induced 
hypoglycemia is established at the physiological level (Hamelink et al., 2002), there are still 
open questions regarding PACAP-dependent mechanisms of cellular plasticity in the adrenal 
glands, specifically with respect to gene expression programs recruited during stress. Also, the 
mouse strain developed in our laboratory has been fully backcrossed since the first 
experiments were conducted, making a careful reassessment of its phenotype necessary. Most 
importantly, although initial data suggested otherwise, there is a wealth of evidence clearly 
indicating that HPA axis activity will be blunted during stress in PACAP-deficient mice, pointing 
towards PACAP as a central regulator of the hypothalamus. In this context, the main questions 
underlying the present work were as follows: 
 
1. Are PACAP-deficient mice normal in the absence of stress, i.e. do their serum hormone 
concentrations and gene expression profiles resemble those of wild-type mice?  
2. What are the hormone secretion patterns and gene expression profiles elicited by 
stressor exposure in neuroendocrine circuits, most importantly the hypothalamus, 
pituitary and adrenal glands (HPA axis), in PACAP-deficient compared to wild-type 
mice? 
3. Overall, are PACAP-deficient mice a useful model for the study of acute and chronic 
stress responses in vivo? 
 
To address these questions, gene expression profiles were measured on the transcriptome 
scale, to discover candidate genes implicated in PACAP-dependent stress responses. Time 
courses of gene expression changes, as well as their precise cellular localization, were 
determined in subsequent experiments. Measurements of circulating hormones were carried 
out to determine the extent of endocrine responses in wild-type compared to PACAP-deficient 








5. Materials and Methods 
5.1. Experiments in vivo 
5.1.1. Mouse strains 
The PACAP-deficient mouse strain used in the present work was first described by Hamelink 
and others (Hamelink et al., 2002). Mice carrying the null allele of the gene encoding PACAP 
(Adcyap1) were mated with wild-type C57BL/6 mice (National Cancer Institute’s Animal 
Production Program) over twelve generations, such that a complete backcross was achieved. 
This provides a homogenous genetic background for all experiments, minimizing potential 
phenotypic contributions of the strain in which the initial gene targeting was performed 
(129SvJ). It also allows commercially available C57BL/6 mice to be used as paired controls for 
PACAP-/- animals generated in-house. For our experiments, mice were generated either via 
heterozygous breeding pairs, in which case littermate controls were used, or by mating 
homozygous males and females. In some cases, C57BL/6 mice (see above) were ordered as 
controls. For a description of the genotyping method, see the corresponding section below. 
All mice were housed in a temperature- (24˚C on average) and humidity-controlled 
breeding facility, with 12h/12h light/dark cycle. Regular rodent chow (Rodent NIH-31, Zeigler 
Bros) and tap water were provided ad libitum. Upon weaning (typically at three weeks of age), 
mice from a given litter were separated into males and females, and they received serially 
numbered ear tags to allow unambiguous identification. Corresponding to each unique ear tag 
number, a small tail biopsy for genomic DNA extraction and genotyping (see below) was 
obtained. Pups from heterozygous breeding pairs were routinely genotyped, and pups from 
homozygous breeders were intermittently tested to verify correct genotype assignment. Tail 
biopsies or genomic DNA preparations were archived to allow future verification if necessary. 
Note that several synonyms for the two PACAP genotypes are used interchangeably 
throughout the present work. These synonyms are WT and PACAP+/+ for wild-type mice, 
versus knock-out, KO and PACAP-/- for PACAP-deficient mice. 
5.1.2. Experiments involving exposure to stressors 
In the animal facility, mice were separated by sex and housed 2-5 per cage. About 18 hours 
before an experiment, mice were transported to the laboratory and placed into individual home 
cages. In addition to the time frame (between 09:00 AM and 12:00 noon) during which 
experiments were conducted, parameters that could affect reactivity to stressors were carefully 
controlled, i.e. noise levels and traffic in the laboratory were kept to a minimum. Thus, although 
the mice were not individually accustomed to handling prior to the experiments (other than the 
handling associated with regular activities of caretakers in the animal facility), a stable baseline 
condition was established to minimize variability in the results, especially with regards to 
measurement of stress hormone secretion.  
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All procedures were approved by the National Institute of Mental Health Animal Care 
and Use Committee (NIMH ACUC). We made every effort to minimize the number of mice used 
in each experiment. 
5.1.2.1. Transient versus prolonged stressor exposure 
Hypoglycemia and restraint (see below) were applied either in a transient or prolonged fashion, 
for two main reasons. The first was to assess whether a brief stimulus is sufficient for hormone 
release and gene induction, or whether it has to be present for an extended period of time in 
order to elicit the full response. The second was to assess whether responses are transient, i.e. 
whether hormone concentrations and mRNA abundance return to baseline after an initial rapid 
change. In other words, the two variations address the onset and recovery of responses to 
stressor exposure. The following schematic depicts the setup: 
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In this example, “group 1h + 5h” represents transient stressor exposure, whereas “group 6h” 
represents prolonged exposure. The control group consists of untreated animals (sacrificed 
without prior treatment). 
5.1.2.2. Insulin-induced hypoglycemia (systemic stress) 
For all experiments involving hypoglycemia, mice were fasted overnight (approximately 18 
hours) by removing all chow from the cages, while water remained available ad libitum. Human 
recombinant insulin (Humulin R, Eli Lilly & Co) was diluted in sterile saline solution (0.9% NaCl) 
to a working concentration of 0.5 U/ml. For each mouse, intraperitoneal (i.p.) injection of 4 µl 
per gram body weight thus equaled a dose of 2 U/kg body weight. This setup was chosen to 
avoid injection of excessive volumes. Mice were returned to their home cage after injection. 
In the first set of experiments, mice were killed after different intervals following 
injection of insulin. These experiments thus represent “prolonged stressor exposure”, and the 
corresponding groups of mice are labeled 1h, 2h, 4h etc. In subsequent experiments, mice 
were injected with glucose (2 g/kg, i.p.) 1h after injection of insulin in order to terminate the 
hypoglycemic stimulus. These experiments thus represent 1h of systemic stress followed by 
several hours of recovery (“transient stressor exposure”), and the corresponding groups are 
labeled 1h + 2h, 1h + 5h, 1h + 11h etc. Control mice were either injected with saline or 
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untreated (see description of results and figure legends for details). All experiments were 
started between 09:00 AM and 12:00 noon. 
5.1.2.3. Cholinergic ganglionic blockade 
To determine the effect of cholinergic neurotransmission on adrenal gene expression during 
stress, antagonists for nicotinic (chlorisondamine) and muscarinic (atropine) acetylcholine 
receptors were employed. Chlorisondamine and atropine (Sigma-Aldrich) were diluted in sterile 
saline solution (0.9% NaCl) to concentrations of 2 mg/ml and 0.4 mg/ml, respectively. For each 
mouse, 2.5 µl of the resulting solution per gram body weight (injected i.p.) thus equaled co-
administered doses of 5 mg/kg chlorisondamine and 1 mg/kg atropine.  
Experiments with ganglionic blockade involved two injections per mouse, namely pre-
treatment (injection 1) with either the two antagonists or saline, followed by treatment (injection 
2) with either insulin or saline. Thus, these experiments included four groups: saline + saline 
(“control”), saline + insulin (“hypoglycemia”), antagonists + saline (“antagonist control”) and 
antagonists + insulin (“ganglionic blockade”). Note that injections 1 and 2 were administered i.p. 
into the left and right lower abdominal region, respectively. 
5.1.2.4. Restraint (processive stress) 
Mice were restrained in tapered plastic film envelopes (DecapiCones, Braintree Scientific), 
such that they were held immobile, with all four limbs underneath them, unable to turn around 
or perform significant movement. DecapiCones feature a hole in the front where the animal’s 
head is located, and to assure unobstructed breathing, this hole was widened. After being 
restrained, mice were placed into their home cage. The total time needed for pickup, restraint 
and return to the home cage was less than one minute. Similar to the systemic stress 
paradigm, stressor exposure was either prolonged or transient, such that mice were restrained 
and killed at different time points thereafter, or restrained for 1h, released into their home cage, 
and killed 5h after release. The corresponding groups were labeled 1h, 3h and 6h (prolonged 
stressor exposure) or 1h + 5h (transient stressor exposure). Untreated mice (non-stressed 
controls) were picked up from their home cage by the tail, placed in DecapiCones and 
decapitated immediately (time from pickup to decapitation <20 seconds). Mice from the 
prolonged restraint groups were decapitated while still restrained. Restraint-released mice 
(group 1h + 5h) were picked up and decapitated the same way as untreated animals. 
5.1.3. Dissection of tissue samples 
Tissue samples were collected either for RNA extraction or preparation of frozen sections. All 
samples were stored at -80˚C until use. 
5.1.3.1. Tissue samples for RNA extraction 
Immediately after mice were killed, a cut through the skin of the abdomen was made along the 
midline, and the abdominal cavity was revealed. Adrenal glands were dissected, excess 
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adipose tissue was carefully removed, and both glands per mouse were pooled into a regular 
1.5 ml polypropylene tube on dry ice (solid carbon dioxide).  
For dissection of frontal cerebral cortex, hippocampus and hypothalamus, the whole 
brain was removed from the skull and placed in an ice-chilled rodent brain matrix (RBM-2000C, 
ASI Instruments). Four razorblades were then used to make four coronal cuts, with the 
following coordinates based on an atlas of the mouse brain (Paxinos and Franklin, 2001):  
 
Cut 1: through the optic chiasm, approx. at Bregma 0.02.  
Cut 2: 3 mm caudal of cut 1, through the mammillary bodies, approx. Bregma -3.08; 
from the slice obtained between cuts 1 and 2, the hypothalamus (Hy) was excised as a 
block of 2x2 mm (width x height) by cutting dorsal of the third ventricle and 1 mm each 
left and right of the ventral midline. From the same tissue slice, samples of 
hippocampus (Hc; both hemispheres separate) were obtained. Hc was carefully 
dissected starting from the caudal aspect of the tissue slice, since the most rostral part 
(about 1 mm of the slice) contains no hippocampal tissue. It must also be noted that Hc 
does not include the entire hippocampus, as tissue more caudal to cut 2 was 
discarded. Thus, Hc represents mostly the dorsal hippocampus, while some ventral 
parts were excluded. 
Cut 3: 1 mm rostral of cut 1, approx. Bregma 0.98.  
Cut 4: 1 mm rostral of cut 3, approx. Bregma 1.98; from the slices obtained between 
cuts 1+3 and 3+4, frontal cortex (FrCx; both hemispheres separate) was dissected by 
removing and discarding the most ventrolateral aspects of the slices, while retaining 
cerebrocortical tissue. The aforementioned Bregma coordinates from the mouse brain 
atlas (Paxinos and Franklin, 2001) and other landmarks were used for orientation. 
 
Pituitary glands (Pit) were carefully collected from the cranial cavity after removal of the brain 
and frozen in polypropylene tubes on dry ice. 
 
5.1.3.2. Tissue samples for frozen sections 
To prepare samples for frozen sections, individual adrenal glands were embedded in O.C.T. 
compound (Tissue-Tek, Sakura Finetek) in disposable vinyl specimen molds (Cryomold 
Intermediate, Sakura Finetek) and quickly dropped into liquid nitrogen. Whole brain samples 
were dropped into isopentane (2-methylbutane), which had been placed in a container on dry 
ice and cooled to about -50˚C, for rapid freezing without cracking of the tissue. All samples 
were stored at -80˚C until use. 
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5.1.4. Measurement of circulating stress hormones 
Secretion of ACTH and corticosterone is a classical readout for activation of stress responses 
in mammals. In our experiments, both hormones were measured in serum, using 
immunoassays either based on radioactive or chromogenic detection methods. 
5.1.4.1. Collection of serum from trunk blood 
Immediately after mice were decapitated, their trunk blood was collected into 1.5 ml 
polypropylene tubes and allowed to coagulate at room temperature for approximately one hour. 
Samples were subsequently centrifuged (10 minutes at 10,000 x g), the resulting blood clot was 
removed, and the serum was transferred to fresh tubes. Residual debris was removed via a 
second centrifugation step (5 minutes at 10,000 x g), after which serum samples were 
immediately frozen and stored at -80˚C until assayed. 
5.1.4.2. ACTH ELISA and corticosterone EIA or RIA 
Circulating levels of ACTH were measured using an enzyme-linked immunosorbent assay 
(ELISA, MD Bioproducts). Corticosterone was measured using either an enzyme-based test 
(EIA, Assay Designs) or radioimmunoassay (RIA, Coat-A-Count, Siemens Medical Solutions 
Diagnostics). In each case, samples from individual mice were measured in duplicate. All three 
kits are commercially available and were used according to the manufacturer’s instructions. 
Serum samples were diluted 1:2 in calibrator A (for ACTH ELISA), 1:10 in assay buffer 
(corticosterone EIA) or used undiluted (corticosterone RIA). 
 
5.2. Molecular biological techniques 
5.2.1. RNA extraction  
Before reverse transcription and quantitative PCR can be carried out to quantify gene 
expression (i.e. mRNA abundance), it is necessary to isolate RNA from the tissues of interest. 
In our experiments, total RNA was extracted from mouse adrenal glands, hypothalamus, 
pituitary, frontal cortex and hippocampus using a commercially available kit (RNeasy Mini, 
Qiagen). For this purpose, frozen tissue samples were transferred to polypropylene tubes 
containing 600 µl of lysis buffer RLT (RNeasy Mini) and immediately homogenized using an 
ultrasonic processor (GE 130PB, Hielscher). All subsequent steps were carried out according 
to the manufacturer’s instructions. After removal of tissue debris via centrifugation, 
homogenates were applied to spin columns, in which RNA is bound to a silica-based 
membrane. RNA was washed using buffers from the kit and several centrifugation steps, and 
eluted in RNase-free water. 
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5.2.2. Determination of nucleic acid concentration 
To determine the concentration of total RNA after extraction and purification, a fraction of each 
sample (2 µl) was measured on a NanoVue spectrophotometer (GE Healthcare). For each 
batch of samples, RNA yields (calculated as concentration x elution volume) were recorded and 
compared to previous batches as a means of “quality control” of the extraction procedure. For 
all tissues studied, it was found that yields were very consistent. 
 Preparations of DNA (e.g. after isolation of plasmids from transformed cells) or cDNA 
(e.g. after gel extraction of PCR-derived fragments) were also measured using the NanoVue 
spectrophotometer. It is worth noting that spectrophotometry does not differentiate between 
nucleic acids, i.e. measures RNA and DNA using the same wavelengths, such that each 
preparation has to be as pure as possible in order to give reliable and meaningful results. 
5.2.3. DNase treatment of extracted RNA 
After extraction, RNA from all mouse tissues was treated with RNase-free DNase I (Roche 
Diagnostics) in order to remove genomic DNA. The protocol was standardized, such that 
downstream applications (reverse transcription, PCR etc.) could be conducted in a uniform 
fashion. All steps were carried out on ice unless otherwise indicated. Per sample, 2.5 µg of total 
RNA were added to a 0.5 ml polypropylene tube and mixed with 5 µl 10x Incubation Buffer 
(Roche). After addition of 10 units DNase I (Roche), DEPC-treated water was added to a final 
volume of 50 µl and tubes were incubated at 37˚C for 30 minutes. Finally, 2 µl of 0.2 M EDTA 
were added and tubes were heated to 75˚C for 10 minutes. Samples were subsequently stored 
at -80˚C or used directly for reverse transcription (see below).  
 For smaller tissue samples, i.e. tissues where RNA yield was significantly lower, the 
above protocol was slightly adjusted. Thus, 1 µg total RNA was mixed with 2 µl 10x Incubation 
Buffer and 5 units DNase I, and DEPC-treated water was added to a final volume of 20 µl. In 
the case of the original (see above) and the adjusted protocol, 10 µl of the final reaction volume 
were used in reverse transcription (see below).  
5.2.4. Reverse transcription (cDNA synthesis) 
To synthesize cDNA, reverse transcription was carried out using DNase-treated total RNA. For 
this purpose, 10 µl aliquots of each DNase-treated sample were added to 0.5 ml polypropylene 
tubes. Given a starting amount of 2.5 µg RNA (original protocol) or 1 µg RNA (adjusted 
protocol) during DNase treatment (see above), 10 µl represent about 0.5 µg RNA per reverse 
transcription reaction. All enzymes, buffers and other reagents used in reverse transcription 
were from a commercial kit (SuperScript First-Strand Synthesis System, Invitrogen). All steps 
were carried out on ice unless otherwise indicated. 
 To the DNase-treated RNA aliquots (10 µl each), 1 µl random hexamers and 1 µl 10 
mM dNTP mix were added. Samples were incubated at 65˚C for 5 minutes and then on ice for 
2 minutes. The remaining components were premixed (per sample: 2 µl 10x RT buffer, 4 µl 25 
mM MgCl2, 2 µl 0.1 M DTT, 0.5 µl RNase OUT, 1 µl SuperScript Reverse Transcriptase [50 
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U/µl] and 0.5 µl RNase-free water) and 10 µl mix were added per sample. Subsequently, 
samples were incubated at 25˚C for 10 minutes, 42˚C for 50 minutes, 70˚C for 15 minutes and 
then quickly chilled on ice. The final reaction volume (22 µl per sample) was diluted 1:2 by 
addition of 22 µl RNase-free water, and cDNA was stored at -20˚C until use. 
 As a negative control, aliquots of RNA were processed as above, but in the absence of 
the reverse transcriptase enzyme. These so-called -RT (or “minus RT”) controls allow 
identification of contamination from genomic DNA or exogenous sources, preventing false-
positive results. Thus, whenever -RT reactions yielded a band in subsequent PCR, the samples 
were excluded and cDNA synthesis was repeated using different RNA aliquots. 
5.2.5. Extraction of genomic DNA from mouse tail biopsies 
Mouse tail biopsies were suspended in 500 µl tail lysis buffer (see “Self-made reagents”, 
section 5.6.1.1) and incubated overnight on a thermomixer (Eppendorf) at 50˚C and 600 rpm. 
On the next day, samples were vortexed and then centrifuged (12,000 x g for 5 minutes) to 
remove residual fur and tissue debris. DNA was precipitated by transferring the supernatants to 
fresh tubes containing 500 µl isopropanol, mixing well, and centrifuging at 12,000 x g for 1 
minute. The isopropanol was then carefully discarded and the DNA pellet washed by adding 
300 µl of ice cold 70% ethanol and vortexing. After centrifugation (12,000 x g for 1 minute) the 
ethanol was discarded, the DNA pellet was allowed to air-dry and subsequently resuspended in 
300 µl TE buffer. A final incubation on the thermomixer (10 minutes, 50˚C, 1000 rpm) was 
performed to ensure complete dissolution of the DNA.  
5.2.6. Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) is an extremely versatile technique widely used in 
practically every molecular biology laboratory. It allows the specific isolation and amplification of 
DNA fragments for a variety of purposes, and numerous applications have been derived from 
the original method. In our experiments, conventional PCR was used to generate DNA 
fragments complementary to cellular mRNA transcripts, and to detect the presence of wild-type 
or knock-out gene alleles in DNA samples from individual mice.  
5.2.6.1. Amplification of transcripts of interest 
After synthesis of cDNA, primers (short DNA oligonucleotides; see section 5.6.2 for all 
sequences) specific for a given gene of interest were used in PCR to amplify a fragment 
corresponding to the gene’s expressed mRNA. Thus, in tissues such as hypothalamus, pituitary 
and adrenal glands, expression of the target gene could be detected, and a specific fragment 
could be amplified for use in downstream applications. In cases where fragments were 
intended to serve as standards for quantitative PCR (qPCR), primers were chosen that amplify 
relatively short fragments, as these are necessary for qPCR. Fragment length was typically 
between 100-200 base pairs (bp; minimum 84, maximum 247). Most of these primers were 
retrieved from a validated database in which all primers are designed according to uniform 
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criteria (Wang and Seed, 2003). If no primers were available in the database, they were 
designed using Primer3 (available online, e.g. at http://frodo.wi.mit.edu) based on the current 
mRNA Reference Sequence (RefSeq) for the genes of interest. Primers to be used in the 
generation of templates for cRNA production were designed to yield sizes between 400-500 bp, 
and were based on the same RefSeqs that were used to design primers for qPCR (where 
applicable, i.e. where primers for qPCR had been designed before). 
Reagents used for PCR were from one commercial source (AmpliTaq Gold reagents 
and GeneAmp dNTP mix, Applied Biosystems). Primers were ordered from IDT (Integrated 
DNA Technologies). In a typical PCR, a master mix was prepared by mixing (per sample) 2.5 µl 
10x PCR buffer, 1 µl MgCl2 (25 mM), 2 µl dNTP mix (2.5 mM of each dNTP), 0.1 µl AmpliTaq 
Gold DNA polymerase, and 17.4 µl DEPC-treated water. To the resulting 23 µl per sample, 1 µl 
of a pre-made mix of forward and reverse primers (5 µM each; final concentration 200 nM) and 
1 µl cDNA template were added, for a final reaction volume of 25 µl. Samples were pipetted 
into 0.2 ml PCR tubes (MicroAmp, Applied Biosystems). PCR was performed on a PTC-200 
thermocycler (MJ Research), and a typical program looked as follows: 
 
Step  temperature  time   
1  95˚   5 minutes 
2  95˚   30 seconds 
3  60˚   45 seconds 
4  72˚   45 seconds 
5  return to step 2  34 times  
6  72˚   7 minutes  
7  4˚   forever  
 
Since the DNA sequences and thermodynamic characteristics of the oligonucleotide primers 
define the exact conditions for a given PCR program, the above parameters were adjusted 
when needed. For example, the temperature used for annealing of the primers to the cDNA 
template (step 3) was raised when unspecific amplification occurred, or lowered in case of no 
amplification. For transcripts whose abundance was very low, additional cycles were inserted 
(step 5) to further prolong the chain reaction. When PCR remained unsuccessful, alternative 
primers were designed and tested.  
 In some cases, e.g. when target transcript abundance was low (larger volumes needed 
for visualization on agarose gels), or the amplified fragment was to be extracted from the 
agarose gel or purified from the PCR mixture, the volume of all reagents was linearly scaled up 
(e.g. doubled) according to the specific need. 
5.2.6.2. Genotyping PCR 
Genotypes were determined by gel electrophoresis of PCR products generated using primers 
for the wild-type and knock-out alleles of the gene encoding PACAP (see section 5.6.2 for 
primer sequences). Wild-type mice (homozygous, alleles +/+) display one band around 510 bp, 
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while knock-out mice (homozygous, alleles -/-) display a single band around 310 bp (Hamelink 
et al., 2002). Samples from heterozygous mice (genotype +/-) result in two PCR products, 
apparent as two bands around 510 bp and 310 bp. DNA samples from mice of known 
genotypes were frequently included as controls to ensure generation of correctly sized PCR 
products. PCR reagents were from one commercial source (Invitrogen). Samples were pipetted 
into 0.2 ml PCR tubes (MicroAmp, Applied Biosystems) as follows: 
 
Reagent    volume [µl] final concentration 
10x PCR buffer    5  1x 
MgCl2 (50 mM)    1.5  1.5 mM 
dNTP mix (10 mM each)   1  200 nM 
primer Neo-OF (10 µM)   1  500 nM 
primer PACAP-2-R (10 µM)  1  500 nM 
primer PNT1-R (10 µM)   1  500 nM 
Platinum Taq Polymerase   0.5  0.05 U/µl 
genomic DNA from tail biopsies  1  not applicable 
DEPC-treated water   38  not applicable 
 
The following program was run on a PTC-200 thermocycler (MJ Research): 
 
Step  temperature  time   
1  94˚C   3 minutes 
2  94˚C   30 seconds 
3  63˚C   45 seconds 
4  72˚C   1 minute 
5  return to step 2   34 times 
6  72˚C    10 minutes 
7  4˚C   forever 
 
5.2.7. Agarose gel electrophoresis 
After completion of PCR, an aliquot of each sample was used for agarose gel electrophoresis. 
This method allows visualization of specific cDNA fragments as bands, separated according to 
their size, indicating successful PCR and expression of the target gene in the tissue of interest. 
In addition, specific bands (i.e. the fragments they represent) can be excised from the gel, 
purified and used in downstream applications. Gels were prepared as 1-2% agarose (UltraPure 
Agarose, Invitrogen) in 1x TAE buffer (Quality Biologicals), and ethidium bromide (Invitrogen) 
was added to the gel for a final concentration of 0.5 µg/ml. Ethidium bromide intercalates into 
DNA and fluoresces when exposed to ultraviolet light, allowing visualization of bands.  
Typically, for simple visualization of bands, 15-20 µl PCR product were mixed with 2-4 
µl 6X Orange DNA Loading Dye (Fermentas), carefully dispensed into the gel pockets, and 
subjected to electrophoresis at 5 V/cm for about 45-60 minutes (depending on the expected 
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fragment sizes). In cases where the bands were to be extracted from the gel, larger volumes 
(up to 40 µl) of the PCR product were loaded. To identify bands based on their electrophoretic 
migration pattern, size markers were run in parallel with the samples (GeneRuler 100 bp Plus 
DNA Ladder, Fermentas). Bands were visualized, and corresponding images saved as digital 
files, using a dedicated imaging system (KODAK Image Station 440 CF).  
5.2.8. Gel extraction of PCR-derived cDNA fragments 
After exposure to ultraviolet light, specific bands were identified and excised using a scalpel. 
Slices of agarose gel containing cDNA fragments of interest were processed using a 
commercially available kit, based on DNA binding to silica membranes and subsequent column 
purification, according to the manufacturer’s instructions (NucleoSpin Extract II, Macherey-
Nagel). After elution, cDNA concentrations were measured (see “Determination of nucleic acid 
concentration”) and samples were stored at -20˚C until use. 
5.2.9. Purification of cDNA fragments from PCR mixtures 
In cases where cDNA fragments had previously been properly identified, e.g. by means of gel 
electrophoresis and/or sequencing, they were purified directly from the PCR reaction mixture. 
This method circumvents electrophoresis, excision from the gel and removal of agarose, 
resulting in a simpler workflow and potentially cleaner samples. Purification of cDNA fragments 
was carried out using the same kit employed for gel extraction (NucleoSpin Extract II, 
Macherey-Nagel). 
5.2.10. Serial dilution of cDNA fragments for standard curves  
To generate standard curves for quantitative PCR, i.e. a range of known cDNA concentrations 
against which transcript abundance in a sample can be measured, serial dilutions of gel-
extracted or purified cDNA fragments were generated. The first standard concentration was 
prepared to represent 1 pg/µl of the cDNA of interest. Via serial 1:5 dilutions in DEPC-treated 
water, the following standards were made: 0.2, 0.04, 0.008, 0.0016, 0.00032, 6.4*10-5 pg/µl. 
Occasionally, when transcript abundances in experimental samples were found to be outside of 
this range, more or less concentrated standards were added as needed. All standards were 
stored at -20˚C and used repeatedly, unless their performance deteriorated, in which case fresh 
serial dilutions were prepared. 
5.2.11. Quantitative PCR (qPCR) 
Quantitative PCR represents one of the many technological developments based on the 
conventional PCR method. In contrast to conventional PCR, where amplified fragments are 
visualized at the end of the procedure (endpoint PCR), quantitative PCR allows for detection of 
amplification products as they appear in the reaction (real-time PCR). In our experiments, 
detection was accomplished through the use of a fluorescent dye (SYBR Green I) that binds to 
double-stranded DNA, thus producing increasing levels of fluorescence as amplification 
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products accumulate. We used a master mix containing SYBR Green I, dNTPs, DNA 
polymerase, MgCl2, and several additional components (iQ SYBR Green Supermix, Bio-Rad). 
Reactions were assembled in 96-well optical PCR plates (Bio-Rad) as follows: per sample, 10 
µl master mix, 1 µl primer mix (5 µM each; see 5.6.2 for sequences) and 9 µl DEPC-treated 
water were combined, and 20 µl of this mixture were dispensed into each well. Duplicates of 
cDNA samples (2 µl per well) prepared from tissues of interest were then added for a final 
volume of 22 µl per well. Plates were loaded into an iCycler iQ Real Time PCR System (Bio-
Rad) and run using the following PCR conditions:  
 
Step  temperature  time   
1  95˚C   3 minutes 
2  95˚C   10 seconds 
3  55˚C   45 seconds 
4  return to step 2   39 times 
5  95˚C    1 minute 
6  55˚C   1 minute 
 
Finally, to verify generation of a unique amplicon, a melting curve was performed (80 steps of 
+0.5˚C increments, 10 seconds each, from 55˚C to 95˚C).  
Fluorescence data were continuously monitored and recorded by the iCycler’s software 
(Optical System Software, Version 3.1, Bio-Rad). Based on the cDNA standard curves included 
in each run, the software calculated transcript abundance in unknown samples. Values for 
standards and samples were transferred to a Microsoft Excel spreadsheet in which further 
calculations were carried out (see “Calculation of experimental results”, section 5.4.1). 
Note that the combination of reverse transcription (RT) and quantitative PCR (qPCR) is 
sometimes referred to as qRT-PCR in the present work. 
5.2.12. Microarray expression analysis 
To determine the expression levels of thousands of transcripts in parallel, DNA oligonucleotide 
microarrays were used. These microarrays consist of small chips on which thousands of 
oligonucleotides are printed in a regular grid, each representing a particular mRNA. Our 
experiments were carried out by the NINDS/NIMH/NHGRI Microarray Core facility, using in-
house printed chips equipped with the Array-Ready Oligo Set for the Mouse Genome, Version 
3.0 (originally provided by Qiagen). This set of DNA oligonucleotides covers about 70% of the 
mouse genome (Verdugo and Medrano, 2006), as known at the time the experiments were 
carried out (2007-2008). To compare gene expression levels between two cohorts of samples 
or conditions, e.g. between wild-type and PACAP-deficient mice, or between untreated and 
stressed animals, RNA was extracted and processed according to a typical two-color 
hybridization workflow. In this method, samples are labeled with the fluorescent dyes Cy3 
(condition 1) or Cy5 (condition 2), mixed, and subsequently applied to the microarray chips 
using specialized chambers. Over time, samples from the two conditions hybridize with the 
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oligonucleotides on the chips. After laser-induced excitation, a given spot (nucleic acid 
sequence) on the microarray will thus emit more or less Cy3 and Cy5 fluorescence, reflecting 
the abundance of the corresponding complementary nucleic acid sequence in the samples. 
Gene expression levels (mRNA abundances) are thus ultimately measured as ratios of 
fluorescent light at two wavelengths, and comparisons of mRNA abundance between 
conditions 1 and 2 (e.g. untreated and stressed) are made based on these ratios. 
5.2.12.1. Amplification and labeling of RNA 
RNA was extracted from tissues as usual. For amplification (Amino Allyl MessageAmp II aRNA 
Amplification Kit, Applied Biosystems/Ambion) and fluorescent labeling (CyDye Post-Labeling 
Reactive Dye Pack, GE Healthcare), commercial kits were used by the Microarray Core facility, 
according to modified manufacturer’s instructions. Briefly, the procedure entails amplification of 
input RNA through cDNA synthesis followed by in vitro transcription. By coupling to reactive 
moieties incorporated into the amplified RNA (aRNA), Cy3 and Cy5 labels are introduced, after 
which the labeled aRNA is purified and fragmented. 
5.2.12.2. Microarray hybridization  
Cy3- and Cy5-labeled aRNA preparations were mixed, applied to the DNA microarrays in 
specialized 12-chamber hybridization mixers (MAUI Mixers FL, BioMicro Systems, now Roche 
NimbleGen), and incubated about 18-24 hours at 45°C. After hybridization, microarrays were 
washed and dried. 
5.2.12.3. Self-self hybridization controls 
To control for dye-specific effects occurring during microarray hybridization, which potentially 
influence the measured gene expression ratios, different controls are commonly used. During 
our experiments, so-called self-self hybridizations were most often included to control for 
potential dye bias (Fang et al., 2007). Self-self hybridizations were carried out by pooling 
samples from different experimental groups (e.g. aliquots of every sample from the study), 
splitting this pool in half and labeling one half each with Cy3 or Cy5. Thus, after hybridization on 
microarrays, theoretically all gene expression ratios should be 1. In experiments where self-self 
controls were present, genes with spurious self-self ratios (greater than 1.5 or smaller than 
0.66, respectively) were excluded from further analysis. Alternatively, a dye swap was 
performed, i.e. the labeling of the two sample cohorts with Cy3/Cy5 was reversed in a second 
hybridization, and results from the two hybridizations were checked for congruence. 
5.2.12.4. Scanning, data acquisition and analysis 
Microarrays were scanned using a DNA Microarray Scanner (Agilent Technologies). Primary 
image processing was carried out using the DeArray suite for IPLab software (Scanalytics Inc.) 
and data were obtained from the Microarray Core facility as image and result files. These were 
uploaded into the mAdb microarrary analysis environment (http://madb.nci.nih.gov) and 
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analyzed. Analysis entailed normalization (LOWESS correction), quality-filtering (Ratio Quality 
Measure >= 0.8) and statistical evaluation (SAM, significance analysis of microarrays), where 
false discovery rate was typically set to ~1%. Data were subsequently exported to Microsoft 
Excel, and only those transcripts with 2-fold or greater difference in abundance between 
conditions 1 and 2 (untreated and stressed, or wild-type and PACAP-deficient) were retained. 
Multiple oligonucleotide targets representing a single Entrez GeneID were collapsed by 
calculating the average of the respective mean expression ratios. 
5.2.13. Cloning of PCR-derived fragments 
Cloning provides a means to modify (recombine) and propagate DNA fragments by inserting 
them into vectors, introducing these vectors into cells, growing the cells (thereby replicating the 
inserted recombinant DNA) and finally isolating DNA from them. Different vectors, in 
conjunction with an array of restriction enzymes, provide a variety of options for modification of 
DNA, and recombinant DNA technology has provided powerful tools for molecular biology. 
Also, once cells harboring recombinant DNA have been produced, they can be frozen and 
stocked for future propagation and use.  
For our experiments, a relatively simple plasmid vector was employed whose features 
of interest consist of two promoters, in opposite orientation, to which the bacteriophage-derived 
SP6 and T7 RNA polymerases bind. The pGEM-T vector (Promega) can therefore be used to 
produce RNA species of defined orientation, i.e. sense or antisense relative to a cellular mRNA, 
after a cDNA fragment (“insert”) specific to this mRNA is inserted between the SP6 and T7 
promoters and in vitro transcription is performed (see below).  
5.2.13.1. Ligation of inserts into a plasmid vector 
After extraction from agarose gels or direct purification from PCR mixtures, cDNA fragments 
were used for ligation. During this process, the ends of the cDNA fragment are joined with the 
open ends of the vector via the enzymatic activity of a DNA ligase. Reactions were assembled 
in 0.5 ml polypropylene tubes by mixing 5 µl 2x Rapid Ligation Buffer, 1 µl pGEM-T Vector (50 
ng), 3 µl PCR product, and 1 µl T4 DNA Ligase. Based on the concentrations of cDNA 
fragments obtained during purification, and given that the inserts were all about 0.5 kb in size, 
the molar ratio of vector to insert typically was about 3:1 (see pGEM-T manual for details). After 
incubation at room temperature and 4°C for 1h each, ligated samples were either stored at 4°C 
or used for transformation of bacterial cells. 
5.2.13.2. Transformation and plating of competent cells 
In order to produce relatively large quantities of very pure DNA sequences of interest, cDNA 
fragments were introduced into bacterial cells after ligation into the pGEM-T vector. These cells 
take up exogenous DNA quite readily (they are “competent” for transformation) and grow fast, 
thereby effectively amplifying the cDNA fragments that were introduced. The cells used in our 
experiments were from a strain of Escherichia coli that does not require electroporation 
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(OneShot MAX Efficiency DH10B-T1R Competent Cells, Invitrogen), making it very easy to 
handle. Reactions were assembled according to the manufacturer’s instructions, briefly as 
follows: one vial of competent cells (50 µl) per ligated fragment was thawed on ice, 5 µl of each 
fragment were dispensed directly into the competent cells, both were mixed by tapping the vial 
gently and then incubated on ice for 30 minutes. Vials were subsequently incubated for exactly 
30 seconds in a water bath at 42°C (without mixing or shaking!) and quickly placed on ice 
afterwards. After addition of 250 µl pre-warmed (42°C) SOC medium (Invitrogen) per vial, all 
samples were incubated in a shaker/incubator at 37°C for exactly 1 hour at 225 rpm. In the 
meantime, using ready-made powdered mixes (E. coli FastMedia, Fermentas), two agar plates 
were prepared per sample, containing ampicillin (50 µg/ml), IPTG (100 µg/ml) and X-gal (100 
µg/ml). After incubation, 20 µl (plate 1) and 50-200 µl (plate 2) of bacterial cell suspension were 
spread on these plates. Plates were inverted and incubated at 37°C overnight. Remaining 
bacterial cell suspension was stored at 4°C and plated out the next day, if necessary. 
5.2.13.3. Selection and culture of bacterial cells harboring recombinant DNA 
On the day after plating, bacterial cultures were inspected for clones harboring the pGEM-T 
vector and carrying the successfully inserted cDNA fragment of interest. Clones that did not 
take up the vector or an insert-negative vector (i.e. empty vector DNA without fragment of 
interest) appeared blue, while clones that successfully incorporated the vector plus insert 
appeared white. Single white clones were picked using sterile inoculating loops and transferred 
to 15 ml conical polypropylene tubes (Sarstedt) containing 4 ml LB broth (Quality Biological) 
supplemented with 100 µg/ml ampicillin. Tubes were incubated in a shaker overnight at 37˚C 
and 225 rpm. On the next morning, cell suspensions were checked for sufficient bacterial 
growth and absence of obvious contamination, and either stored at 4˚C or directly used for 
preparation of frozen stocks or DNA extraction (see below). 
5.2.13.4. Frozen stocks of bacterial cell cultures 
Frozen stocks of bacterial cell suspension cultures are a convenient means of archiving the 
recombinant DNA contained in the cells. For this purpose, glycerol was added as a 
cryoprotectant as follows: the 15 ml tubes containing bacterial cultures were agitated so that 
the cells were evenly suspended. 200 µl glycerol (UltraPure Glycerol, Invitrogen) were 
dispensed into tubes suitable for freezing at very low temperatures (NUNC CryoTubes, Thermo 
Fisher Scientific). 800 µl bacterial culture were added, and thorough mixing was achieved by 
pipetting up and down several times. Tubes were placed on dry ice for immediate freezing and 
transferred to -80˚C for long-term storage. 
5.2.14. Isolation of plasmid DNA from transformed cells 
For extraction of plasmid DNA from bacterial cells, a commercial column-based kit was used 
(QIAprep Spin Miniprep Kit, Qiagen). As starting material, an aliquot of 1.7 ml bacterial cell 
suspension per culture was transferred to a 2 ml polypropylene tube, and the cells were 
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condensed into a pellet by centrifugation (3 minutes at 12,000 x g). Subsequent steps were 
carried out according to the manufacturer’s instructions, and DNA was eluted with 50 µl DEPC-
treated water. Quality and quantity of DNA in all batches of preparations were monitored as 
described above (see “Determination of nucleic acid concentration”) and found to be very 
consistent. 
5.2.15. Identity verification of cloned DNA via sequencing and BLAST  
To confirm that fragments of interest were cloned correctly, and to avoid spurious results in 
downstream applications, aliquots of every plasmid DNA were sequenced by the NINDS DNA 
Sequencing Facility. Reactions were carried out on ABI PRISM 3100 Genetic Analyzers 
(Applied Biosystems). Using standard SP6 and T7 oligonucleotides for priming, both strands of 
the plasmid DNA were read, and resulting sequences were saved as digital files. These files 
were opened using freely available software (Chromas Lite Version 2.01) and exported in 
FASTA format. Finally, sequences were analyzed using a nucleotide BLAST algorithm 
(http://blast.ncbi.nlm.nih.gov) by querying the "Mouse genomic plus transcript” database. All 
sequences were found to exactly match the transcript sequences they were designed for, and 
sense versus antisense strand orientation of the cloned fragments was determined. 
5.2.16. Preparation of radioactively labeled complementary RNA (cRNA) probes 
RNA probes complementary to expressed mRNA (cRNA probes) can be used to detect 
transcripts of interest in cells or tissues. While other methods (such as real-time PCR) allow 
more precise quantification of transcript abundance in extracts of cells or tissues, cRNA probes 
hybridize with their corresponding mRNA at the very location of its expression, and this location 
can be revealed using specific labeling and detection strategies. Thus, in situ hybridization 
histochemistry (see below) using cRNA probes provides important information about gene 
expression in complex tissues such as the brain.  
5.2.16.1. Production of DNA templates for in vitro transcription (Insert-PCR) 
After confirming the identity and orientation of every cloned fragment (insert) by sequencing, 
corresponding plasmid DNA was used in a PCR primed with oligonucleotides corresponding to 
the SP6 and T7 promoter sequences. Since these promoters flank the multiple cloning site of 
the pGEM-T vector, PCR using SP6 and T7 primers resulted in amplification of the entire insert 
adjacent to the promoters. After purification from the PCR mixture, amplicons could thus be 
used for in vitro transcription (see below). For insert-PCR, reactions were scaled up to a final 
volume of 100 µl per fragment, containing 10 ng of plasmid DNA and 200 nM of each primer. 
The insert-PCR program was adjusted relative to typical programs, based on relatively large 





Step  temperature  time   
1  95˚C   3 minutes 
2  94˚C   45 seconds 
3  60˚C   1 minute 
4  72˚C   1 minute 
5  return to step 2   29 times 
6  72˚C    6 minutes 
7  4˚C   forever 
 
In addition to sequencing, insert-PCR provided information on the orientation of cDNA 
fragments inserted into the pGEM-T vector. By priming the reaction with either an SP6 or T7 
promoter-bearing oligonucleotide and a fragment-specific forward primer, the RNA polymerase 
(SP6 or T7) that produces sense or antisense transcripts during in vitro transcription (see 
below) could be deduced. In our experiments, sequencing and insert-PCR were used as a 
means of cross-validation, and they agreed in all cases. 
5.2.16.2. In vitro transcription, DNase treatment and purification of cRNA 
In our experiments, cRNA probes were initially prepared using non-radioactive methods, in 
which UTP labeled with digoxigenin (DIG) is incorporated and later revealed using chromogenic 
or fluorescent techniques (DIG RNA Labeling Kit, DIG Nucleic Acid Detection Kit and HNPP 
Fluorescent Detection Set; Roche Diagnostics). However, the adrenal cortex was found to 
display an unacceptably large degree of unspecific staining, both with sense and antisense 
probes, such that subsequent experiments were carried out using only radioactively labeled 
cRNA.  
Per reaction, an aliquot of 35S-labeled UTP [uridine 5’-(alpha-thio)triphosphate, 1250 
Ci/mmol, 12.5 mCi/ml; Perkin Elmer] was dispensed into a 0.5 ml polypropylene tube and dried 
in a refrigerated centrifugal evaporator (SpeedVac Concentrator, Savant). The desired volume 
of sense probes was only half of the volume needed for antisense probes. Thus, for the 
preparation of antisense and sense cRNA, 4 µl and 2 µl 35S-UTP were typically used, 
respectively, and volumes of all other reagents were scaled accordingly. All steps during the 
procedure were carried out on ice unless otherwise indicated, and volumes in the subsequent 
paragraphs correspond to the protocol followed for production of an antisense probe.  
A master mix was prepared by combining (per antisense probe) 1 µl NTP-U (mixture of 
ATP, CTP and GTP; 5 mM each; Bioline), 1 µl DTT (100 mM; Roche), 1 µl 10x Transcription 
Buffer (Roche), 0.5 µl RNase inhibitor (40 U/µl; Bioline) and 0.5 µl DEPC-treated water (Quality 
Biologicals). Dried radioactive aliquots were resuspended in 5 µl plasmid DNA, which equaled 
90-180 ng DNA. After addition of 4 µl master mix and 1 µl SP6 or T7 RNA polymerase (Roche), 
tubes were incubated for 90 minutes at 37°C in a water bath. To remove template DNA, 1 µl 
RNase-free DNase I was added (Roche) and tubes were incubated for another 15 minutes at 
37°C in the water bath. The reaction volume was brought to 40 µl (volumepre) by addition of 29 
µl DEPC-treated water, and an aliquot of 1 µl was added to 5 ml of scintillation cocktail (Ultima 
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Gold, Perkin Elmer) to determine radioactivity (dpmpre) on a scintillation counter (LS6500, 
Beckman Coulter). Unincorporated nucleotides were removed by column purification according 
to the manufacturer’s instructions (RNase-free Micro Bio-Spin P-30 Tris Chromatography 
Columns, Bio-Rad). After elution from the column, the reaction volume was determined 
(volumepost) and another aliquot of 1 µl was prepared for scintillation counting (dpmpost). The 
efficiency with which 35S-UTP was incorporated into the cRNA probes was calculated using the 
following formula:   
 
% incorporation = (dpmpost * volumepost * 100) / dpmpre * volumepre)  
 
Efficiency of incorporation was monitored as a quality index for the in vitro transcription 
reaction, and was usually found to be between 60-80%. 
5.2.16.3. Dilution of radioactive cRNA in hybridization buffer 
Hybridization buffer was prepared in 10 ml aliquots and stored at -20°C until use. It was made 
up of 10% dextran sulfate (EMD Chemicals), 600 mM NaCl, 10 mM Tris-HCl (both Quality 
Biological), 1 mM EDTA disodium salt (Promega), 0.05% yeast tRNA (Invitrogen), 1x 
Denhardt’s solution (USB Corporation), 100 µg/ml sonicated salmon sperm DNA 
(SABiosciences, now Qiagen) and 50% formamide. To achieve a specific activity of 50,000 
dpm/µl (activityfinal), hybridization buffer, 1 M DTT (Roche) and DEPC-treated water were added 
to the purified cRNA probes according to the following formula: 
 
total final probe volume = dpmpost * (volumepost / activityfinal) 
 
Hybridization buffer was added to make up 90% of the total final probe volume, DTT was added 
to make up 2%, and DEPC-treated water to fill up the remainder. Probes were stored at -20°C 
and used within days after preparation. 
5.3. In situ hybridization histochemistry 
In situ hybridization histochemistry (ISH) allows visualization of gene expression in tissues, 
providing important information concerning the function of complex organs such as the brain. 
The molecular biological aspects of the method rely on the pairing of bases in nucleic acids 
(hybridization), and gene transcripts (mRNA) can in principle be detected via complementary 
DNA or RNA probes. An advantage of DNA probes is their rapid availability, as oligonucleotide 
synthesis has become very cheap in recent years. In our experiments, complementary RNA 
probes were used, primarily for two reasons: 
1. RNA:RNA hybrids are more stable than DNA:RNA once they have formed in situ. 
2. Relatively long cRNA (400-500 bases) provides very good specificity of hybridization. 
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In addition to these molecular biological considerations, ISH involves histochemical techniques 
that have been developed and refined over many years. Together, they provide an essential 
tool for the understanding of gene expression and function in the context of tissues and 
organisms. 
5.3.1. Preparation of frozen sections 
Frozen sections were prepared using a cryostat (Thermo Microm HM 525, Thermo Fisher 
Scientific), which consists of a microtome housed in a temperature-controlled chamber. Tissue 
samples were removed from storage at -80°C and transferred to the cryostat, where they were 
allowed to equilibrate to chamber temperature (around -18°C) for at least 20 minutes. Brains 
and adrenal glands (left gland per mouse) were then embedded in O.C.T. compound (Tissue-
Tek, Sakura Finetek) and thoroughly frozen using the cryostat’s heat extractor. After cutting at 
14 µm thickness, sections (one brain per slide, or two adrenals per slide) were carefully thaw-
mounted onto microscope slides (Fisherbrand Superfrost Plus, Thermo Fisher Scientific), air-
dried at room temperature, and either processed directly or stored at -80˚C.  
5.3.2. Prehybridization 
All prehybridization steps were carried out at room temperature, with solutions agitated in 
beakers using magnetic stir bars. For fixation, the glass slides with air-dried sections were 
immersed in 4% formaldehyde in PBS (freshly prepared from paraformaldehyde) for 60 
minutes. After three washes in PBS (10 minutes each), sections were permeabilized using 
0.4% Triton X-100 in PBS for 10 minutes, washed again in PBS for 5 minutes, and then rinsed 
in distilled water. Acetylation was carried out in TEA buffer (1.3% triethanolamine in PBS, pH 
8.0) by adding 1.25 ml acetic anhydride while stirring vigorously, and then incubating for 10 
minutes. This was followed by washing in PBS for 10 minutes and rinsing in distilled water. 
Finally, sections were dehydrated by rinsing in 50% and 70% isopropanol for one minute each, 
allowed to air-dry, and either used directly or stored frozen at -20˚C until hybridization. 
5.3.3. Hybridization 
To create a humidified incubation chamber, the bottom of a plastic dish (NUNC BioAssay Dish, 
Thermo Fisher Scientific; dimensions: 245 x 245 x 30 mm, length x width x height) was covered 
with blotting paper (3MM Chr, Whatman, part of GE Healthcare) soaked in 50% formamide. For 
sections of mouse brain, 20 µl of radioactive probe were dispensed onto an 18 x 18 mm glass 
cover slip. For sections of mouse adrenal glands, 25 µl of probe were dispensed onto a 22 x 22 
mm glass cover slip. By lowering the slide with the tissue sections facing the drop of probe 
solution, the cover slips were carefully picked up, such that they adhered closely to the glass 
slide, covering the section completely. Care was taken to exclude air bubbles. Slides were then 
placed in the humidified chamber and incubated in an oven at 65˚C for 16-18 hours. 
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5.3.4. Posthybridization 
One by one, slides were picked up from the humidified chamber, briefly dipped into a beaker 
containing 2x SSC, and the glass cover slips were carefully lifted off using a forceps. Slides 
were placed into a slide holder in a second beaker with 2x SCC until all cover slips had been 
removed. All subsequent washing steps in SSC and distilled water were carried out in beakers 
where solutions were agitated using a magnetic stir bar.  
 Slides were washed in 2x SCC and 1x SCC (20 minutes each), before removal of non-
specifically bound probes was accomplished by incubation in RNase buffer (see “Self-made 
reagents”) for 1 hour at 37˚C. Subsequently, washes were carried out in 1x, 0.5x and 0.2x SSC 
(20 minutes each), followed by a “hot wash” in 0.2x SCC at 60˚C for 1 hour. After additional 
washes in 0.2x SSC and distilled water (15 minutes each), slides were dehydrated by rinsing in 
50% and 70% isopropanol for one minute each, and allowed to air-dry. 
5.3.5. Autoradiography using film (regional analysis) 
After posthybridization, slides were aligned in an 8 x 10 inch autoradiography cassette 
(Research Products International). In a darkroom, a sheet of autoradiography film (Kodak 
Biomax MR, Carestream Health) was then apposed to the sections on the slides, and the 
cassette was closed tightly and stored for various exposure times. Films were developed using 
an automatic processor (Kodak X-OMAT 2000A, Carestream Health) and visually inspected. 
For transcripts with very high abundance in a given tissue, signals were evident after as little as 
4 hours of exposure, whereas others took around 20 hours to appear. In our experiments, film 
autoradiography was used to estimate the exposure time of sections after coating with 
emulsion (see below), and to analyze gene expression at the regional level. For the latter 
purpose, the films were scanned at high resolution (2400 or 4800 dpi) on a conventional flatbed 
scanner (Scanjet 4890, Hewlett-Packard). 
5.3.6. Autoradiography using emulsion (cellular analysis) 
In order to identify individual cells expressing transcripts of interest, radioactive cRNA probes 
can be visualized in tissue sections after coating with autoradiographic emulsion. The energy 
emitted during radioactive decay generates microscopic silver grains while passing through the 
emulsion, and these silver grains can be visualized under a microscope, together with the 
underlying cells. In our experiments, autoradiography emulsion Type NTB (Carestream 
Molecular Imaging) was diluted 1:2 in double distilled water and stored as aliquots at 4˚C, 
tightly shielded from light to avoid even the slightest unintentional exposure. All work involving 
emulsion was carried out in a darkroom. An aliquot of emulsion was placed in a water bath at 
42°C, together with a special glass dipping cuvette (Dip Miser, Electron Microscopy Sciences), 
and equilibrated for about 45 minutes. Subsequently, the emulsion was carefully poured into 
the cuvette, allowed to sit for a few minutes, after which a glass slide was dipped into the 
emulsion to check for air bubbles. 
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 Slides with tissue sections, sorted according to estimated exposure times, were dipped into 
the emulsion, excess emulsion was drained on the rim of the cuvette, and slides were tapped 
carefully on a paper towel. Slides were then placed in a gridded paper box, in an upright 
fashion, with the frosted end facing the experimenter. Several open plastic tubes containing 
desiccant (Drierite, W.A. Hammond Drierite) were also placed in the box to ensure a dry 
atmosphere, and the box was left in the darkroom overnight. On the next day, dried slides were 
sorted into boxes, which were wrapped in two layers of aluminum foil, and placed at 4°C. After 
varying exposure times (40-90 hours), development was carried out as follows: slides were 
placed into a metal slide holder and submerged in a glass jar containing Developer D-19 
(Kodak; obtained through Ted Pella Inc.) for 4 minutes, followed by tap water for 30 seconds, 
and Fixer (Kodak) for 10 minutes. Lastly, slides were rinsed in running demineralized water 
overnight. 
5.3.7. Counterstaining of tissue sections 
After rinsing overnight, glass slides carrying the tissue sections were cleaned by carefully 
removing residual emulsion from the back of the slides, using a razor blade and tissue wipes. 
All following steps were carried out in glass staining jars, each holding about 400 ml of solution. 
Sections were briefly stained in cresyl violet solution (see section 5.6.1.3) for about 1 minute to 
visualize cells without masking hybridization signals (silver grains). After washing in 
demineralized water (twice for 2 minutes), slides were passed through a graded series of 
isopropanol (70%, 80%, 96%, 100%, 100%; 2 minutes each) and fully dehydrated via three 
steps of xylene (5 minutes each). One by one, slides were removed from the last xylene jar, 
covered with DPX mounting medium (Sigma) and a cover slip, and allowed to cure in a fume 
hood overnight. 
5.3.8. Microscopic analysis of tissue sections  
Images of tissue sections were obtained through a microscope (Eclipse 50i, Nikon Instruments) 
connected to a CCD camera (Retiga 1300i Fast 1394, QImaging) and captured using iVision 
software (version 4.0.14, BioVision Technologies) running on an Apple Macintosh computer. To 
visualize silver grains as bright white speckles over cells, a Darklite illuminator was used (Micro 
Video Instruments). Most images were obtained using 4x or 20x microscope objectives. 
5.4. Calculation of experimental results 
5.4.1. Calculation of gene expression levels based on qPCR data 
Based on the cDNA standard curves included in each qPCR run, the thermocycler’s software 
determined transcript abundance (pg/µl) in unknown samples (result). We then calculated 
transcript abundance per tissue, e.g. per pair of adrenal glands or pituitary, based on the 
elution volume of total RNA after extraction (30 µl), RNA aliquots used for DNase treatment (x) 
and cDNA synthesis (1:5), dilution of cDNA after synthesis (1:2), and the cDNA aliquot used for 
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qPCR (1:22). The following formula is based on the standard workflow for a pair of adrenal 
glands:  
 
expression per tissue = result * 22 * 2 * 5 * [1/(x / 30 µl)] * 2 
 
The final multiplier (2) is added to achieve the correct expression level in pg/µl, because 2 µl of 
each standard were dispensed per well. 
5.4.2. Calculation of circulating hormone levels 
Corticosterone levels were determined via radioimmunoassay (RIA) or enzyme immunoassay 
(EIA). RIA samples were measured on a gamma counter (Wizard 1470, Wallac) and results 
were calculated by the counter’s internal software (RiaCalc WIZ program 3.4), based on a 
weighted parabolic regression. EIA samples were measured on a microplate 
spectrophotometer (SpectraMax 340, Molecular Devices) and results were calculated using 
dedicated software (SoftMax Pro 5.3, Molecular Devices) based on four parameter logistic 
curve fitting. Circulating levels of ACTH were measured via ELISA, using the same microplate 
spectrophotometer and software as for the corticosterone EIA. However, data were exported to 
Prism 4 (GraphPad Software) and results calculated using a cubic spline interpolation 
algorithm. Since results from these assays can in principle be analyzed using different 
mathematical procedures, we compared these procedures and found the results to be 
practically identical, showing that our data were reliable and robust. 
5.5. Statistical analyses 
For all statistical analyses, Prism 4 (GraphPad Software) was used. Results from experiments 
in vivo were usually calculated using two methods. First, the effects of treatment (stressor 
exposure) within genotype were assessed, separately for wild-type and PACAP-deficient mice, 
using one-way analysis of variance (ANOVA). Dunnett’s post-test was used to compare 
untreated mice and mice at various treatment time points. Second, the effects of genotype, i.e. 
differences between wild-type and PACAP-deficient mice at each of these time points, were 
analyzed by two-way ANOVA with Bonferroni post-test. In cases where experiments included 
only one treatment period, effects and differences were assessed by one-way ANOVA with 
Newman-Keuls post-test (comparison of all four groups). Whenever only two groups were 
compared, a two-tailed unpaired t-test was used. P values of <0.05 were considered significant. 




5.6. Chemicals, buffers and other reagents 
Common chemicals (salts, alcohols, solvents etc.) were obtained through Sigma-Aldrich or 
Thermo Fisher Scientific, unless otherwise indicated. Common buffers (TAE, PBS, SSC), 
DEPC-treated water and miscellaneous solutions (Tris-HCl, NaCl, 10% and 20% SDS etc.) 
were from Quality Biological. Sources of special materials, such as enzymes, kits and 
apparatuses are listed directly in the sections describing the experiments to which they pertain. 
Oligonucleotides were purchased from Integrated DNA Technologies. 
5.6.1. Self-made reagents 
Some reagents were prepared as needed, e.g. when they could not be obtained from 
commercial sources. Their recipes are listed here. 
5.6.1.1. Tail lysis buffer 
100 mM Tris-HCl, pH 8.0 
200 mM NaCl 
5 mM EDTA 
0.2% SDS 
0.2 mg/ml Proteinase K (Roche) 
Store at 4°C. Use no longer than one month. 
5.6.1.2. RNase buffer 
10 mM Tris-HCl, pH 8.0 
500 mM NaCl      
1 mM EDTA             
40 µg/ml RNase A (Roche) 
2000 U RNase T1 (Roche) 
Store at 4°C. Can be used 10-15 times. 
5.6.1.3. Cresyl violet staining solution 
5 g cresyl violet acetate (Sigma-Aldrich) 
600 ml demineralized water 
60 ml 1 M sodium acetate (from acetic acid, sodium salt) 
340 ml 1 M acetic acid 
Stir in the dark for several days. 




5.6.2. Oligonucleotide primers  
 
Table 2A: Primers for qRT-PCR         
primer  sequence (5’-3’)    amplicon [bp] Primer Bank ID  
3ßHSD-F TGGACAAAGTATTCCGACCAGA  250  6680289a1 
3ßHSD-R GGCACACTTGCTTGAACACAG   
AVP-F  GCCAGGATGCTCAACACTACG  123  6753150a1 
AVP-R  TCTCAGCTCCATGTCAGAGATG   
CRH-F  CTCAGCAAGCTCACAGCAAC  141  N.A. 
CRH-R  GGAGCTGCGATATGGTACAGA   
DBH-F  CGGCTACTGCACAGACAAGTG  91  N.A. 
DBH-R  GCCCGTCAGGTGTGTATGAA   
Dusp1-F  ATGCAGCTCCTGTAGTACCC  102  7305423a3 
Dusp1-R ATATCCTTCCGAGAAGCGTGA   
Egr1-F  AGCGAACAACCCTATGAGCAC  100  6681285a2 
Egr1-R  TCGTTTGGCTGGGATAACTCG   
Fos-F  CGGGTTTCAACGCCGACTA  166  6753894a1 
Fos-R  TTGGCACTAGAGACGGACAGA 
Fosl1-F  ATGTACCGAGACTACGGGGAA  140  6753896a1 
Fosl1-R  CTGCTGCTGTCGATGCTTG   
GAL-F  GGCAGCGTTATCCTGCTAGG  104  6753940a1 
GAL-R  CTGTTCAGGGTCCAACCTCT    
Ier3-F  GCTCTGGTCCCGAGATTTTCA  195  19526808a1 
Ier3-R  AGATGATGGCGAACAGGAGAA   
Nor1-F  AGGATTCACTGATCTCCCCAA  140  7657397a1 
Nor1-R  GATGCAGGACAAGTCCATTGC   
Nur77-F  TTGAGTTCGGCAAGCCTACC  100  6754216a1 
Nur77-R  GTGTACCCGTCCATGAAGGTG   
Nurr1-F  AACACTGAAATTACTGCCACCA  138  7305325a2 
Nurr1-R  TTCTACCTTAATGGAGGACTGCT   
P45011ß-F AGACACAAGAGAAAGAGGAT  183  N.A. 
P45011ß-R TAGCACTCTAAGGAAGAGAA   
P450c17-F GCGGATAGTAGTAGCTCCTGG  117  6681097a3 
P450c17-R ACACAGTGAGTTGGCTTCCTG   
P450c21-F TACAGACCCTTCACGACTGTG  102  6753570a2 
P450c21-R GGTTGGGGAGGAACCTGAG   
P450scc-F AAAGACCGAATCGTCCTAAACC  117  9789921a3 
P450scc-R CTTGATGCGTCTGTGTAAGACT   
PNMT-F  GACTGGAGTGTGTATAGTCAGCA 109  6679405a3 
PNMT-R  CGATAGGCAGGACTCGCTTC   
POMC-F ATGCCGAGATTCTGCTACAGT  170  6679415a1 
POMC-R TCCAGCGAGAGGTCGAGTTT   
SF-1-F  GCCCTGTTGGATTACACCTTG  135  20522231a2 
SF-1-R  GTTGCCCAAATGCTTGTGGTA   
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StAR-F  ATGTTCCTCGCTACGTTCAAG  122  31543776a1 
StAR-R  CCCAGTGCTCTCCAGTTGAG   
Stc1-F  CTACTTTCCAGAGGATGATCGC  * 100  N.A. 
Stc1-R  ACTTCAGTGATGGCTTCCGG   
TH-F  CTGTCTCGGGCTTTGAAAGTG  163  6678337a2 
TH-R  GACGCACAGAACTGAGGAGG   
VGluT1-F GAGCGCAAATACATTGAGGATGC 131  33859827a3 
VGluT1-R CAAAAGTTCGCAACGATGATGG   
VGluT2-F TGGAAAATCCCTCGGACAGAT  120  31543717a1 
VGluT2-R CATAGCGGAGCCTTCTTCTCA   
VIP-F  AGTGTGCTGTTCTCTCAGTCG  162  30794516a1 
VIP-R  GCCATTTTCTGCTAAGGGATTCT   
VMAT2-F ATGCTGCTCACCGTCGTAG  247  27369732a1 
VMAT2-R GGACAGTCGTGTTGGTCACAG   
 
PAC1-F  GGCCCTGTAGTTGGCTCTATAATGG **  N.A. 
null-R  GAGAGAAGGCAAATACTGTG  187/271  N.A. 
hop-R  AGAGTAATGGTGGATAGTTCTGACA 200  N.A. 
hip-R  TGGGGACTCTCAGTCTTAAA  142  N.A. 
 
 
Table 2B: Primers for generation of cRNA probe templates      
primer  sequence (5’-3’)    amplicon [bp] target RefSeq  
CRH-F2  ATCCGCATGGGTGAAGAATA  408  NM_205769.1 
CRH-R2  AAGCGCAACATTTCATTTCC   
Egr1-F2  CCACAACAACAGGGAGACCT  466  NM_007913.5 
Egr1-R2  TCTTGCGTTCATCACTCCTG   
GAL-F2  GTGACCCTGTCAGCCACTCT  422  NM_010253.3 
GAL-R2  ACGATTGGCTTGAGGAGTTG   
Nor1-F2  GTGTCGGGATGGTTAAGGAA  455  NM_015743.2 
Nor1-R2  CTGAAGTCGATGCAGGACAA   
Nur77-F2 CAATGCTTCGTGTCAGCACT  450  NM_010444.1 
Nur77-R2 TCTGCCCACTTTCGGATAAC   
Nurr1-F2 AGTCTGATCAGTGCCCTCGT  432  NM_013613.1 
Nurr1-R2 AATGCAGGAGAAGGCAGAAA   
SP6  CGATTTAGGTGACACTATAG  ***  N.A. 
T7  TAATACGACTCACTATAGGG  ***  N.A. 
 
 
Table 2C: Primers for PACAP genotyping         
primer  sequence (5’-3’)    amplicon [bp]    
Neo-OF  CACCGGCCTTTAGGGACCCTTGTA wild-type allele yields 510 bp, 
PACAP-2-R GCTATTCGGCGTCCTTTGTTTTTAACCC knock-out allele yields 310 bp; 
PNT1-R  TAGGGGAGGAGTAGAAGGTGGCGC heterozygotes display both sizes 
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Table 2: Primers used for qRT-PCR, generation of cRNA probe templates and genotyping. (A) Mouse primers were 
retrieved from Primer bank (http://pga.mgh.harvard.edu/primerbank/index.html) (Wang and Seed, 2003) or designed 
using Primer3 (available online, e.g. at http://frodo.wi.mit.edu). (B) Primers were designed using Primer3 and the 
indicated official reference sequences (RefSeq). (C) Primers for PACAP genotyping are based on Hamelink and others 
(Hamelink et al., 2002). * Stc1-F was originally designed for rat, therefore there is one mismatch with mouse Stc1 
mRNA (second base is a T instead of G). ** Detection of all three PAC1 splice variants is carried out with a universal 
forward primer and variant-specific reverse primers. Primer combination PAC1/null yields two fragments, which indicate 
the expression of null (187 bp) and hop (271 bp), respectively. *** PCR amplification of subcloned fragments using SP6 
and T7 primers yields different amplicon sizes for each fragment. Thus, no amplicon size is indicated for these two 
primers. F denotes forward primer, R denotes reverse primer. N.A., not applicable. Note that primer names were 
chosen based on the most commonly used name for the corresponding gene product in mouse. For example, 
neuropeptides and catecholaminergic enzymes are labeled in capital letters, whereas most other factors are labeled 
according to their gene symbol or most common synonym. See http://www.ihop-net.org/UniPub/iHOP for a 
comprehensive database of synonyms for any given factor. In the text, measurements of mRNA abundance are 
described as such, and references to peptide or protein levels are clearly distinguished to avoid confusion. 
 
5.7. Index of commercial sources of materials and reagents 
The following is a list of companies and institutions from which materials and reagents were 
obtained. In the description of materials and methods used in our experiments, companies are 
listed only by their name, whereas additional information can be found here. 
 
Company       Location    
Agilent Technologies     Santa Clara, CA, USA 
Applied Biosystems      Foster City, CA, USA 
Applied Biosystems/Ambion     Austin, TX, USA 
ASI Instruments      Warren, MI, USA 
Assay Designs      Ann Arbor, MI, USA 
Beckman Coulter      Brea, CA, USA 
Bioline       Taunton, MA, USA 
Bio-Rad       Hercules, CA, USA 
BioVision Technologies     Exton, PA, USA 
Braintree Scientific      Braintree, MA, USA 
Carestream Health      Rochester, NY, USA 
Carestream Molecular Imaging    New Haven, CT, USA 
CEDARLANE Laboratories     Burlington, NC, USA 
Electron Microscopy Sciences     Hatfield, PA, USA 
Eli Lilly & Co.      Indianapolis, IN, USA 
EMD Chemicals      Gibbstown, NJ, USA 
Eppendorf      Hamburg, Germany 
Fermentas      Glen Burnie, MD, USA 
GE Healthcare      Piscataway, NJ, USA 
GraphPad Software      La Jolla, CA, USA 
Hewlett-Packard      Palo Alto, CA, USA 
Hielscher       Ringwood, NJ, USA 
Integrated DNA Technologies     Coralville, IA, USA 
Invitrogen       Carlsbad, CA, USA 
Macherey-Nagel      Düren, Germany 
MD Bioproducts      St Paul, USA 
Micro Video Instruments     Avon, MA, USA 
MJ Research      Waltham, MA, USA 
Molecular Devices      Sunnyvale, CA, USA 
National Cancer Institute’s Animal Production Program  Frederick, MD, USA 
Nikon Instruments      Melville, NY, USA 
NUNC       Roskilde, Denmark 
Perkin Elmer      Boston, MA, USA 
Promega       Madison, WI, USA 
Qiagen       Valencia, CA, USA 
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QImaging       Surrey, BC, Canada 
Quality Biological      Gaithersburg, MD, USA 
Research Products International    Mt. Prospect, IL, USA 
Roche Diagnostics      Mannheim, Germany 
Roche NimbleGen      Madison, WI, USA 
Sakura Finetek      Torrance, CA, USA 
Sarstedt       Newton, NC, USA 
Scanalytics Inc.      Fairfax, VA, USA 
Siemens Medical Solutions Diagnostics    Los Angeles, CA, USA 
Sigma-Aldrich      St. Louis, MO, USA 
Ted Pella Inc.      Redding, CA, USA 
Thermo Fisher Scientific     Waltham, MA, USA 
USB Corporation      Cleveland, OH, USA 
W.A. Hammond Drierite     Xenia, OH, USA 
Zeigler Bros.      Gardners, PA, USA 
 
 
Some companies have been merged with or acquired by others, such that they no longer 
operate under their original name. Companies that no longer exist are not listed here.  
 
Note that ™, ©, ® and other symbols representing intellectual property rights or proprietary 
technologies have been omitted from the text for clarity. All rights to names and methods lie 

























6.1. Observations concerning the phenotype of PACAP-deficient mice 
Several laboratories have reported the generation of mouse strains in which the gene encoding 
PACAP is disrupted (Colwell et al., 2004; Gray et al., 2001; Hamelink et al., 2002; Hashimoto et 
al., 2001). The mice used in our laboratory harbor the PACAP knock-out allele first described 
by Hamelink and others, which in the meantime has been fully backcrossed into the C57BL/6 
strain. To determine how these mice compare with reported phenotypes, we assessed several 
basic parameters over the course of our studies. 
6.1.1. Fertility is impaired in PACAP-deficient mice 
It has previously been shown that disruption of the gene encoding PACAP causes deficits in 
female fertility, defined as the ratio of productive matings (where the female delivers pups) to 
the total number of matings. In a study where the PACAP knock-out allele had been 
backcrossed over 10 generations into the C57BL/6 strain, fertility of PACAP-deficient mice was 
only 21% compared to 100% measured for wild-types (Isaac and Sherwood, 2008). Results 
from another group showed higher values, which depended on the background strain, such that 
PACAP-deficient compared to wild-type fertility was 33% versus 85%, or 50% versus 80%, 
respectively, in two different mouse lines (Shintani et al., 2002). In our hands, where PACAP+/+ 
and PACAP-/- mice were maintained on the C57BL/6 background via breeding of homozygous 
pairs, the aforementioned results were largely confirmed. Thus, fertility of PACAP-deficient 
compared to wild-type mice was 52% versus 84%, the latter number agreeing exactly with the 
value for C57BL/6 in standard mouse breeding literature (Green and Witham, 1991).  
6.1.2. Postnatal survival of PACAP-deficient mice appears to be normal 
Whereas previous studies have reported increased rates of postnatal death in PACAP-deficient 
mice (Gray et al., 2001) due to inadequate heat production (Gray et al., 2002), we found no 
direct evidence for this phenotype in our strain. However, it should be noted that the average 
temperature in our animal facility (24˚C) is above the temperature at which the aforementioned 
effects were described (21˚C). Also, we did not monitor every single breeding pair at all times, 
such that exact calculations of litter size and pup survival rate were not possible. This caveat 
also pertains to the calculation of fertility, although the results clearly appear robust (see 
above). 
6.1.3. PACAP deficiency causes a lean phenotype 
Measuring body weights before and after fasting (approx. 18 hours overnight), we found that 
PACAP-deficient mice are significantly lighter than their corresponding wild-type controls 
(before fasting: PACAP+/+ 31.95+/-0.74 g, PACAP-/- 27.3+/-0.44 g; N = 49; see Figure 2A). 
This is in agreement with recent reports using two different PACAP-deficient strains, even 
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though these reports provide different explanations for the leaner phenotype (Adams et al., 
2008; Tomimoto et al., 2008). Our finding of lower body weight was replicated in several 
cohorts, also occurred in female mice (see Figure 2B), and correlated with lower amounts of fat 
tissue observed during organ dissection (not quantified). In addition to being leaner, PACAP-
deficient mice in our study lost more body weight as a consequence of food deprivation 
(PACAP +/+ 9.0+/-0.32%, PACAP -/- 11.83+/-0.43% of initial body weight; N = 49). Statistically 
significant differences in weight loss were found in most but not all cohorts. Representative 



































































Figure 2. PACAP deficiency causes a lean phenotype. (A) Male mice. Average weight before and after fasting (approx. 
18h without food; water continuously available ad libitum), as well as weight loss, were compared between wild-type 
and PACAP knock-out mice (N = 49 per genotype; average age: 4.2 months). (B) Female mice. Average weight before 
fasting was recorded and compared between genotypes (N = 16-17 per genotype; average age: 8.8 months). Data are 
displayed as means +/- SEM. Asterisks indicate significant difference from wild-types. Unpaired t-test (*p<0.05, 
***p<0.0001). 
 
6.1.4. Hypoglycemia-induced mortality is higher than previously reported 
Initial experiments with the PACAP-deficient mice generated in our laboratory revealed a 
significant deficiency in the response to sustained systemic stress, such that 10-15% died from 
hypoglycemia within a few hours after i.p. injection of 2 U/kg insulin (Hamelink et al., 2002). In 
the present series of studies conducted with fully backcrossed PACAP-/- mice, this number was 
substantially higher when the same dose was administered, resulting in mortality rates of up to 
40% per cohort. Therefore, we adjusted the hypoglycemia paradigm as follows: 1h after insulin 
injection as usual (2 U/kg, i.p.), mice were injected with glucose (2 g/kg, i.p.) and returned to 
their home cage. Glucose injections were highly effective, preventing mortality in 100% of the 
mice. The adjusted experimental paradigm thus represents transient systemic stress, as rescue 
with glucose eliminates the initial stressor. This is in contrast to prolonged systemic stress, 
where insulin injection is followed by sustained hypoglycemia without rescue. Results in the 
following sections are specifically labeled to reflect these two different paradigms.   
It should be noted that wild-type mice never showed obvious symptoms of hypoglycemic 
shock after i.p. administration of insulin at a dose of 2 U/kg, while PACAP-deficient mice 
invariably did. Within less than one hour after injection, they displayed lower breathing rates, 
hyporesponsiveness to touch, significant hypothermia, and mild to massive convulsions. 
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6.2. Microarray analysis of brain and adrenal glands in untreated mice 
6.2.1. Basal transcriptome of the adrenal glands 
In a first survey, microarray analysis of the adrenal gland transcriptome had yielded no 
dramatic differences between wild-type and PACAP-deficient mice (Samal et al., 2007). 
However, the cDNA microarray platform used in this early study did not provide the same level 
of gene annotation and genome coverage available with current platforms. Therefore, we 
analyzed the basal transcriptome of the adrenal glands in wild-type (WT) and PACAP-deficient 
(knock-out, KO) mice using high density DNA oligonucleotide microarrays. Using both adrenal 
glands per mouse, total RNA was extracted from six individual KO mice. After amplification and 
labeling, these samples were hybridized with fractions of a pool generated from six WT 
samples, which had been amplified and labeled in parallel. Data derived from microarray 
hybridizations were extracted, normalized, quality-filtered and statistically evaluated in mAdb 
(http://nciarray.nci.nih.gov) and subsequently exported to Microsoft Excel. Here, only those 
transcripts with 2-fold or greater difference in abundance between the two genotypes were 
retained. Genes with spurious self-self ratios (greater than 1.5 or smaller than 0.66, 
respectively) were removed. Multiple oligonucleotide targets representing a single Entrez 
GeneID were collapsed by calculating the average of the respective mean expression ratios. 
Tables 3a and 3b (see appendix) show the results derived from this global expression analysis. 
It was found that, as measured by microarray, there was a larger number of genes 
expressed more abundantly in adrenal glands from PACAP KO mice (40 transcripts, 39 of 
which have GeneIDs; see Table 3b, appendix) than there were genes expressed less 
abundantly (16 transcripts, 15 of which have GeneIDs; see Table 3a, appendix). The overall 
number of differentially expressed genes was small, supporting the notion that lack of PACAP 
does not grossly perturb basal function of the adrenal glands. This is further corroborated by 
the fact that none of the genes were expressed at a greater than ~3.7-fold difference (see 
Elovl3, Alb, Nefl).  
6.2.2. Basal transcriptome of the cerebral cortex 
For analysis of the cerebrocortical transcriptome, samples obtained from 3-4 month old male 
mice were used. As in the case of the adrenal glands, the cutoff for differential expression was 
defined as a 2-fold difference in abundance per transcript. Only eight PACAP-dependent genes 
were found in the cerebral cortex based on this definition (see Table 4, appendix). As noted for 
the adrenal glands, the absence of large differences in the cerebrocortical transcriptome 
between wild-type and PACAP-deficient mice suggests that there are no gross abnormalities in 
this tissue under basal resting conditions. 
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6.3. Microarray analysis of gene expression patterns in mouse adrenal 
glands after sustained systemic stress 
Having established that the transcriptome of the adrenal glands is not very different between 
wild-type and PACAP-deficient mice under basal conditions, i.e. in untreated animals, we set 
out to determine changes in gene expression in response to stress. Although the adrenal 
glands are composed of two main functional zones, namely the cortex and medulla, whose 
structural integrity is lost during total RNA extraction, we reasoned that microarray analysis 
should provide important initial clues regarding the functional state of the glands. There are a 
number of genes whose expression is known to be restricted to either the cortex or the 
medulla, allowing preliminary assignment to the zones after generation of global gene 
expression patterns. Ultimately however, after validation by qRT-PCR, important novel 
candidate transcripts must be followed up by in situ hybridization histochemistry to provide 
unequivocal information regarding their localization. 
6.3.1. Differential gene expression during hypoglycemia 
To screen for genes differentially expressed in the adrenal glands during sustained systemic 
stress, we conducted a first microarray experiment (Experiment 1) using insulin-induced 
hypoglycemia as the stressor. Female mice (average age 15 months, age range 12-17 months) 
were treated with insulin (2 U/kg, i.p.) and killed 3h thereafter. Adrenal glands were excised, 
total RNA was extracted, and microarray hybridization was carried out as described. The 
experimental design was as follows: samples from six insulin-treated wild-type (WT) mice were 
pooled, and fractions of this pool were hybridized with samples from six individual insulin-
treated PACAP-deficient (KO) mice. Duplicates of these six hybridizations were carried out as a 
dye-swap control (labeling of WT/KO with Cy3/Cy5 reversed), such that a total of 12 microarray 
slides were used, each slide representing hybridization of insulin-treated WT versus insulin-
treated KO. 
Analysis after 3h of hypoglycemia revealed 62 unique transcripts whose abundance in 
wild-types was at least 2-fold higher, i.e. appeared PACAP-dependent (Table 5a, appendix). Of 
those, 58 represent known genes with official symbol and GeneID, while four transcripts were 
identified as Ensembl clones or UniGene clusters. Interestingly, two neuropeptides were 
differentially expressed, both of which have previously been shown to be upregulated by 
hypoglycemia-induced stress in rat adrenal glands (Anouar and Eiden, 1995; Fischer-Colbrie et 
al., 1992). Thus, GAL (encoding galanin; 2.28-fold) and Tac1 (encoding tachykinins, including 
substance P; 4.45-fold) were more abundantly expressed in wild-types. On the other hand, 66 
unique transcripts (representing 64 known genes and two uncharacterized clones) were 2-fold 
more abundant in adrenal glands from PACAP-deficient mice compared to wild-types, i.e. 
appeared PACAP-repressed (Table 5b, appendix). Somewhat surprisingly, the latter group 
included a number of genes whose expression is induced by PACAP in PC12 cells in culture, 
such as Dusp1 (dual specificity phosphatase 1), Egr1 (early growth response 1), Fosl1 (fos-like 
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antigen 1), Ier3 (immediate early response 3), Nr4a1 (Nur77) and Nr4a2 (Nurr1) (Eiden et al., 
2008; Samal et al., 2007), all of which are rapid response genes. 
6.3.2. Upregulation of gene expression induced by hypoglycemia  
In microarray Experiment 2, male WT and KO mice (average age six months, age range 4.8-
6.4 months) were injected with insulin (2 U/kg, i.p.) or 0.9% saline. Three hours after the 
injection, both adrenals were excised per animal and processed for microarray hybridization as 
described. This time, however, the experimental setup was as follows: for each genotype, 
samples from six saline-treated mice were pooled, and fractions of this pool were hybridized 
with samples from six individual insulin-treated mice. Expression levels (signal ratios) as 
measured by microarray thus represent insulin-treated WT versus saline-treated WT, and 
insulin-treated KO versus saline-treated KO. In other words, the effect of insulin-induced 
systemic stress was assessed within genotype, separately for WT and KO. No dye-swap was 
performed. 
The experiment revealed induction of a large number of transcripts in adrenal glands 
from PACAP-deficient mice after 3h of stress, whereas wild-type mice displayed relatively few 
changes. Thus, 222 transcripts showed two-fold or higher induction in KO compared to only 41 
transcripts in WT adrenals (Table 6a, appendix). The genes upregulated after hypoglycemia in 
WT mostly represented a subset of those induced in KO mice, with only nine transcripts being 
PACAP-dependent (Table 6b, appendix; Figure 3a). Five of these PACAP-dependent genes 
are Ensembl clones for which no functional annotation was available at the time of analysis. 
6.3.3. Overlap between differentially expressed and stress-regulated genes 
The two microarray experiments above served to address two basic questions. First, which are 
the genes differentially expressed in WT and KO adrenal glands during systemic stress? 
Second, which are the genes upregulated by systemic stress in WT and KO? While answers to 
each warrant further investigation, we were especially interested in the overlapping set, i.e. the 
list of genes that are both differentially expressed in the first and upregulated in only one 
genotype in the second experiment, respectively. For example, a transcript that is more 
abundant in WT adrenal glands, and upregulated only in WT after insulin-induced 
hypoglycemia, would appear very likely to be truly PACAP-dependent. Only one transcript 
(Hhip, hedgehog-interacting protein) appeared to be PACAP-dependent according to this 
“overlap criterion”. Its expression level was found to be 2-fold greater in WT compared to KO 
adrenal glands after 3h of hypoglycemia (Experiment 1) and upregulated 2.17-fold in WT 
(Experiment 2), with no significant change seen in KO mice. On the other hand, 36 transcripts 
displayed the opposite profile, i.e. were expressed at higher levels in KO versus WT adrenals, 
and upregulated only or more strongly in KO mice (see Table 7, appendix; see also Venn 
diagram Figure 3b), thus appearing to be PACAP-repressed in vivo. Notably, 39% (14/36) of 
these transcripts have recently been shown to be rapidly upregulated by PACAP in PC12 cells, 




Figure 3. Venn diagrams illustrating results from microarray Experiments 1 and 2. (A) Of all the genes upregulated in 
mouse adrenal glands during 3h of sustained systemic stress (Experiment 2), only 9 are upregulated exclusively in 
wild-type (WT) mice. The remainder is either upregulated in both genotypes (32 genes) or only in PACAP knock-out 
(KO) mice (190 genes). (B) Overlap of Experiment 1 (comparison of stressed KO with stressed WT) and Experiment 2 
(comparison of stressed versus control, each for KO and WT). We found 36 candidates in common between the 190 
genes upregulated only in KO (Experiment 2) and the 66 genes expressed at higher levels in KO versus WT 
(Experiment 1); see Table 7 in the appendix. These 36 candidates are very likely to be truly PACAP-repressed. Only 
one transcript (Hhip) displayed the opposite profile, such that the overlap of our two microarray experiments revealed 
only one PACAP-dependent candidate. 
 
6.4. Validation of microarray results by qRT-PCR 
Microarray experiments 1 and 2 had both been carried out with samples obtained after 3h of 
prolonged systemic stress. To confirm the regulation of some of the target genes thus 
identified, aliquots of the same RNA samples used for microarray analysis in Experiment 2 
were reverse transcribed and subjected to quantitative PCR. We found that, as indicated by 
microarray, transcripts encoding Ier3 and Nurr1 were upregulated in PACAP-deficient adrenal 
glands after 3h of hypoglycemia, reaching significantly higher levels than those observed in 
wild-type mice at the same time point. On the other hand, Egr1 was induced to the same extent 
in both genotypes, even though microarray had indicated higher expression levels in PACAP-
deficient adrenal glands. Thus, two out of three transcripts we tested confirmed the microarray 
results (Figure 4), both with respect to differential expression (more abundant in KO, 
Experiment 1) and induction (upregulated 2-fold only in KO, Experiment 2). It is worth noting 
that the relatively small (and statistically non-significant) increases in Ier3 and Nurr1 expression 
observed after insulin injection in wild-type mice were only 2.3-fold and 2.9-fold compared to 
saline, respectively. Since qRT-PCR provides a more sensitive and quantitative measurement 
of mRNA levels, it is perhaps not surprising that both Ier3 and Nurr1 failed to meet the cutoff (2-
fold induction) during analysis of data from wild-types in Experiment 2, as microarrays tend to 
underestimate the magnitude of differences in transcript abundance. 
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Figure 4. Confirmation of microarray results by qRT-PCR. Male mice (N = 4 per time point; average age: 6 months) 
were injected with 0.9% saline or 2 U/kg insulin (both i.p.) and killed 3h thereafter. Data from qRT-PCR of both adrenal 
glands per mouse are displayed as means +/- SEM. Pound signs indicate significant difference between saline and 
insulin within each genotype. Asterisk indicates significant difference between genotypes. One-way ANOVA with 
Newman-Keuls multiple comparison test; #p<0.05, ##p<0.01, *p<0.05. 
 
As mentioned, transcripts encoding Egr1, Ier3 and Nurr1 are rapidly induced in PC12 cells after 
treatment with PACAP (Eiden et al., 2008). Since our microarray experiments and 
corresponding qRT-PCR validation were carried out after 3h of sustained hypoglycemia, we 
questioned whether earlier time points after insulin injection might reveal a PACAP-dependent 
gene expression pattern, rather than a PACAP-repressed pattern as observed so far. We 
therefore performed a time course study in which mice were left untreated (controls) or injected 
i.p. with 2 U/kg insulin and killed 1h, 2h, 4h or 6h thereafter. As shown in Figure 5, all three 
transcripts were already upregulated 1h after insulin injection, with Egr1 and Nurr1 reaching 
identical maximal levels in both genotypes. Only Ier3 appeared PACAP-dependent at this time 
point. Beyond this earliest regulation, the expression patterns differed markedly between wild-
type and PACAP-deficient adrenal glands. Thus, supporting the microarray study and 
corresponding validation by qRT-PCR, all three transcripts remained elevated in knock-out 
mice, an effect that reached statistical significance for Egr1 and Ier3. Taken together, these 
experiments indicate that after an initial peak occurring rapidly after stressor exposure, 
expression is sustained in PACAP-deficient adrenal glands during prolonged hypoglycemia, 
while levels in wild-types return to baseline.  
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Figure 5. Prolonged hypoglycemia induces sustained expression of rapid response genes in adrenal glands from 
PACAP-deficient mice. Data from qRT-PCR of both adrenal glands per mouse are displayed as means +/- SEM (N = 3-
4 male mice per time point; average age: 11.5 months). Pound signs indicate significant difference between untreated 
and post-injection time points within each genotype (one-way ANOVA with Dunnett’s multiple comparison test; #p<0.05, 
##p<0.01). Asterisks indicate significant difference between genotypes (two-way ANOVA with Bonferroni post-test; 
*p<0.05, **p<0.01).  
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Overall, the qRT-PCR results confirm our microarray data, in that induction of gene expression 
was correctly indicated for 3/3 (100%) of the transcripts tested, while differential expression 
was correctly called in 2/3 cases (66%; Ier3 and Nurr1), using intra-sample validation (i.e. 
aliquots of the same RNA for microarray and qRT-PCR). Therefore, having successfully used 
global expression analysis as a means of capturing genes potentially involved in stress 
signaling, several transcripts identified in microarray Experiments 1 or 2 were chosen as 
candidates for further experiments.  
As noted earlier, we found that insulin-induced prolonged systemic stress caused 
mortality in PACAP-deficient mice, at rates far exceeding those previously reported (Hamelink 
et al., 2002). Therefore, in most of the subsequent experiments, transient stress was provoked 
via insulin-induced hypoglycemia, followed 1h later by glucose injection. 
6.5. Regulation of rapid response genes and inducible transcription factors 
during transient systemic stress is largely unaffected by PACAP knock-
out and occurs even in the presence of cholinergic antagonists 
When applied to PC12 cells in culture, PACAP increases expression of rapid response genes, 
including regulators of transcription and cellular signaling (Eiden et al., 2008). In the first set of 
our present experiments (prolonged systemic stress; see above), two examples of these 
PACAP-responsive genes (Egr1 and Nurr1) were found not to be PACAP-dependent in the 
adrenal glands in vivo. In a second part of the study (transient systemic stress), we extended 





















































































































Figure 6. Rapid upregulation of genes encoding inducible transcription factors and signaling proteins in response to 
transient hypoglycemia is largely unaffected by PACAP knock-out. Data from qRT-PCR of both adrenal glands per 
mouse are displayed as means +/- SEM (N = 6-13 male mice per time point; average age: four months). Pound signs 
indicate significant difference between untreated and post-treatment time points within each genotype (one-way 
ANOVA with Dunnett’s multiple comparison test; #p<0.05, ##p<0.01). Asterisks indicate significant difference between 
genotypes (two-way ANOVA with Bonferroni post-test; *p<0.05, ***p<0.001). 
 59
Consistent with the results obtained after prolonged systemic stress, initial induction of most 
rapid response genes we tested was equivalent in both genotypes. Thus, 1h after injection of 
insulin, robust upregulation was observed for Egr1 and Nur77, two transcription factors known 
to be regulated by diverse stimuli in a variety of tissues (see Figure 6). Likewise, Dusp1 and 
Fos (FBJ osteosarcoma oncogene) expression displayed an identical pattern in adrenal glands 
from wild-type and PACAP-deficient mice. In contrast to prolonged hypoglycemia, where 
microarray and qRT-PCR had indicated sustained induction of rapid response genes in 
PACAP-deficient adrenal glands, transient hypoglycemia provoked transient induction, with 
expression levels returning to baseline after the initial peak at 1h. An exception to this pattern 
was Fosl1. Diverging from the first set of results, Nurr1 mRNA upregulation was blunted by 
about 40% in PACAP-deficient relative to wild-type mice (see Figure 6). 
The main neurotransmitter at the sympathoadrenal synapse, i.e. the interface between 
the sympathetic splanchnic innervation and adrenal chromaffin cells, is acetylcholine (ACh), 
and PACAP is known to be a co-transmitter for ACh in splanchnic nerve terminals. Since the 
rapid induction of transcripts like Egr1 and Nur77 appeared unaffected by PACAP knock-out, 
we therefore reasoned that their expression in response to systemic stress could be inhibited 
by pretreatment with cholinergic antagonists. To pharmacologically block nicotinic and 
muscarinic ACh receptors, respectively, chlorisondamine (5 mg/kg, i.p.) and atropine (1 mg/kg, 
i.p.) were co-administered 15 minutes prior to injection of insulin. These doses have previously 
been shown to block hypoglycemia-induced gene expression in the adrenal glands (Kanamatsu 
et al., 1986). Mice were either pretreated with saline or antagonists, treated 15 minutes later 
with saline or insulin, and killed 1h after treatment. Thus, there were one control and three 
experimental groups per genotype, according to pretreatment + treatment, respectively: control 
(saline + saline), hypoglycemia (saline + insulin), antagonist control (antagonists + saline) and 
ganglionic blockade (antagonists + insulin).  
In wild-type mice (Figure 7, left panels), insulin-induced stress significantly upregulated 
expression of Egr1 and Nur77, to the same extent as seen in previous experiments. 
Pretreatment with antagonists alone (antagonist control) provoked the same magnitude of 
upregulation, and values from mice in the ganglionic blockade group were indistinguishable 
from the two other experimental groups. Thus, all three experimental groups showed 
significantly higher expression levels of Egr1 and Nur77 compared to the control. There were 
no statistically significant differences between the three experimental groups. Essentially the 
same pattern was found in adrenal glands from PACAP-deficient mice, with all three 
experimental groups displaying higher Egr1 and Nur77 mRNA abundance compared to controls 
(Figure 7, right panels). The only statistically significant exception was that Egr1 was more 
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Figure 7. Pharmacological blockade of cholinergic signaling does not prevent hypoglycemia-induced expression of 
rapid response genes in the adrenal glands, even in PACAP-deficient mice. Mice were pretreated with saline or 
cholinergic antagonists (antag.; 5 mg/kg chlorisondamine plus 1 mg/kg atropine, co-administered i.p.) 15 minutes 
before treatment with saline or insulin, and adrenal glands were dissected 1h after treatment. Data from qRT-PCR of 
both adrenal glands per mouse are displayed as means +/- SEM (N = 4 male mice per time point; average age: 5.4 
months). Values are means +/- SEM. Pound signs indicate significant difference from the saline control group 
(##p<0.01, ###p<0.001). Asterisk indicates differences between other groups (*p<0.05). One-way ANOVA with Newman-
Keuls Multiple comparison test. 
 
 
In PACAP-deficient mice, pretreatment with cholinergic antagonists followed by saline elicited 
mild symptoms reminiscent of insulin-induced hypoglycemia. Although somewhat less obvious, 
the same was true for wild-types, which also became noticeably hyporesponsive. Pretreatment 
with antagonists followed by treatment with insulin provoked clear signs of stress in wild-type 
mice. This was in stark contrast to previous experiments, where wild-type mice had never been 
visibly affected by insulin treatment alone. Animals were hyporesponsive, had reduced 
breathing rates, and rested on the floor of their cages in a sprawled, immobile position. Thus, 
although cholinergic blockade did not inhibit stress-induced gene expression as expected, it 
was clearly physiologically effective. 
6.6. Systemic stress-induced expression of the “promiscuous” rapid 
response gene Egr1 occurs in the adrenal cortex and medulla 
Several rapid response genes, most prominently Egr1 and Fos, have been described as 
“promiscuous” because their expression is induced by a variety of factors in many cells and 
tissues. This discriminates them from genes whose inducible expression appears in a more 
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specific fashion, e.g. in response to cellular depolarization (Machado et al., 2008). Rapid 
induction of Egr1 mRNA occurred equally pronounced in both PACAP genotypes, with some of 
our evidence suggesting that expression is transient in wild-type but sustained in PACAP-
deficient adrenal glands, at least under conditions of prolonged systemic stressor exposure. 
Since the latter phenomenon could potentially be explained by zonal differences in expression, 
e.g. genotype-independent induction in adrenal medulla but PACAP knock-out-specific 
maintenance in cortex, we determined the cellular localization of Egr1 mRNA using in situ 
hybridization histochemistry. Mice were subjected to insulin-induced hypoglycemia, killed 1h 
after treatment, and adrenal glands were analyzed after autoradiographic processing of frozen 
sections. 
 
+/+  1h -/- 1h
+/+  untreated -/- untreated
200 µm
 
Figure 8. In situ hybridization of 
Egr1 mRNA in mouse adrenal 
glands after hypoglycemia-induced 
stress. Frozen sections of adrenal 
glands from wild-type (+/+) and 
PACAP-deficient mice (-/-) were 
incubated with a 35S-labeled cRNA 
probe for Egr1. After coating with 
autoradiographic emulsion and 
exposure for 40 hours, slides were 
developed and silver grains 
(representing specific hybridization 
signals) were visualized using 
darkfield microscopy. Scale bar = 
200 µm. Note strong increase of 
signals in cortex and medulla. 
 
Evaluation of tissue sections after relatively short exposure times (40 h) revealed very low Egr1 
expression levels in untreated mice. Within 1h after insulin injection, substantial induction 
occurred in both genotypes, with intense hybridization signals throughout both adrenal cortex 
and medulla (Figure 8). While we did not analyze large series of sections and did not quantify in 
situ expression levels (e.g. via densitometry on autoradiographic film or silver grain counting on 
sections), Egr1 mRNA abundance in the adrenal cortex appeared to be somewhat higher in 
PACAP-deficient compared to wild-type mice. Induction throughout the gland suggests that 
both hormonal (HPA axis) and neural signals (via the splanchnic nerve) participate in regulation 
of Egr1 expression in response to systemic stress. 
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6.7. PACAP controls expression of critical adrenomedullary factors 
6.7.1. Expression of adrenomedullary neuropeptides implicated in adrenal 
secretory activity is PACAP-dependently induced during stress 
Microarray Experiment 1 revealed differential expression of GAL (encoding galanin) after 3h of 
systemic stress, with higher levels found in wild-type compared to PACAP-deficient adrenal 
glands (Table 5a, appendix). However, no upregulation was found in microarray Experiment 2, 
even though GAL mRNA is known to be induced by hypoglycemia in the rat (Anouar and Eiden, 
1995). To determine whether GAL mRNA is indeed induced in mouse adrenal glands during 
stress, we conducted several additional experiments with wild-type mice and measured 
expression by qRT-PCR. Prolonged hypoglycemia (insulin, 2 U/kg i.p.) was found to increase 
GAL abundance within 6h. Absolute expression levels and magnitude of stress-induced 
upregulation were very similar in male and female mice (Figure 9A). Transient hypoglycemia in 
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Figure 9. Upregulation of GAL mRNA in mouse adrenal glands after systemic stress. Wild-type mice were injected with 
insulin (2 U/kg, i.p.) and killed 1h or 6h later. (A) Prolonged hypoglycemia in female (N = 3 per group; average age: 8 
months) and male mice (N = 4 per group; average age: 11.5 months). Controls were injected with saline or untreated. 
(B) Transient hypoglycemia in male mice (N = 7-8 per group; average age: 4.5 months). Mice in the 1h + 5h group 
received insulin, followed 1h later by glucose (2 g/kg, i.p.), and were killed 5h after the glucose injection. Controls were 
untreated. Data from qRT-PCR of both adrenal glands per mouse are displayed as means +/- SEM. (A) Pound signs 
indicate significant difference from controls (unpaired t-test; #p<0.05, ##p<0.01). (B) Pound signs indicate significant 
difference from untreated (one-way ANOVA with Dunnett’s Multiple comparison test; ##p<0.01). 
 
 
Having established upregulation after 6h in adrenal glands from wild-type mice, we determined 
whether control of GAL mRNA expression is PACAP-dependent, as expected based on 
microarray Experiment 1. Thus, a time course after transient stressor exposure was performed, 
where wild-type and PACAP-deficient mice were killed at various times (2h, 5h, 11h) after a 1h 
period of hypoglycemia. GAL mRNA was significantly induced as early as 3h after insulin 
injection, and abundance was significantly higher in wild-types at all time points tested. A very 
modest but statistically significant upregulation also occurred in PACAP-deficient mice (Figure 
10A). Similarly, expression of VIP (vasoactive intestinal peptide) was found to be PACAP-
dependent, in that abundance was significantly higher in wild-type adrenal glands at most time 
points. Hypoglycemia induced VIP mRNA 2.5-fold and 1.8-fold in wild-type and PACAP-
deficient mice, respectively, although the increase in wild-types did not reach statistical 




























































Figure 10. Upregulation of GAL and VIP mRNA in mouse adrenal glands after hypoglycemia- and restraint-induced 
stress. (A) Male mice (average age: 3.8 months; N = 4 per group) were injected with insulin (2 U/kg, i.p.), followed 1h 
later by glucose (2 g/kg, i.p.), and killed at various times after glucose injection. Controls were untreated. (B) Male mice 
(average age: 5.5 months; N = 5 per group) were continuously restrained for different durations and compared to 
untreated controls. Data from qRT-PCR of both adrenal glands per mouse are displayed as means +/- SEM. Statistical 
analysis is identical for A and B. Pound signs indicate significant difference from controls (one-way ANOVA with 
Dunnett’s Multiple comparison test; #p<0.05, ##p<0.01). Asterisks indicate significant difference between genotypes 
(two-way ANOVA with Bonferroni post-test; *p<0.05, **p<0.01, ***p<0.001). 
 
 
Expression of GAL mRNA in response to restraint displayed the same magnitude and PACAP-
dependent pattern seen after hypoglycemia, suggesting that induction of this neuropeptide is a 
common element of the adrenal reaction to stress. Upregulation was much more pronounced in 
wild-type mice, leading to significantly higher expression levels compared to PACAP-deficient 
animals (Figure 10B). It is worth noting that GAL mRNA abundance was very consistent across 
all experiments, with basal and maximal levels in male and female mice being very similar. 
In situ hybridization was carried out to assess the localization of stress-induced GAL 
mRNA expression. Adrenal gland sections from mice subjected to transient hypoglycemia were 
used for this purpose. In control animals (untreated), weak hybridization signals were observed 
in the adrenal medulla, and only few cells displayed sizeable GAL expression. In contrast, a 
marked increase in GAL-specific signal was observed after treatment (group 1h + 5h), which 
was restricted to the medulla and clearly more pronounced in wild-type (+/+) compared to 
PACAP-deficient mice (-/-). These results confirm our qRT-PCR data and show that GAL 
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Figure 11. Localization of GAL mRNA in 
mouse adrenal glands after transient 
hypoglycemia. Complementary RNA 
probes labeled with 35S-UTP were added 
to 14 µm-thick frozen sections of adrenal 
glands. Sections were coated with 
autoradiography emulsion, developed 
after 50 hours of exposure, and 
counterstained with cresyl violet. Images 
were captured under darkfield 
illumination to visualize silver grains 
representing specific hybridization 
signals. Six hours after insulin injection, 
adrenals from wild-type (+/+) and knock-
out mice (-/-) show a significant increase 
in GAL hybridization signal throughout 
the medulla, and this increase is clearly 
more pronounced in wild-types. Scale bar 
= 200 µm. 
The adrenal cortex did not show any detectable expression, and hybridizations with GAL sense 
cRNA probe (negative control) yielded no signals (data not shown). 
 
6.7.2. Induction of catecholamine-synthesizing enzymes is PACAP-dependent 
in response to processive and systemic stressors 
PACAP is known to be required for adrenomedullary catecholamine secretion in response to 
systemic stress (Hamelink et al., 2002). To investigate whether the catecholaminergic system is 
also subject to PACAP-dependent transcriptional regulation, expression of transcripts encoding 
tyrosine hydroxylase (TH) and phenylethanolamine N-methyltransferase (PNMT) was 
measured in the adrenal glands after exposure of wild-type and PACAP-deficient mice to 
hypoglycemia- and restraint-induced stress. TH and PNMT are the rate-limiting and final 
enzyme, respectively, required for the biosynthesis of epinephrine. First, effects of transient 
versus prolonged restraint were compared. TH was found to be upregulated 2.2-fold only in 
wild-types (not statistically significant), and levels were significantly lower in PACAP-deficient 
mice (Figure 12A, following page). In a second experiment, both genotypes showed significant 
upregulation, and TH mRNA was again more abundant in wild-types (Figure 12B, following 
page). Results for PNMT were practically identical in both experiments, such that a small but 
significant increase occurred in PACAP-deficient mice, with a larger increase observed in wild-
types (Figure 12A and B). Thus, TH and PNMT mRNAs were found to be clearly PACAP-
dependent, with maximal expression levels in wild-type being significantly higher than in 
PACAP-deficient mice. 
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Figure 12. Regulation of adrenomedullary catecholaminergic factors after restraint and hypoglycemia. (A, B, D) 
Restraint. Male mice (average age: 4.8 months; N = 4-6 per group) were restrained for different durations. Data from 
qRT-PCR are displayed as means +/- SEM. Pound signs indicate significant difference from controls (one-way ANOVA 
with Dunnett’s Multiple comparison test; #p<0.05, ##p<0.01). Asterisks indicate significant difference between genotypes 
(two-way ANOVA with Bonferroni post-test; *p<0.05, **p<0.01, ***p<0.001). (C) Hypoglycemia. Male mice (average 
age: 5.9 months; N = 4-6 per group) were injected with insulin (2 U/kg, i.p.) and killed 3h later. Controls were injected 
with saline. Data from qRT-PCR are displayed as means +/- SEM. Pound signs indicate significant difference from the 
respective genotype’s saline control group (#p<0.05, ##p<0.01). Asterisks indicate differences between genotypes 




Results for both transcripts were similar in response to systemic stress. After 3h of prolonged 
hypoglycemia, TH and PNMT were PACAP-dependently upregulated, with levels in wild-type 
significantly exceeding those in PACAP-deficient mice. In contrast to all other control 
conditions, we found PNMT mRNA abundance in saline-treated mice from the sustained 
hypoglycemia experiments to be significantly higher in wild-types, possibly attributable to 
fasting or mild injection-related stress (Figure 12C). 
 Transcript levels of dopamine beta-hydroxylase (DBH), the enzyme converting 
dopamine into norepinephrine, were unaffected by stress and equivalent in both genotypes. 
Abundance of mRNA encoding the vesicular monoamine transporter 2 (VMAT2) was 
significantly increased in wild-type and PACAP-deficient mice (Figure 12D). Taken together, 
our results therefore suggest that PACAP-dependent effects on expression of 
catecholaminergic factors during stress are restricted to specific target genes, namely the first 
and the final enzyme required for epinephrine biosynthesis. 
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6.7.3. Transcription factors implicated in control of adrenomedullary TH and 
PNMT expression are PACAP-dependently induced in response to 
restraint 
Transcripts encoding Egr1, Fos and Nurr1, inducible transcription factors (ITF) implicated in 
control of TH and PNMT expression, were PACAP-dependently upregulated in the adrenal 
glands in response to restraint. Within 1h, transcript abundance robustly increased in both 
genotypes, but the response in PACAP-deficient mice was significantly impaired, such that 
mRNA levels were up to <50% relative to wild-types (Figure 13). Upregulation was transient, 
and there was no statistically significant difference between prolonged (group 6h) and transient 
restraint (group 1h + 5h), although a trend towards higher expression levels after prolonged 













































Figure 13. Inducible transcription factors are PACAP-dependently upregulated in mouse adrenal glands in response to 
restraint. Data from qRT-PCR are displayed as means +/- SEM (N = 4-6 male mice per time point; average age: 4.1 
months). Pound signs indicate significant difference between untreated and post-treatment time points within each 
genotype (one-way ANOVA with Dunnett’s multiple comparison test; #p<0.05, ##p<0.01). Asterisks indicate significant 
difference between genotypes (two-way ANOVA with Bonferroni post-test; ***p<0.001). 
 
6.8. Stress induces PACAP-dependent expression of potential 
cytoprotectants in the adrenal glands, but not the hypothalamus 
Most of the rapid response genes we tested, such as Egr1 and Fos, displayed a stressor-
specific expression pattern, with maximal induction in the adrenal glands following 
hypoglycemia and restraint being PACAP-independent and -dependent, respectively. In 
contrast, Ier3 and Stc1 (stanniocalcin 1), encoding putative cytoprotective factors, were found 
to be PACAP-dependent in both paradigms. Upregulation occurred within 1h and was 
significantly blunted in PACAP-deficient adrenal glands (Figure 14A and B, following page). 
Interestingly, restraint-induced expression levels of Stc1 mRNA returned to baseline within 5h 
after termination of stressor exposure (group 1h + 5h), while they remained elevated in the 
continued presence of the stressor (group 6h; Figure 14B).  
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Figure 14. PACAP-dependent expression of potential cytoprotectants is induced by stress in the adrenal glands, but 
not the hypothalamus. (A) Hypoglycemia (N = 11-13 male mice per time point; average age: four months) and (B) 
restraint (N = 4-6 male mice per time point; average age: four months) induce expression of Ier3 and Stc1 in mouse 
adrenal glands. Data from qRT-PCR are displayed as means +/- SEM. Pound signs indicate significant difference 
between untreated and post-treatment time points within each genotype (one-way ANOVA with Dunnett’s multiple 
comparison test; #p<0.05, ##p<0.01). Asterisks indicate significant difference between genotypes (two-way ANOVA with 
Bonferroni post-test; *p<0.05, **p<0.01, ***p<0.001). (C) Effects of ganglionic blockade on adrenal gene expression in 
wild-type mice (N = 4 male mice per time point; average age: 5.5 months). Pound signs indicate significant difference 
from the control group (saline + saline). One-way ANOVA with Newman-Keuls multiple comparison test (#p<0.05, 
##p<0.01, ###p<0.001). Asterisk indicates difference from the group exposed to hypoglycemia (saline + insulin; *p<0.05). 
(D) Expression in hypothalamus (N = 5-6 male mice per time point; average age: four months). Statistics are the same 
as for A and B. 
 
 
Similar to what we observed in the case of Egr1 and Nur77 mRNA, Ier3 and Stc1 were 
elevated above control levels after treatment with cholinergic antagonists (chlorisondamine plus 
atropine). Pretreatment with antagonists alone resulted in Ier3 expression levels that were 
almost identical to those elicited by hypoglycemia, and pretreatment with antagonists followed 
by hypoglycemia was not different (Figure 14C). Stc1 displayed a similar pattern, although 
hypoglycemia-induced mRNA abundance significantly exceeded all other conditions, and 
pretreatment with antagonists followed by hypoglycemia was not different from saline controls 
(Figure 14C). 
In the hypothalamus, transcripts encoding Ier3 and Stc1 were unaffected by restraint 
stress and equally abundant in both genotypes (Figure 14D). This suggests that the PACAP-
dependent upregulation of these two rapid response genes is tissue-specific, occurring after 
exposure to hypoglycemia and restraint in the adrenal glands, but not the hypothalamus. This is 
in contrast to the stressor-specific regulation of genes such as Egr1 and Fos, whose induction 
depends on PACAP in adrenal glands (see above) and hypothalamus (see section 6.9.4) 
during restraint, but not hypoglycemia. 
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6.9. PACAP is required for responses of the HPA axis to restraint 
6.9.1. Volumes of serum obtained from mice after stress exceed those obtained 
from untreated mice  
For measurements of stress-induced secretion of the HPA axis hormones ACTH and 
corticosterone, trunk blood was collected immediately after decapitation, and the serum was 
separated. Volumes of serum obtained from wild-type and PACAP-deficient mice were identical 
at all time points, i.e. in untreated mice as well as after 1h and 6h of restraint. However, when 
sorting values by time point rather than genotype, we found that volumes of serum obtained 
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Figure 15. Yields of serum are higher after stress compared to controls, but not different between PACAP genotypes. 
Serum was obtained from trunk blood after decapitation. Data are displayed as means +/- SEM. Left panel: samples 
sorted by genotype (N = 7 per time point). No difference was found between genotypes at any time point. Right panel: 
samples from both genotypes sorted by time point (N = 14 per group). Pound signs indicate significant difference 
between untreated and post-treatment time points (one-way ANOVA with Newman-Keuls multiple comparison test; 
###p<0.001).  
 
6.9.2. Secretion of ACTH and corticosterone during stress is blunted in PACAP-
deficient mice 
Stress elicited marked activation of the HPA axis (Figure 16, following page). Serum 
concentrations of ACTH and corticosterone were increased in both genotypes after 1h of 
restraint. After 6h, ACTH had normalized and was no longer significantly elevated, whereas 
corticosterone concentrations remained higher than in untreated animals (Figure 16A). Peak 
responses of ACTH and corticosterone were significantly blunted in PACAP-deficient mice, as 
was the sustained phase of corticosterone secretion. Concentrations of ACTH (+/+ 152 vs. -/- 
38 pg/ml) and corticosterone (+/+ 282 vs. -/- 163 ng/ml) were 75% and 42% lower, respectively, 
compared to wild-types after 1h of restraint. The difference in serum corticosterone became 
even more pronounced after 6h of restraint, with concentrations in PACAP-deficient mice 























































































































Experiment 3  
 
Figure 16. Secretion of ACTH and corticosterone in response to restraint is impaired in PACAP-deficient mice. (A, B) 
Hormone concentrations in serum were measured after 1h and 6h of restraint in PACAP-deficient and wild-type mice 
(N = 5-7 per time point) in two separate experiments. Values are means +/- SEM. Pound signs indicate significant 
difference from the respective genotype's control (untreated). One-way ANOVA with Dunnett's multiple comparison test 
(##p<0.01). Asterisks indicate significant difference between genotypes. Two-way ANOVA with Bonferroni post-test 
(**p<0.01, ***p<0.001). (C) The early phase of secretion was assessed by measuring serum hormone concentrations 
after 30 minutes of restraint (N = 8-10 per time point). Values are means +/- SEM. Pound signs indicate significant 
difference from the respective genotype's untreated control (##p<0.01, ###p<0.001). Asterisks indicate significant 
difference between genotypes (*p<0.05, **p<0.01). One-way ANOVA with Newman-Keuls multiple comparison test. 
 
In order to confirm PACAP-dependent hormone secretion during restraint stress, we 
conducted a second experiment using the same conditions as before (Figure 16B). This time, 
the peak of corticosterone secretion in response to restraint was unaffected in PACAP-deficient 
mice, such that serum concentrations after 1h were not different compared to wild-types. 
However, as in the first experiment, prolonged restraint resulted in a marked difference 
between genotypes, to the effect that corticosterone concentrations were about 50% lower in 
PACAP-deficient mice after 6h (Figure 16B). To clarify whether early secretory responses are 
intact, i.e. ACTH and corticosterone concentrations are normal after briefer stressor exposure, 
a third experiment was conducted. Using a larger number of animals in each group, PACAP-
deficient and wild-type mice were restrained for 30 minutes and compared to untreated 
controls. As in the first experiment, serum concentrations of both hormones were lower in 
PACAP-deficient mice, although the differences were clearly less pronounced compared to 
prolonged restraint (ACTH 42% lower, corticosterone 33% lower; Figure 16C).  
In summary, our results indicate that basal concentrations of ACTH and corticosterone 
are independent of genotype. However, restraint-induced concentrations of corticosterone in 
PACAP-deficient mice are 33% (30 min), 42% (1h) and >60% (6h) lower compared to wild-
types. Thus, immediately after stressor exposure, output of the HPA axis is relatively mildly 
impaired, while differences become more pronounced with persistent stressor exposure. 
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6.9.3. Stress-induced upregulation of CRH mRNA in the paraventricular nucleus 
of the hypothalamus is PACAP-dependent 
Since we found hormonal responses of the HPA axis to restraint significantly blunted in 
PACAP-deficient mice, and regulation of the axis is known to occur chiefly at the level of the 
central nervous system, we measured changes in gene expression in the hypothalamus by 
qRT-PCR and ISH. In response to restraint, mRNA encoding corticotropin-releasing hormone 
(CRH) was upregulated in a PACAP-dependent pattern. After 1h and 6h of restraint, 
abundance was significantly higher in wild-type mice, and no upregulation at all was found in 
hypothalamus from PACAP-deficient animals (Figure 17). Interestingly, our experiment 
revealed that sustained stressor exposure is required to elicit PACAP-dependent upregulation 
of CRH. Thus, after 1h of stress followed by 5h of rest (group 1h + 5h), abundance of CRH 
mRNA was not different from untreated controls, whereas 6h of stress resulted in a 2.2-fold 
increase in expression. In a second experiment, these findings were confirmed. After 1h, 3h 
and 6h of restraint, CRH expression levels were about 2-fold higher compared to untreated 
controls, and no induction at all was observed in PACAP-deficient mice (Figure 17). Thus, 
restraint-induced upregulation of hypothalamic CRH is completely PACAP-dependent, whereas 
basal expression levels appear to be unaffected by genotype (no statistically significant 







































Figure 17. Restraint-induced upregulation of CRH in the hypothalamus is completely abolished in PACAP-deficient 
mice. Transcript levels were measured by qRT-PCR. Data are displayed as means +/- SEM (N = 5-6 male mice per 
time point; average age: 4.8 months). Pound signs indicate significant difference from the respective genotype’s control 
(untreated). One-way ANOVA with Dunnett’s multiple comparison test (#p<0.05, ##p<0.01). Asterisks indicate significant 
difference between genotypes. Two-way ANOVA with Bonferroni post-test (*p<0.05, **p<0.01, ***p<0.001). 
 
 
In situ hybridization confirmed that our qRT-PCR results reflect regulation of CRH in the 
paraventricular nucleus (PVN) of the hypothalamus, where hypophysiotropic neurons 
controlling the HPA axis are located. Specific expression of CRH mRNA was readily apparent 
in the PVN of untreated wild-type and PACAP-deficient mice. After 1h of restraint, hybridization 
signals increased significantly only in wild-types, confirming that CRH regulation during stress 
is fully PACAP-dependent (Figure 18, following page; also see Figure 20 in next section). 
Hybridization signals for CRH also appeared in the amygdala and scattered in the cerebral 














Figure 18. Autoradiographic detection of PACAP-dependent CRH mRNA expression in the paraventricular nucleus 
(PVN) of the hypothalamus. In situ hybridization with a 35S-labeled cRNA probe for CRH was carried out on 14 µm-thick 
coronal sections of mouse brain encompassing the PVN. Sections were exposed to autoradiographic film, which was 
scanned and digitized after development. Images clearly show specific hybridization signals in the PVN, the abundance 
of which increases after stress (restraint 1h) only in wild-type (PACAP+/+), but not in PACAP-deficient (PACAP-/-) 
mice. Hybridization is also observed in the amygdala and in scattered cells of the cerebral cortex. 
 
6.9.4. Stimulus-transcription coupling in the hypothalamus and PVN triggered 
by restraint is attenuated in PACAP-deficient mice 
Activity-regulated transcription factors such as Egr1 and Fos have been widely used to trace 
responses of neural circuitry to incoming stimuli. In response to restraint, we found 
hypothalamic expression of Egr1 and Fos mRNA to be rapidly and transiently induced. Further 
corroborating PACAP-dependent stimulation of the HPA axis at the level of the hypothalamus, 
induction of both factors was significantly attenuated in PACAP-deficient mice (Figure 19A, 
following page). Expression peaked at 1h, reaching levels significantly greater than in untreated 
mice, and returned to baseline thereafter. No difference was found between mice that were 
continuously restrained (group 6h) or restrained and released (group 1h + 5h), indicating that 
the induction of Egr1 and Fos expression is inherently transient, even in the continued 
presence of the stressor (Figure 19A).  
In addition to Egr1 and Fos, mRNAs encoding ITF from the Nr4a family of orphan 
nuclear receptors were differentially upregulated in the hypothalamus. The expression pattern 
was very similar, in that induction was rapid, transient, and significantly attenuated in PACAP-
deficient mice. Nur77 and Nor1 were induced after 1h of restraint, while Nurr1 was unaffected 










































































































Figure 19. Upregulation of inducible transcription factors (ITF) in the hypothalamus in response to restraint is PACAP-
dependent. (A) “Promiscuous” ITF. (B) Nr4a family of orphan nuclear receptors. Data from qRT-PCR are displayed as 
means +/- SEM (N = 5-6 male mice per time point; average age: four months). Pound signs indicate significant 
difference between untreated controls and post-treatment time points within each genotype (one-way ANOVA with 
Dunnett’s multiple comparison test; #p<0.05, ##p<0.01). Asterisks indicate significant difference between genotypes 
(two-way ANOVA with Bonferroni post-test; **p<0.01, ***p<0.001). 
 
 
To determine the localization of PACAP-dependent Nur77 and Nor1 mRNA expression 
after stress, and to see whether it occurs in the same neurons that express CRH, in situ 
hybridization was carried out on brain sections encompassing the hypothalamus including PVN. 
Sense probes were used as negative controls and yielded no specific signal (data not shown). 
As expected, labeling of serial sections with cRNA probes for CRH, Nur77 and Nor1 revealed 
overlapping expression patterns, suggesting that cell groups in the PVN expressing CRH also 
express Nur77 and Nor1 (Figure 20, following page). Hybridization signals increased after 
restraint and were clearly more abundant in wild-type mice. In contrast to CRH and Nur77, 
Nor1 cRNA probes also labeled the suprachiasmatic nucleus of the hypothalamus (data not 
shown) and cells lining the third ventricle, with the latter occurring only in stressed wild-type 
mice. CRH hybridization signals were restricted to the PVN and relatively intense per cell, 
whereas Nur77 and Nor1 mRNA expression in the hypothalamus appeared somewhat diffuse 
(Figure 20). 
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Figure 20. Restraint-induced expression of Nr4a transcription factors overlaps with CRH mRNA in the hypothalamic 
paraventricular nucleus. 14 µm-thick frozen coronal sections of brains from wild-type (+/+) and PACAP-deficient (-/-) 
mice were incubated with 35S-labeled cRNA probes for CRH, Nur77 and Nor1, and coated with autoradiographic 
emulsion. After exposure (68 h for CRH, 92 h for Nur77, 90 h for Nor1) and development, specific hybridization signals 
(white speckles = silver grains) were visualized using darkfield microscopy. Note expression of Nor1 in cells lining the 
third ventricle, which was only observed in stressed (restraint 1 h) wild-type mice. Scale bar = 100 µm. 
 
 
6.9.5. Stress-induced activation of the pituitary gland requires PACAP 
As in the hypothalamus, expression of Nr4a transcription factors in the pituitary gland was 
rapidly and robustly induced by restraint. In wild-type mice, abundance of Nur77 and Nurr1 
mRNA significantly increased within 1h, whereas no induction occurred in PACAP-deficient 
mice. After this initial peak, expression returned to baseline. Nor1 was not statistically 
significantly upregulated in either genotype, but more abundant in pituitaries from PACAP-
deficient mice after 6h of restraint (Figure 21A, following page). Although not statistically 
significant, a modest 1.5-fold increase in proopiomelanocortin (POMC) mRNA expression was 
observed in wild-types. Expression in untreated PACAP-deficient mice appeared variable, with 
two out of six pituitary samples showing mRNA levels far above this group’s average. Overall, 
POMC was more abundant in pituitaries from wild-type mice, significantly so after 6h of 
restraint (Figure 21B, following page). In a second experiment, a larger number of untreated 
mice were used to measure pituitary gene expression, and POMC mRNA in samples from 
PACAP-deficient mice was found to be 90% lower than in wild-types, confirming the trend from 

































































































Figure 21. Restraint-induced stimulus-transcription coupling in the pituitary gland depends on PACAP. Data from qRT-
PCR are displayed as means +/- SEM (N = 5-6 male mice per time point; average age: 5 months). (A, B) Restraint-
induced upregulation of Nr4a factors precedes PACAP-dependent expression of POMC mRNA. Pound signs indicate 
significant difference from the respective genotype’s control (untreated). One-way ANOVA with Dunnett’s multiple 
comparison test (#p<0.05, ##p<0.01). Asterisks indicate significant difference between genotypes. Two-way ANOVA 
with Bonferroni post-test (*p<0.05, **p<0.01, ***p<0.001). (C) Basal expression of pituitary POMC mRNA is lower in 
PACAP-deficient mice (N = 8-10 male mice per time point; average age: 5 months). Asterisks indicate difference 
between genotypes (**p=0.001; unpaired t-test). 
 
6.9.6. Stimulus-transcription coupling in the adrenal cortex triggered by 
restraint is attenuated in PACAP-deficient mice 
In the adrenal glands, all three Nr4a transcription factors were PACAP-dependently induced, as 
measured by qRT-PCR. Peak levels of mRNA expression after 1h of restraint were about 50% 
lower in PACAP-deficient compared to wild-type mice. While expression of Nurr1 and Nor1 
returned to baseline after the initial peak, Nur77 was still elevated after 3h of restraint in wild-
type and significantly higher than control after 6h in PACAP-deficient mice (Figure 22).  
 

















































Figure 22. Upregulation of inducible transcription factors in response to restraint is significantly blunted in adrenal 
glands from PACAP-deficient mice. Transcript levels were measured by qRT-PCR using both glands per animal. Data 
are displayed as means +/- SEM (N = 5 male mice per time point). Pound signs indicate significant difference from the 
respective genotype’s control (untreated). One-way ANOVA with Dunnett’s multiple comparison test (#p<0.05, 




In situ hybridization revealed that all three Nr4a family members were upregulated in the 
adrenocortical compartment, with some degree of zonal differences. Nur77 was strongly 
induced throughout the cortex, whereas Nurr1 and Nor1 were most prominently expressed in 
the outer layers (Figure 23). 
 














Figure 23. Restraint-induced upregulation of PACAP-dependent Nr4a transcription factors occurs in the adrenal cortex. 
14 µm-thick frozen sections of adrenal glands from wild-type (+/+) and PACAP-deficient mice (-/-) were incubated with 
35S-labeled cRNA probes for Nur77, Nurr1 and Nor1. Sections were coated with autoradiographic emulsion, and after 
exposure (44 h for Nur77, 48 h for Nurr1, 68 h for Nor1) and development, specific hybridization signals (white speckles 
= silver grains) were visualized using darkfield microscopy. Scale bar = 500 µm. 
 
 
Although far less pronounced than in the cortex, hybridization signals for Nur77 and Nurr1 also 
appeared to increase after restraint in the adrenal medulla (see Figure 24 for examples of 
Nur77). While bona fide quantification would require densitometry or grain counting, carried out 
systematically on larger series of sections, our preliminary results suggest that 
















Figure 24. Restraint-induced upregulation of Nur77 mRNA in the adrenal cortex and medulla. 14 µm-thick frozen 
sections of adrenal glands from wild-type (+/+) and PACAP-deficient (-/-) mice were incubated with 35S-labeled cRNA 
probes for Nur77. Sections were apposed to autoradiographic film, on which hybridization signals appear as black 
spots. Films were scanned at 2400 dpi on a conventional flatbed scanner. Resulting digital images were cropped and 
compiled. 
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6.9.7. Steroidogenic factors and biosynthetic enzymes of the adrenal cortex are 
induced during stress in a PACAP-dependent fashion 
 
Steroidogenic factor 1 (SF-1; Nr5a1), the most important adrenocortical transcription factor, 
also exhibited a PACAP-dependent expression pattern in response to restraint, providing 
further evidence for PACAP-dependent stimulus-transcription coupling in the adrenal cortex. 
Like the Nr4a factors, SF-1 belongs to the family of orphan nuclear receptors. Its expression in 
the adrenal glands was robustly elevated after 1h of restraint. Expression in wild-type mice was 
maximal after 3h, whereas PACAP-deficient mice displayed only a modest increase at 1h that 
was maintained throughout the time course of the experiment. Thus, peak expression levels of 
SF-1 mRNA were more than 50% lower compared to wild-types (Figure 25A). 
 















































Figure 25. Stressor-induced upregulation of mRNA encoding steroidogenic factor 1 (SF-1) and steroidogenic acute 
regulatory protein (StAR) in the adrenal glands is PACAP-dependent. Data from qRT-PCR are displayed as means +/- 
SEM. (A) Restraint  (N = 5-6 male mice per time point; average age: 5.5 months). Pound signs indicate significant 
difference from the respective genotype’s control (untreated). One-way ANOVA with Dunnett’s multiple comparison test 
(#p<0.05, ##p<0.01). Asterisks indicate significant difference between genotypes. Two-way ANOVA with Bonferroni 
post-test (*p<0.05, **p<0.01, ***p<0.001). (B) Hypoglycemia (N = 6 male mice per time point; average age: 5.9 
months). Pound sign indicates significant difference from the respective genotype’s control (saline). Asterisks indicate 
difference between genotypes. One-way ANOVA with Newman-Keuls multiple comparison test (#p<0.05, **p<0.01). 
 
 
Strikingly, mRNA encoding steroidogenic acute regulatory protein (StAR) was significantly 
induced after restraint in a PACAP-dependent fashion. StAR protein mediates the transfer of 
cholesterol to the inner mitochondrial membrane, thus being the limiting factor for all 
steroidogenic processes. At all time points tested, StAR mRNA was significantly elevated in 
wild-type mice, reaching a maximum at 3h. Although a modest upregulation was also observed 
in PACAP-deficient adrenal glands, abundance of StAR in wild-types was significantly higher 
after 1h and 3h of restraint (Figure 25A). Hypoglycemia elicited a similar expression pattern, 
leading to a significant difference between genotypes 3h after i.p. injection of 2 U/kg insulin. 
Compared to restraint, induction of StAR appeared somewhat less pronounced in this stress 
model (Figure 25B).  
To determine the potential contribution of steroid hydroxylase gene regulation to 
PACAP-dependent corticosterone synthesis, we measured transcript levels of all enzymes from 
the adrenocortical steroidogenic pathway (Figure 26, following page).  
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Figure 26. Transcripts encoding adrenocortical steroidogenic enzymes are induced by restraint stress, some of which 
display a PACAP-dependent pattern. Data from qRT-PCR are displayed as means +/- SEM (N = 5 male mice per time 
point; average age: 5.5 months). Pound signs indicate significant difference from the respective genotype’s untreated 
control (one-way ANOVA with Dunnett’s multiple comparison test; #p<0.05, ##p<0.01). Asterisks indicate significant 
difference between genotypes (two-way ANOVA with Bonferroni post-test; *p<0.05, **p<0.01). 
 
 
P450scc, encoding cholesterol side-chain cleavage enzyme (the first and rate-limiting enzyme 
in steroid biosynthesis), was modestly upregulated in wild-type and PACAP-deficient mice after 
3h of restraint. No difference in abundance was found when comparing the two genotypes. 
Expression of P450c17 mRNA (steroid 17-alpha-hydroxylase) was upregulated in both 
genotypes, but peak levels in wild-types at 6h were more than 3-fold higher compared to 
PACAP-deficient adrenal glands. Transcripts encoding 3ßHSD (hydroxy-delta-5-steroid 
dehydrogenase, 3 beta- and steroid delta-isomerase 1) were induced in both genotypes to a 
similar extent, but the time course in PACAP-deficient mice was shifted relative to wild-types. 
Thus, while expression in the latter group of mice was transiently elevated after 1h of restraint, 
induction in PACAP-deficient mice first occurred after 6h. P450c21 mRNA (steroid 21-
hydroxylase) was rapidly induced in wild-type mice after 1h of restraint, subsequently returning 
to baseline. No induction occurred in PACAP-deficient mice. Finally, no differences were 
observed for P45011ß (steroid 11-beta-hydroxylase), which catalyzes the last step in the 
synthesis of corticosterone, although statistically significant induction occurred only in wild-type 
mice (Figure 26).  
Overall, we found a complex expression pattern of steroid hydroxylases in the adrenal 
glands, with some PACAP-dependent components. The magnitude of regulation was modest 
except in the case of P450c17. On the other hand, stress-induced upregulation of SF-1 and 
StAR mRNA was clearly and robustly PACAP-dependent, suggesting that these two factors are 
more likely to be involved in the PACAP-dependent corticosterone biosynthesis reported here. 
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6.10. Preliminary findings 
Over the course of our experiments, preliminary data were obtained whose further analysis will 
be the subject of future studies. These data pertain to PACAP-dependent gene expression in 
the adrenal glands and brain, as well as potential effects of PACAP on development of the 
pituitary gland. 
6.10.1. Basal expression levels of hypothalamic vasopressin are attenuated in 
PACAP-deficient mice 
Basal levels of mRNA encoding vasopressin (AVP) in the hypothalamus were found to be 
highly significantly PACAP-dependent, with abundance in PACAP-deficient mice being <50% 
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Figure 27. AVP mRNA is less abundant in hypothalamus from PACAP-
deficient mice. Data from qRT-PCR are displayed as means +/- SEM (N = 10 
male mice per genotype) and were compared by unpaired t-test 
(***p<0.0001). Data are expressed as percentage of abundance in 
hypothalamus from wild-type mice (+/+). Abundance in PACAP-deficient 
mice (-/-) is >50% lower.  procedure, this difference most likely reflects differences in the PVN, 
s of the hypothalamus is largely, if not completely, excluded from the 
lds from the pituitary glands of PACAP-deficient mice are low 
d to wild-type mice 
nts, RNA yields from all tissue samples were monitored as a means of 
traction procedure. We noticed that pituitary glands from PACAP-
ly yielded less RNA than pituitary glands from wild-types. This was true 
ll as those exposed to various durations of restraint. As an example, 
ues from a group of untreated animals, in which RNA yields from 
 glands were 23% lower compared to wild-types. 
Figure 28. Pituitary glands from untreated PACAP-deficient mice 
contain significantly lower amounts of RNA. Yields of total RNA 
obtained from pituitary glands (N = 15 per genotype) were compared by 
unpaired t-test (***p<0.0001). Data are expressed as percentage of 
yield from wild-type mice (+/+). Yields from PACAP-deficient mice (-/-) 
are 23% lower. 
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6.10.3. Abundance of mRNA encoding the hop variant of the PAC1 receptor 
(PAC1hop) tends to be lower in adrenal glands from PACAP-deficient 
compared to wild-type mice 
Mouse adrenal glands express all three variants of the third intracellular loop of the PACAP-
specific PAC1 receptor (Figure 29A). PAC1hop mRNA expression levels in adrenal glands from 
PACAP-deficient mice were found to be more than 30% lower compared to wild-types, although 
this did not reach statistical significance (Figure 29B). Given the fact that PAC1hop appears to 
be the most abundant isoform in mouse adrenal glands (Figure 29A), and given the importance 
of PAC1hop in mediating secretion from adrenomedullary chromaffin cells (Mustafa et al., 
2007), analysis of basal and stress-induced expression in a larger cohort of mice is clearly 
warranted. In addition, it remains to be determined whether other variants of the PAC1 receptor 

















































































Figure 29. Expression of transcripts encoding the PACAP-specific PAC1 receptor in mouse adrenal glands and 
hypothalamus. (A) RT-PCR analysis of PAC1 receptor variant expression in mouse adrenal glands (PACAP-deficient 
animal). All three isoforms of the third intracellular loop of the PAC1 receptor are expressed, with PAC1hop being the 
most abundant. PAC1null and PAC1hip are also detected, but levels are clearly lower. Results in adrenal glands from 
wild-type mice are qualitatively similar. In lane 1, variants null and hop are indicated by an arrow and arrowhead, 
respectively. Size marker = 100 bp DNA ladder. (B) Although a trend towards lower expression in PACAP-deficient 
mice is evident, PAC1hop mRNA abundance in the adrenal glands is not statistically significantly different between 
genotypes (left panel). PAC1hop mRNA expression in the hypothalamus is unaffected by systemic stress and equally 
abundant in wild-type and PACAP-deficient mice (right panel). Data from qRT-PCR are displayed as means +/- SEM (N 
= 4-5 male mice per group) and expressed as percentage of abundance in untreated or saline-treated wild-types. 
 
 
Abundance of PAC1hop mRNA in the hypothalamus appeared unaffected by systemic stress 






6.10.4. Chemokine expression in response to hypoglycemia is enhanced in 
PACAP-deficient adrenal glands 
Microarray analysis after 3h of prolonged hypoglycemia had indicated that factors involved in 
inflammatory responses were PACAP-repressed in the adrenal glands. Thus, transcripts 
encoding Ccl2, Ccl7, Cxcl1 and IL6 were more abundant compared to wild-type, and/or 
upregulated exclusively in adrenal glands from PACAP-deficient mice (Tables 5-7, appendix). 
 


























Figure 30. Ccl2 mRNA is induced by hypoglycemia and far more abundant in 
adrenal glands from PACAP-deficient mice. Data from qRT-PCR are displayed 
as means +/- SEM (N = 4-5 male mice per time point; average age: 4 months). 
Pound signs indicate significant difference from the respective genotype’s 
untreated control (one-way ANOVA with Dunnett’s multiple comparison test; 
#p<0.05, ##p<0.01). Asterisks indicate significant difference between genotypes 
(two-way ANOVA with Bonferroni post-test; ***p<0.001). Note that Ccl2 mRNA 
abundance is higher in PACAP-deficient mice at all time points, although a 
statistically significant difference is only observed after 12h. 
 
Selecting Ccl2 as an example, we confirmed this microarray-derived result in a time course 
experiment after transient hypoglycemia, measuring Ccl2 mRNA by qRT-PCR. As shown in 
Figure 30, Ccl2 mRNA was induced in both genotypes, with maximal levels in PACAP-deficient 
mice 12h after insulin injection being 15-fold higher than in wild-types. Although not statistically 
significant due to the large induction and variability at the 12h time point, it is worth noting that 
Ccl2 mRNA abundance in untreated mice was already 8-fold higher in PACAP-/- compared to 
PACAP+/+ adrenal glands, and higher at all other time points as well. 
 
6.10.5. Vesicular glutamate transporter 2 mRNA is significantly more abundant 
in hippocampus from PACAP-deficient compared to wild-type mice 
Preliminary analysis of gene expression was carried out by qRT-PCR using samples of 
hippocampus from one hemisphere per mouse. Transcripts encoding the vesicular glutamate 
transporter isoform 2 (VGluT2) were found to be significantly more abundant in hemi-













































Figure 31. VGluT2 mRNA expression is higher in 
PACAP-deficient hippocampus. Hippocampal 
tissue was obtained from one hemisphere per 
animal, and mRNA expression levels were 
measured by qRT-PCR. Data are displayed as 
means +/- SEM (N = 5-6 male mice per time point; 
average age: 3 months). Asterisk indicates 




A similar trend was observed for VGluT1 mRNA, but this was much less pronounced and not 
statistically significant (Figure 31).  
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7. Discussion 
7.1. The PACAP knock-out mouse is a useful model for acute stress 
responses 
To study the impact of stress on an organism, and to dissect the functional role of particular 
peptides or proteins in stress responses and subsequent disease states, it is desirable to have 
access to animal models in which detailed analyses can be carried out on the behavioral, 
physiological, cellular and molecular levels. To that end, transgenic mice have been used very 
successfully in biological research, confirming the function of factors already known to be 
critical for stress responses, and uncovering important new candidates (Chourbaji et al., 2008; 
Muller et al., 2004). However, there are limitations to the usefulness of such models, especially 
when the gene of interest is mutated in every cell at every stage of development, such as in a 
“conventional” germline knock-out. Ideally, mouse models for stress would display little or no 
phenotypic differences when compared to their wild-type counterparts under basal or resting 
conditions, while showing distinct reactions when exposed to particular stressors. This would 
allow dissection of the specific pathways and factors that contribute to altered stress 
responses, based on an individual strain being more susceptible or more resilient to stress than 
a wild-type strain. A pronounced phenotype in the absence of stress, due only to the genetic 
mutation in all cells of the organism, provides a relatively unfavorable background against 
which stressor-induced mechanisms could be difficult to discern. 
The mouse strain used in the present work was created using a conventional gene 
knock-out approach, where the PACAP-coding region was replaced with a selectable marker 
via homologous recombination in embryonic stem cells (Hamelink et al., 2002). Mice from this 
strain do not express PACAP at any time in any cell, thus being completely PACAP-deficient. In 
the absence of challenge, they are healthy and appear mostly normal, i.e. show no gross 
differences from the C57BL/6 strain into which the PACAP knock-out allele has now been fully 
backcrossed. However, several features of PACAP-deficient mice have been reproducibly 
detected by different laboratories using independently created strains. Compared with wild-type 
mice, breeding deficits (Isaac and Sherwood, 2008; Shintani et al., 2002) and a leaner 
phenotype were observed (Adams et al., 2008; Tomimoto et al., 2008), both of which we 
confirmed during our present studies. Also, genetic disruption of PACAP or its specific PAC1 
receptor alters behavior, affecting the social, emotional and psychomotor phenotype (Girard et 
al., 2006; Hashimoto et al., 2001; Nicot et al., 2004; Otto et al., 2001a; Otto et al., 2001b). 
Nonetheless, for the purpose of our present studies, which are mainly concerned with PACAP’s 
role during acute neuroendocrine stress responses, PACAP-deficient mice are a useful model. 
The reasons for this view are presented in the following paragraphs. 
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7.1.1. Function of stressor-responsive systems is normal in PACAP-deficient 
mice in the absence of stimulation 
The first experiments with the PACAP-deficient strain generated in our laboratory were 
concerned with the role of PACAP at the sympathoadrenal synapse, where it is released as a 
transmitter from the splanchnic nerve and responsible for catecholamine synthesis and 
secretion during hypoglycemia-induced stress (Hamelink et al., 2002). These experiments 
showed that adrenal morphology and adrenomedullary chemical neuroanatomy are unaltered 
in PACAP-deficient mice, suggesting that development and basal function of the glands are 
normal, further supported by the fact that adrenal epinephrine content and circulating 
corticosterone concentrations do not differ between genotypes. In our present experiments, 
these findings were confirmed and extended. There were no significant differences in serum 
concentrations of ACTH or corticosterone between untreated PACAP-deficient and wild-type 
mice (Figure 16), clearly suggesting that activity and output of the HPA axis are normal in the 
absence of stimulation. 
7.1.2. Basal transcriptome profiles are largely unaffected by PACAP knock-out 
Microarray analyses provided further evidence for the notion that, in the absence of stimulation 
or challenge, tissues involved in neuroendocrine stress responses function normally in PACAP-
deficient mice. Global expression profiles of the adrenal glands yielded few differentially 
expressed genes, and the magnitude of differences between genotypes was only modest. The 
transcriptome of the cerebral cortex provided similar results (see Tables 3 and 4, appendix). 
More detailed expression analysis of specific genes by qRT-PCR corroborated these findings, 
showing that key genes involved in adrenomedullary hormone production (TH, DBH, PNMT) 
and function of the HPA axis (CRH, StAR, steroidogenic enzymes) are equally abundantly 
expressed in untreated wild-type and PACAP-deficient mice. Expression of mRNA encoding 
adrenomedullary PNMT and hypothalamic CRH tended to be slightly lower in PACAP-deficient 
mice, but this was not statistically significant. Notable exceptions to this overall pattern are 
pituitary POMC and hypothalamic AVP (lower in PACAP-/-), and hippocampal VGluT2 (higher 
in PACAP-/-).   
 
Taken together, the aforementioned data support our use of PACAP-deficient mice in 
experimental models of acute stress in vivo. Neither secretory activity nor gene expression 
patterns of the sympathoadrenal system and HPA axis are distorted by disruption of the gene 
encoding PACAP, providing a useful background for the study of stressor-induced responses 
and their underlying mechanisms. 
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7.2. Global gene expression patterns in mouse adrenal glands after 
prolonged systemic stress are difficult to interpret – sustained 
hypoglycemia in PACAP-deficient mice as a confounding factor 
Our microarray analyses of gene expression in whole adrenal glands after hypoglycemia 
revealed several interesting candidate transcripts, whose regulation was validated by qRT-PCR 
and investigated further in subsequent experiments. The overall pattern emerging from 
microarray Experiment 1 and 2 was that PACAP-repressed genes (i.e. genes induced only or 
more strongly in PACAP-deficient adrenal glands after stress) were much more numerous than 
PACAP-dependent genes (i.e. genes induced only or more strongly in wild-types; see Tables 5-
7, appendix). Somewhat surprisingly, the union of the gene lists derived from Experiment 1 and 
2 included a large number of genes (14/36 or 39%) that we had recently characterized as being 
PACAP-responsive, i.e. induced in cultured PC12 pheochromocytoma cells after treatment with 
PACAP (Eiden et al., 2008). Three examples of these were followed up in a time course 
experiment and measured by qRT-PCR after 1h, 2h, 4h and 6h of hypoglycemia. Egr1, Ier3 
and Nurr1 mRNAs were all found to increase rapidly in both genotypes, with expression levels 
returning to baseline in wild-type but persisting in PACAP-deficient mice, thus confirming the 
pattern observed by microarray after 3h of hypoglycemia (Figure 5). Stress-induced expression 
of Egr1 was further characterized by in situ hybridization and found to occur in the adrenal 
cortex and medulla in both genotypes (Figure 8). 
Two main reasons prompted us to reconsider prolonged hypoglycemia as a model in the 
context of global expression analysis. First, the numbers of PACAP-deficient mice dying after 
insulin injection were far higher than previously reported (Hamelink et al., 2002). In our 
experiments, mortality rates were up to 40% per cohort, compared to 0% in wild-type. During all 
of our experiments, wild-type mice never showed obvious symptoms of insulin shock after i.p. 
administration of 2 U/kg, while PACAP-deficient mice invariably displayed lower breathing 
rates, hyporesponsiveness to touch, and mild to massive convulsions. Hypothermia, which is a 
survival response during prolonged hypoglycemia (Buchanan et al., 1991), was also observed 
predominantly in knock-out animals. Second, our microarray experiments suggested that the 
gene expression changes seen after 3h are largely due to prolonged hypoglycemia-induced 
cellular stress, rather than directly reflecting lack of PACAPergic signaling at the 
sympathoadrenal synapse. For example, metallothionein 1 and 2 (Mt1, Mt2), genes known to 
be induced by oxidative stress (Formigari et al., 2007; Haq et al., 2003), and sulfiredoxin 
(Srxn1), a target and regulator of peroxide (H2O2)-mediated signaling (Rhee et al., 2005), were 
upregulated in the adrenal glands after hypoglycemia. Mt1 (8.15 vs 2.29-fold) and Srxn1 (5.51 
vs 3.44-fold) showed more pronounced induction in knock-out compared to wild-type mice, and 
Mt2 was induced only in the former (microarray Experiment 2). Mt1 was also found to be more 
abundant in knock-out compared to wild-type adrenal glands after 3h of sustained 
hypoglycemia (microarray Experiment 1). Given that decreased availability of glucose is well 
known to cause oxidative stress (Moley and Mueckler, 2000), it appears reasonable to assume 
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that sustained and more profound hypoglycemia in PACAP-deficient mice would exacerbate 
oxidative stress in cells of the adrenal glands. In fact, PACAP-deficient mice have very recently 
been proposed to be more susceptible to oxidative stress (Ohtaki et al., 2010). Thus, 
transcriptome patterns after 3h of hypoglycemia seem to reflect a secondary effect (e.g. 
oxidative stress) rather than the primary effect (reduced synaptic transmission) of lack of 
PACAP at the sympathoadrenal synapse. Furthermore, the extreme physiological symptoms of 
insulin shock in these animals, such as severe convulsions, possibly precipitate a whole range 
of other confounding factors, making global transcriptome analysis of peripheral tissues after 
several hours of hypoglycemia impractical. A stressor circumventing direct metabolic 
manipulation, such as restraint, would provide a more unbiased approach. 
7.3. PACAP controls the sympathoadrenal hormonal system during stress 
7.3.1. Secretory activity is coupled to expression of catecholaminergic 
enzymes and release-modulating neuropeptides 
PACAP-dependent production and secretion of adrenomedullary catecholamines (chiefly 
epinephrine) during systemic stress are a matter of life and death. Due to insufficient activation 
of tyrosine hydroxylase (TH), the enzyme that catalyzes the rate-limiting step in catecholamine 
biosynthesis, PACAP-deficient mice dose-dependently succumb to insulin-induced 
hypoglycemia (Hamelink et al., 2002). Our present experiments indicate that, in addition to the 
previously described catecholamine secretion and posttranslational control of TH, PACAP is 
required for stimulus-transcription coupling in the adrenal glands, leading to regulation of genes 
encoding catecholamine biosynthetic enzymes. In response to hypoglycemia and restraint, 
transcripts encoding TH and PNMT were PACAP-dependently upregulated in our studies 
[(Stroth and Eiden, 2010) and present results; see Figure 12]. Regulation of TH and PNMT 
during stress has been studied in great detail [reviewed in (Kvetnansky et al., 2009; Sabban 
and Kvetnansky, 2001)] and suggested to sustain adrenomedullary function during periods of 
increased secretory demand (Tai et al., 2007),  
PACAP-dependent signaling during stress was also found to increase expression of 
GAL mRNA in the adrenal medulla, both in response to hypoglycemia and restraint (Figures 9-
11). Galanin mRNA and peptide have previously been shown to be upregulated after 
hypoglycemia-induced reflex activation of the splanchnic nerve in the rat, with peptide levels 
robustly elevated for up to two weeks (Anouar and Eiden, 1995; Fischer-Colbrie et al., 1992). 
This suggests that the PACAP-dependent changes we observed after exposure of mice to two 
different stressors are indeed part of a specific adrenomedullary response pattern. Interestingly, 
a previous study in rats demonstrated that galanin potentiates epinephrine responses to a 
psychosocial stressor, without affecting epinephrine levels in unstressed animals (Ceresini et 
al., 1998). Transcript levels of VIP were also PACAP-dependent in the adrenal glands. While 
the 2.5-fold upregulation in response to hypoglycemia was not statistically significant, mRNA 
abundance was clearly higher in wild-type compared to PACAP-deficient mice (Figure 10). In 
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the perfused rat adrenal gland, VIP has been shown to stimulate secretion of catecholamines 
(Malhotra and Wakade, 1987; Wakade et al., 1991). 
In summary, it appears that PACAP, in addition to regulating the catecholaminergic 
system directly, controls expression of adrenomedullary neuropeptides that modulate 
catecholamine secretion. This could provide a mechanism for functional plasticity of the 
sympathoadrenal hormonal system, recruited specifically in response to stressful stimuli.  
7.3.2. The PAC1hop receptor is most likely responsible for PACAP’s effects 
The receptor through which PACAP controls adrenomedullary function is most likely the PAC1 
receptor, specifically the PAC1hop splice variant, based on the following observations. While all 
three PACAP receptors (PAC1, VPAC1, VPAC2) are expressed in the adrenal medulla of the 
rat (Mazzocchi et al., 2002), in situ hybridization and receptor autoradiography show that 
patterns of PAC1 mRNA expression and 125I-PACAP-27 binding are practically identical (Moller 
and Sundler, 1996). It is generally agreed that adrenomedullary effects of PACAP are largely 
mediated through PAC1 [reviewed in (Conconi et al., 2006)], and PAC1hop appears to be the 
predominant splice variant in the rat (Nogi et al., 1997) and mouse (Ushiyama et al., 2007). A 
recent study found PAC1 expression at the plasma membrane of mouse adrenomedullary 
chromaffin cells, in close apposition to PACAP-positive splanchnic nerve terminals, and 
demonstrated PACAP-evoked catecholamine secretion from mouse adrenal slices in response 
to direct electrical stimulation of the splanchnic nerve (Kuri et al., 2009). Finally, the hop 
cassette has been shown to couple calcium signaling to catecholamine secretion in cultured 
cells (Mustafa et al., 2007). Our present RT-PCR analysis clearly suggests that PAC1hop is the 
most abundant splice variant in mouse adrenal glands, confirming and extending the 
aforementioned findings. While not statistically significant, we found a trend for PAC1hop 
mRNA levels in adrenal glands from PACAP-deficient mice to be lower compared to wild-types 
(Figure 29). This preliminary result warrants further investigation into the role of PAC1hop in the 
adrenal glands, and how it is affected by PACAP knock-out. 
7.4. Rapid upregulation of inducible transcription factors in the adrenal 
glands in response to hypoglycemia – PACAP and ACh are not required  
In our experiments with insulin-induced hypoglycemia, we observed rapid upregulation of ITF in 
the adrenal glands. Within 1h of insulin injection, expression of Egr1, Fos, Fosl1, Nur77 and 
Nurr1 increased robustly in both genotypes. Only Nurr1 was affected by PACAP knock-out, 
with peak levels being about 40% lower compared to wild-type mice (Figure 6). When stressor 
exposure was transient, i.e. animals received a glucose injection 1h after insulin, ITF 
expression levels returned to baseline after the initial peak (Fosl1 being an exception). When 
stressor exposure was prolonged, expression remained elevated only in PACAP-deficient mice, 
which we confirmed by microarray and qRT-PCR analysis (see above). In both cases, as 
mentioned, rapid induction of these genes was largely unaffected by knock-out of PACAP. This 
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was somewhat surprising, as we had recently shown that all factors are PACAP-responsive in 
cell culture, i.e. upregulated after exposure of PC12 cells to PACAP (Eiden et al., 2008).  
To determine whether PACAP-independent gene regulation is mediated by 
acetylcholine (ACh), hypoglycemia was initiated in wild-type mice after pretreatment with 
nicotinic and muscarinic ACh receptor antagonists. Chlorisondamine (5 mg/kg) and atropine (1 
mg/kg) were co-administered at doses previously shown to block elevation of adrenal 
neuropeptide expression caused by hypoglycemia in rats (Kanamatsu et al., 1986). 
Surprisingly, we found that this did not appear to inhibit hypoglycemia-induced regulation of 
PACAP-independent, i.e. potentially ACh-dependent transcripts. In fact, mRNA abundance of 
Egr1 and Nur77 was robustly elevated above control values when antagonist pretreatment was 
followed by saline injection (group “antagonist control”; see Figure 7). Maximal values were 
almost identical in all groups that received cholinergic antagonists and/or insulin. 
Chlorisondamine (Santajuliana et al., 1996; Schiltz et al., 1997; Singewald et al., 1993) and 
atropine (Hamel and Ford-Hutchinson, 1985) are known to cause hypotension, which in turn 
evokes splanchnic nerve reflex activation (Donnerer, 1988; Jordan and Miller, 1991; Vollmer et 
al., 2000). Therefore, it appeared possible that PACAP release at the sympathoadrenal 
synapse, elicited by hypotension-induced splanchnic neural activity, caused adrenal gene 
regulation in the absence of cholinergic signaling in wild-type mice. This suggested that genetic 
disruption of PACAP, in combination with pharmacological inhibition of ACh, should abolish all 
sympathoadrenal transsynaptic effects. However, repetition of the above experiment in 
PACAP-deficient mice yielded practically identical results, both in terms of response magnitude 
and pattern (Figure 7). The exception was Egr1, where the two insulin-treated groups showed 
higher expression levels than the antagonist control group. 
Taken together, our results indicate that neither PACAP nor ACh are necessary for 
upregulation of ITF such as Egr1 and Nur77 in the adrenal glands during hypoglycemia. Since 
hemodynamic manipulations such as hemorrhage can activate the HPA axis (Plotsky et al., 
1985), it is possible that hypotension caused by ganglionic blockade (Hamel and Ford-
Hutchinson, 1985; Santajuliana et al., 1996; Schiltz et al., 1997; Singewald et al., 1993) 
increases ITF expression via this pathway when PACAPergic and cholinergic neural 
transmission is blocked. Alternatively, unknown neurotransmitters might stimulate adrenal gene 
expression. Although section of the splanchnic nerve could provide additional insight, there are 
precedents for stress-induced effects on gene expression in the adrenal glands that require 
neither the pituitary (ruling out involvement of the HPA axis), nor cholinergic signaling, nor the 
splanchnic nerve (ruling out the neural pathway) (Kvetnansky et al., 1996; Nankova et al., 
1994). Also, it is important to note that administration of cholinergic antagonists affected the 
phenotype of both wild-type and PACAP-deficient mice. Most remarkably, when pretreatment 
with antagonists was followed by insulin injection, wild-type mice displayed clear signs of 
hypoglycemia-induced stress, which had never been the case in experiments with insulin alone. 
Therefore, dissection of the mechanism controlling ITF expression in the absence of cholinergic 
and PACAPergic signaling might ultimately prove to be very difficult. 
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7.5. Rapid upregulation of inducible transcription factors in the adrenal 
glands during restraint – responses in PACAP-deficient mice are 
attenuated 
Expression of ITF rapidly increased in the adrenal glands in response to restraint, with maximal 
mRNA abundance of each being very similar to what was observed in response to 
hypoglycemia. However, in contrast to the latter stressor, upregulation after exposure to 
restraint was significantly blunted in PACAP-deficient mice (Figures 13 and 22). At 1h, peak 
expression of transcripts such as Egr1, Fos, Nur77, Nurr1 and Nor1 was reduced by 
approximately 50% compared to wild-type mice. With the exception of Nur77, where 
significantly elevated expression persisted in wild-types up to 3h after onset of restraint, mRNA 
abundance returned to baseline after the initial peak. 
Our data thus show that PACAP-dependent regulation of ITF in the adrenal glands is 
stressor-specific, i.e. occurs in response to restraint, but not hypoglycemia. This is in contrast to 
some of their putative target genes, such as GAL, TH and PNMT, all of which are PACAP-
dependently upregulated in response to both stressors. If factors such as Egr1 and Fos were 
critically involved in PACAP-dependent regulation of GAL, TH and PNMT, expression patterns 
in response to different stressors would have to correlate with the expression patterns of their 
putative target genes. However, as shown in our present results, this is not the case. 
7.6. What are the mechanisms underlying PACAP-dependent expression of 
adrenomedullary neuropeptides and catecholaminergic enzymes? 
There is evidence for PACAP-induced regulation of galanin (Anouar et al., 1999) and 
catecholaminergic enzymes (Choi et al., 1999; Corbitt et al., 2002; Tonshoff et al., 1997; Wong 
et al., 2002) in primary cultures of bovine adrenomedullary cells and in PC12 cells. 
Transcription factors including Egr1 and Fos have been implicated in controlling their 
expression in vitro and in vivo (Anouar et al., 1999; Kvetnansky et al., 2009; Morita et al., 1996; 
Sabban and Kvetnansky, 2001; Tai et al., 2001), and these transcription factors (among others) 
are PACAP-responsive in PC12 cells (Eiden et al., 2008). Therefore, it can not be completely 
excluded that ITF participate in stress-induced upregulation of GAL, TH and PNMT, although 
their PACAP-dependent expression patterns after hypoglycemia and restraint do not match 
(see above). To further address this issue, detailed in situ hybridization is required to localize 
expression of all ITF. Our experiments with hypoglycemia show that regulation of Egr1 occurs 
both in the adrenal cortex and medulla, and it remains to be determined whether the cortical 
and/or medullary compartment is the source of PACAP-dependent increases measured by 
qRT-PCR after exposure to restraint. 
 Our studies concerning the adrenal glands revealed one case in which expression 
patterns of transcription factor and putative target gene largely matched across stressors. Thus, 
both Nurr1 and TH were PACAP-dependently upregulated in response to hypoglycemia (some 
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experiments) and restraint (all experiments). Nurr1 is known to control TH in vitro and in vivo 
(Eells et al., 2006; Kim et al., 2003; Sakurada et al., 1999), and its potential role in PACAP-
dependent TH expression clearly warrants further investigation, even though our present 
results (see ISH, Figure 23) suggest that upregulation of its mRNA in the adrenal medulla after 
1h of restraint is relatively modest. Interestingly, Nurr1 could also be involved in the PACAP-
dependent expression of VIP mRNA reported here, as the mouse VIP gene is a transcriptional 
target of Nurr1 (Luo et al., 2007). 
There are other mechanisms that could account for the apparent discrepancy between 
expression of ITF and their putative target genes. For example, it has been proposed that 
stability and DNA binding activity of Egr1 are modulated via its phosphorylation state (Cao et 
al., 1992; Cao et al., 1993). Similarly, posttranslational control has been shown to affect the 
activities of Nr4a factors such as Nur77 and Nurr1 (Sacchetti et al., 2006; Wingate and Arthur, 
2006), and specific intracellular signaling pathways regulate translocation of Nur77 to the 
nucleus (Klopotowska et al., 2005). It is possible that such mechanisms are differentially 
recruited for target gene expression in response to specific stressors, independent of 
transcriptional regulation of ITF. Thus, protein abundance, phosphorylation status and cellular 
localization of the ITF would have to be determined. In the case of PNMT, PACAP-dependent 
corticosterone production is most likely responsible for the PACAP-dependent increase in 
mRNA expression during stress, activating transcription via the glucocorticoid receptor. 
7.7. Rapid upregulation of putative cytoprotectants in the adrenal glands is 
PACAP-dependent in response to different stressors 
The present study identified two rapid response transcripts whose expression in the adrenal 
glands was PACAP-dependently elevated by hypoglycemia and restraint (Figure 14). Ier3 has 
been implicated in regulation of apoptosis (Wu, 2003), with recent data suggesting that positive 
effects on cell survival are due to Ier3-mediated inhibition of intracellular reactive oxygen 
species (Shen et al., 2006). Stc1 has been shown to be neuroprotective, presumably by 
regulating cellular calcium homeostasis (Westberg et al., 2007; Zhang et al., 2000). Notably, 
levels of Stc1 remained elevated in the continued presence of a stressor (restraint), while 
subsiding within 5h of rest, indicating that Stc1 might be a marker for ongoing cellular 
stimulation (Figure 14B). Although it remains to be determined whether PACAP-dependent 
upregulation of Ier3 and Stc1 occurs in the adrenal cortex and/or medulla, it is tempting to 
speculate that their protein products provide protection of adrenal cells during periods of high 
secretory demand. In other words, PACAP might counter cellular stress by inducing 
cytoprotective factors. In contrast to the adrenal glands, stress-induced upregulation of both 
transcripts did not occur in the hypothalamus, suggesting that it is a tissue-specific response. 
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7.8. Responses of the HPA axis to hypoglycemia – expression of adrenal 
“index genes” suggests that PACAP-deficient mice secrete less ACTH 
and corticosterone during insulin-induced stress 
Early experiments with the PACAP-deficient mouse strain developed in our laboratory had 
indicated that its HPA axis is intact. Plasma concentrations of corticosterone were identical in 
both PACAP genotypes, at rest and in response to 2h of insulin-induced hypoglycemia 
(Hamelink et al., 2002). However, our present studies reveal that “index genes” of increased 
HPA activity are PACAP-dependently induced in response to restraint and hypoglycemia. In the 
former stress model, expression of these index genes clearly correlates with PACAP-
dependent secretion of ACTH and corticosterone. Thus, it appears that the HPA axis response 
to hypoglycemia, although initially thought to be unperturbed in PACAP-deficient mice, should 
be reexamined. 
7.8.1. Index gene 1 – StAR 
Steroidogenic acute regulatory protein (StAR) is the limiting factor for all steroidogenic 
processes. Its production is tightly linked with steroid biosynthesis in steroidogenic cells, and 
ACTH is the main hormonal stimulus for its transcriptional induction [reviewed in (Lavoie and 
King, 2009; Manna et al., 2009; Sewer and Waterman, 2003)]. The experiments presented here 
indicate PACAP-dependent upregulation of StAR mRNA in response to hypoglycemia (Figure 
25B), suggesting that ACTH (upstream of StAR) and corticosterone (downstream of StAR) are 
also PACAP-dependently increased during insulin-induced stress. 
7.8.2. Index gene 2 – PNMT 
The PNMT gene is regulated by several transcription factors [reviewed in (Kvetnansky et al., 
2009; Sabban and Kvetnansky, 2001; Wong et al., 2008)]. In vivo, glucocorticoids play a major 
role in stimulating PNMT expression (Wong et al., 1992), and stress-induced increases in 
PNMT mRNA abundance are completely abolished when the HPA axis is disrupted by 
hypophysectomy in rats (Viskupic et al., 1994). Furthermore, mice with targeted deletions of the 
glucocorticoid receptor express no PNMT (Finotto et al., 1999). Our present results show 
PACAP-dependent PNMT mRNA upregulation in response to hypoglycemia (Figure 12C), 
suggesting reduced HPA axis activity and diminished corticosterone secretion in PACAP-
deficient compared to wild-type mice. Since adrenal denervation is ineffective in blocking 
stress-induced increases in PNMT mRNA expression (Viskupic et al., 1994), it is unlikely that 
PACAP release from the splanchnic nerve is involved. 
 
Based on the aforementioned considerations, our PACAP-deficient mouse strain, now 
completely backcrossed, is going to be reexamined. Experiments are currently underway to 
compare responses of the HPA axis to hypoglycemia, lipopolysaccharide injection (systemic 
immunological stressor) and restraint. 
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7.9. Responses of the HPA axis to restraint are markedly PACAP-dependent 
The most extensive part of our present results deals with restraint-induced activation of the 
HPA axis, and how it is affected by disruption of the gene encoding PACAP in mice. PACAP-
dependent phenomena were observed at all three levels (hypothalamus, pituitary gland, 
adrenal cortex), suggesting a link between neuronal activation, stimulus-transcription coupling, 
as well as production and secretion of hormones throughout the HPA axis. The following 
paragraphs will discuss these phenomena in detail. 
7.9.1. Expression of CRH in the paraventricular nucleus in response to stress – 
evidence for PACAP mediating central control of the HPA axis 
Coordination of mammalian stress responses is achieved through complex circuitry that senses 
stressors, signals to the central nervous system, integrates afferent information and generates 
adequate output. Although different stressors elicit different patterns with relatively specific 
neurochemical and neuroendocrine “signatures” (Goldstein and Kopin, 2008; Pacak and 
Palkovits, 2001), the hypothalamic PVN is invariably involved in the generation of these 
responses. With respect to activation of the HPA axis, specialized neurons in the PVN that 
express and release CRH represent the central relay station. These neurons summate 
excitatory and inhibitory inputs from a multitude of sources into a hypophysiotropic secretory 
signal, which in turn dictates the magnitude and duration of pituitary and adrenocortical 
activation (Herman and Cullinan, 1997; Herman et al., 2003).  
PACAP emerged as a potential regulator at this very central locus, based on several 
important findings. First, PACAP-containing nerve terminals form synaptic contacts with CRH-
immunoreactive neurons in the PVN (Legradi et al., 1998). Second, intracerebroventricular 
(i.c.v.) administration of PACAP causes upregulation of CRH mRNA (Grinevich et al., 1997) 
and secretion of corticosterone (Agarwal et al., 2005; Yi et al., 2010). Providing direct in vivo 
evidence for the significance of these findings and the functional relevance of the endogenous 
PACAPergic system, we recently showed that CRH mRNA induction is completely abolished, 
and sustained corticosterone secretion is diminished, in PACAP-deficient mice exposed to 
restraint (Stroth and Eiden, 2010). We subsequently confirmed these crucial results and 
significantly expanded them, proposing potential mechanisms for PACAP-dependent control of 
hypophysiotropic neurons.  
In two independent experiments, we quantified CRH mRNA in hypothalamic extracts 
from wild-type and PACAP-deficient mice, using qRT-PCR. In response to varying durations of 
prolonged restraint, transcript abundance increased compared to untreated controls, 
exclusively in wild-type mice (Figure 17). This was very reproducible, varying only within a 
narrow range of 1.75-fold to 2.15-fold induction, suggesting that there is a maximum level of 
CRH mRNA expression in the PVN, which is not exceeded by the particular stressor employed 
in our studies. Interestingly, expression of CRH was not maintained when stressor exposure 
was only transient, such that transcript abundance had returned to baseline 5h after a 1h period 
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of restraint. An additional experiment confirmed, by in situ hybridization, that the change in 
CRH expression indeed occurred exclusively in the PVN of the hypothalamus. 
7.9.2. Restraint-induced pituitary function is attenuated 
Our present experiments show that output of the pituitary gland is normal in unstressed 
PACAP-deficient mice, as indicated by serum concentrations of ACTH being identical with 
those in wild-types. However, after exposure to restraint, increases in ACTH secretion are 
markedly blunted, and this effect becomes more pronounced with increasing duration of the 
stressor (Figure 16). Together with the pituitary expression pattern of Nur77 and Nurr1, this 
clearly shows that stimulation of the gland is strongly diminished (Figure 21). The most obvious 
potential explanation is that CRH, the principal hypophysiotropic factor (Denver, 2009), is 
PACAP-dependently regulated during stress, for which our experiments provide important 
evidence. Thus, stored CRH peptide appears initially sufficient for causing ACTH secretion, but 
as stressor exposure is sustained, and no compensatory CRH biosynthesis occurs in PACAP-
deficient mice [(Stroth and Eiden, 2010), and present results], pituitary output becomes 
increasingly PACAP-dependent. In rats, it has been shown that PACAP is released into the 
hypophyseal portal blood (Dow et al., 1994), and about 50% of ACTH-producing cells bind 
PACAP (Vigh et al., 1993), suggesting that PACAP could also directly stimulate anterior 
pituitary hormone secretion in vivo (Rawlings and Hezareh, 1996), perhaps acting in parallel 
with CRH. PACAP-induced secretion of ACTH also occurs in cultured anterior pituitary cell lines 
(Aoki et al., 1997; Boutillier et al., 1994; Braas et al., 1994; Koch and Lutz-Bucher, 1992; 
Propato-Mussafiri et al., 1992), although doubts have been raised with respect to the in vivo 
relevance of these findings (Rawlings and Hezareh, 1996). 
Despite normal basal ACTH output, two pieces of evidence from our experiments 
suggest that the pituitary gland in PACAP-deficient mice is itself predisposed towards 
responding insufficiently to stressors. First, RNA yields from pituitaries are >20% lower in 
PACAP-deficient mice, suggesting that the glands are smaller in size (Figure 28). Second, 
abundance of POMC mRNA, the precursor from which ACTH is ultimately derived, is 
significantly diminished (Figure 21). While neither result can automatically be attributed to the 
anterior pituitary, i.e. the compartment most relevant for the HPA axis, it is clearly warranted to 
further investigate whether pituitary weight, size and cellular composition differ between 
PACAP genotypes, and whether expression of the POMC or ACTH peptides is reduced. Given 
that PACAP is known to stimulate POMC promoter activity as well as hnRNA and mRNA 
expression in pituitary cells and pituitary-derived cell lines (Aoki et al., 1997; Boutillier et al., 
1994; Braas et al., 1994; Rene et al., 1996), our results may suggest that tonic PACAP release 
is required for normal POMC expression levels in vivo, and perhaps for completely normal 
development of the pituitary gland. 
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7.9.3. Restraint-induced corticosterone production and secretion is blunted 
Historically, it was thought that the adrenal cortex stores little of its secretory products 
(Holzbauer, 1957; Vogt, 1943), whereas recent functional and ultrastructural data suggest that 
some form of storage may occur (Mohn et al., 2005). Our results clearly indicate that inducible 
and sustained adrenocortical steroidogenesis is required for a fully intact response to stressors 
such as restraint. This inducible steroidogenic response is impaired in PACAP-deficient mice, 
whereas basal corticosterone concentrations in serum are normal (Figure 16). Although steroid 
production and secretion in the adrenal cortex are chiefly mediated through ACTH via the HPA 
axis, there is evidence for functional innervation of the adrenal cortex by the sympathetic 
splanchnic nerve (Engeland, 1998). Specifically, it appears that the splanchnic nerve modulates 
adrenocortical responses during stress by increasing adrenal sensitivity to ACTH (Ulrich-Lai 
and Engeland, 2002). 
Our results clearly indicate that PACAP-dependent corticosterone secretion in response 
to prolonged restraint is controlled far upstream of the adrenal cortex. Activation of the 
hypophysiotropic PVN is diminished in PACAP-deficient mice, including insufficient CRH 
biosynthesis. This in turn causes the pituitary response to fail, resulting in strongly attenuated 
secretion of ACTH. Consequently, the expression of adrenocortical transcription factors (SF-1, 
Nur77, Nurr1 and Nor1) and StAR, important for regulation of steroidogenic enzyme expression 
and steroid biosynthesis, respectively, is inadequately stimulated (Figures 22, 23 and 25), and 
corticosterone production is impaired. The expression patterns of Nur77 and Nurr1 observed in 
our experiments are in exact agreement with those elicited by ACTH injection (Davis and Lau, 
1994), further strengthening our notion that the impaired adrenocortical response of PACAP-
deficient mice is indeed due to impaired activation of the HPA axis. 
7.10. Nr4a orphan nuclear receptors – inducible transcription factors with 
important potential roles throughout the HPA axis 
The Nr4a family of orphan nuclear receptors has been implicated in regulation of the HPA axis, 
mostly based on their function as transcription factors. For example, Nur77 and Nurr1 enhance 
transcriptional activity of the CRH and POMC gene promoters, while also being induced by 
CRH treatment in pituitary cells, thereby mediating expression of hypothalamic and pituitary 
stress hormones (Kovalovsky et al., 2002; Murphy and Conneely, 1997; Philips et al., 1997a; 
Philips et al., 1997b). In addition, induction of Nur77 and Nurr1 has been observed in the 
adrenal glands in response to stress or ACTH injection (Davis and Lau, 1994; Honkaniemi et 
al., 2000), showing that all three compartments of the HPA axis are likely targets of Nr4a-
mediated effects. Our present results provide important new insights into the expression of 
Nr4a factors during stress in vivo. 
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7.10.1. Potential role in PACAP-dependent expression of CRH in the PVN 
When CRH is released during stress responses, compensatory biosynthesis is achieved 
primarily through enhanced CRH gene transcription (Aguilera et al., 2007). The CRH promoter 
is highly conserved across species and contains a number of response elements for different 
transcriptional regulators, including an NGFI-B response element (NBRE) (Yao and Denver, 
2007) that can be bound by the Nr4a family of orphan nuclear receptors. Via ligand-
independent, monomeric and homo- or heterodimeric binding to their shared DNA response 
elements (NBRE and NurRE), Nr4a factors activate target gene promoters, with specific 
combinations effecting gene- and sequence-specific response patterns (Maira et al., 1999). The 
CRH promoter also includes binding sites for the glucocorticoid receptor (Yao and Denver, 
2007). The glucocorticoid receptor (GR) is a nuclear receptor that binds corticosterone and 
controls negative feedback within the HPA axis, required for appropriate termination of acute 
stress responses, partly via repression of CRH transcription (Aguilera et al., 2007).  
A number of studies have shown that within the rodent hypothalamus in vivo, stress 
induces increases in Nur77 expression that occur in the paraventricular nucleus (PVN), where 
CRH-containing neuroendocrine neurons are located (Chan et al., 1993; Honkaniemi et al., 
1994; Imaki et al., 1996; Kovacs and Sawchenko, 1996b; Umemoto et al., 1994; Umemoto et 
al., 1997). Furthermore, CRH induces Nur77 expression in the PVN in vivo, potentially as a 
means of autoregulation (Parkes et al., 1993). In our present experiments, expression of Nur77 
and Nor1 in the hypothalamus was found to be rapidly induced in response to restraint, and our 
in situ hybridization data show that Nur77 and Nor1 mRNA indeed overlaps with CRH mRNA in 
cells of the PVN (Figures 19 and 20). Regulation of Nur77 and Nor1 was significantly blunted, 
and regulation of CRH completely abolished, in PACAP-deficient compared to wild-type mice. 
Transcriptional activation of the CRH promoter has been shown for Nurr1 (Murphy and 
Conneely, 1997), and Nr4a factors are known to antagonize GR-mediated negative feedback 
via protein-protein interactions and competition for DNA binding (Martens et al., 2005; Philips et 
al., 1997b). Thus, the PACAP-dependent upregulation of Nur77 and Nor1 we observed could 
theoretically affect CRH expression directly (activation) and indirectly (inhibition of negative 
feedback). The latter scenario has previously been proposed for the AP-1 transcription factors 
Fos and Jun (Umemoto et al., 1997). However, several pieces of evidence suggest that neither 
ITF nor protein synthesis are required for immediate increases in CRH gene transcription. First, 
the time course with which ITF and putative target genes are upregulated in the PVN during 
stress do not appear to match (Imaki et al., 1996; Kovacs and Sawchenko, 1996a; Kovacs and 
Sawchenko, 1996b). Second, injection of antisense oligonucleotides against Fos or Jun into the 
PVN (Itoi et al., 1996) or systemic administration of cycloheximide (Kovacs et al., 1998) is 
ineffective in blocking hypoglycemia- or ether-induced increases in CRH mRNA or hnRNA, 
respectively. Based on this, it would appear more likely that Nr4a factors control sustained CRH 
mRNA expression via inhibition of GR-mediated negative feedback, rather than acute and 
direct transcriptional activation.  
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Most studies clearly point towards cAMP responsive element binding protein (CREB) 
as the dominant activator of immediate stress-induced CRH gene transcription [see for 
example evidence provided by (Itoi et al., 1996; Kovacs et al., 1998)]. In this regard, it is 
important to note that phosphorylation of CREB in CRH-positive neurons has been observed 
after i.c.v. injection of PACAP (Agarwal et al., 2005). Thus, it is tempting to speculate that 
PACAP activates a) CREB to control immediate transcriptional induction of CRH, and b) Nr4a 
factors to maintain CRH expression in the face of elevated glucocorticoid levels. In fact, given 
that all three Nr4a factors are known transcriptional targets of CREB, as are the PACAP-
dependent transcription factors Egr1 and Fos (Impey et al., 2004), it is possible that 
PACAPergic signaling in the PVN controls PACAP-dependent expression of ITF via activation 
of CREB (see Figure 32 for a schematic summary of this proposed mechanism). Supporting 
this notion, a very recent study showed that the Nr4a factors are induced by CREB and 













Figure 32. Schematic representation of putative molecular mechanisms by which PACAP controls expression of CRH 
mRNA in the PVN during stress responses in vivo. Question mark indicates that the source of PACAPergic signals 
impinging on neurons in the PVN (or hypothalamic areas in the vicinity) is not known with certainty (see section 7.11). 
Plus signs indicate stimulation, minus signs indicate inhibition. See text for details and abbreviations.  
 
 
At the least, regardless of the postulated molecular mechanisms, PACAP-dependent induction 
of Nur77 and Nor1 as reported here indicates PACAP-dependent functional activation of PVN 
neurons (Chan et al., 1993). The fact that CRH mRNA upregulation is completely abolished in 
PACAP-deficient mice strongly supports the notion that PACAP controls the HPA axis at this 
central locus. Our finding of Nurr1 expression being unaffected by stressor exposure is in 
agreement with previous work (Honkaniemi et al., 1994). Future experiments could address 
potential colocalization of CRH peptide with Nur77 and Nor1 proteins, using standard 
immunohistochemical techniques, to see whether they are indeed expressed in the very same 
hypophysiotropic neurons. Also, it would be very interesting to determine whether Nur77 and 
Nor1 actually bind to the CRH gene promoter after stressor exposure in vivo, and whether there 
are other genes in hypophysiotropic neurons regulated by these transcription factors. 
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Experiments in cell culture could be used to determine whether knock-down of the Nr4a family 
interferes with target gene expression (such as sustained CRH mRNA elevation), e.g. by 
application of RNA interference to primary hypothalamic neurons. Unfortunately, the mouse 
hypothalamic cell lines we intended to use for this purpose did not express CRH, although they 
had been advertised as such (results not shown). 
7.10.2. Potential role in control of pituitary function during stress 
Transcripts encoding the three Nr4a factors are upregulated by CRH in pituitary cells and the 
pituitary-derived cell line AtT-20 (Kovalovsky et al., 2002; Maira et al., 1999; Murphy and 
Conneely, 1997). The POMC gene promoter is known to be controlled by Nr4a factors 
(Fernandez et al., 2000; Kovalovsky et al., 2002; Maira et al., 1999; Martens et al., 2005; 
Murphy and Conneely, 1997), implicating them as mediators of CRH effects. Furthermore, a 
Nur-responsive element (NurRE) in the POMC promoter is crucial to integration of positive 
(Nr4a-mediated activation) and negative (GR-mediated glucocorticoid feedback) signals 
affecting POMC mRNA expression (Martens et al., 2005; Murphy and Conneely, 1997; Philips 
et al., 1997b). In our current experiments, POMC was found to be upregulated only modestly 
(1.5-fold at 6h versus untreated mice), which only occurred in wild-type mice but did not reach 
statistical significance (Figure 21). This suggests that rapid PACAP-dependent upregulation of 
Nur77 and Nurr1 may contribute to inhibition of negative feedback, perhaps by binding to GR 
(Martens et al., 2005), rather than directly activating POMC expression, although the latter is 
also possible. Absence of induction (Moncek et al., 2001) and elevated hnRNA, but unchanged 
mRNA (Noguchi et al., 2006), have previously been reported for POMC in response to brief 
acute stress. Other studies indicate that repeated stressor exposure maximally increases 
POMC mRNA (Marti et al., 1999; Noguchi et al., 2006). PACAP-dependent Nr4a factor 
induction in the pituitary could therefore support POMC expression during sustained or chronic 
stress, and the phenotype of PACAP-deficient mice during such paradigms is the subject of 
future experiments. 
Glucocorticoid-dependent negative feedback regulation of ACTH secretion is firmly 
established (Keller-Wood and Dallman, 1984), and some evidence indicates that it requires 
new mRNA and protein synthesis (Dayanithi and Antoni, 1989). Notably, overexpression of 
Nur77 has been shown to antagonize GR-mediated inhibition of ACTH secretion (Okabe et al., 
1998), suggesting that PACAP-dependent upregulation of Nr4a factors in vivo could maintain 
ACTH output of the pituitary via this non-genomic mechanism. See Figure 33 (following page) 














Figure 33. Schematic representation of putative molecular mechanisms by which PACAP controls expression of 
POMC mRNA in the pituitary gland in vivo. Basal stimulatory effects are deduced from significantly reduced POMC 
mRNA abundance in pituitary glands from PACAP-deficient mice. Inducible expression (although modest in response 
to acute stressors) is proposed to proceed via PACAP- and CRH-dependent induction of Nr4a factors (see section 
7.10.2). Plus signs indicate stimulation, minus signs indicate inhibition. See text for details and abbreviations. 
 
7.10.3. Potential role in adrenocortical stimulus-transcription coupling 
Our experiments show that all three Nr4a family members are PACAP-dependently 
upregulated in the adrenal cortex during stress. Rapid and pronounced increases in 
adrenocortical Nur77 and Nurr1 expression are consistent with the literature (Davis and Lau, 
1994; Honkaniemi et al., 2000) whereas, to our knowledge, we are the first to describe 
stressor-induced increases in Nor1 abundance. The zone-specific expression patterns of the 
three factors were distinct, with Nur77 showing strong upregulation throughout the cortex, while 
Nurr1 and Nor1 were most prominently induced in the outer layers (Figure 23). The pattern we 
observed for Nur77 and Nurr1 is in agreement with previous reports and identical with that 
elicited by ACTH injection (Davis and Lau, 1994), suggesting that PACAP-dependent Nr4a 
induction in adrenocortical cells is a direct consequence of the PACAP-dependent ACTH 
secretion shown here. 
ACTH controls all of the factors required for adrenocortical steroid biosynthesis, 
including those that produce corticosterone. Most of these are subject to transcriptional control 
by SF-1 (Nr5a1) (Sewer and Waterman, 2003), another member of the orphan nuclear receptor 
superfamily. In the present experiments, SF-1 mRNA was found to be significantly upregulated, 
with expression levels reaching a peak after 3h of restraint, a response that was significantly 
attenuated in PACAP-deficient mice (Figure 25). 
Most importantly, we found mRNA encoding steroidogenic acute regulatory protein 
(StAR) to be PACAP-dependently induced in the adrenal glands in response to stress (Figure 
25). StAR is the limiting factor for steroidogenesis, mediating the transfer of cholesterol (the 
precursor for all steroids) to the inner mitochondrial membrane. Production of its mRNA and 
protein are tightly linked, as well as tightly coupled to steroid biosynthesis (Manna et al., 2009). 
Transcriptional activators of StAR include SF-1 as well as the Nr4a family (Lavoie and King, 
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2009; Martin et al., 2008; Martin and Tremblay, 2009). Since Nur77, Nurr1 and Nor1 were all 
PACAP-dependently induced in the adrenocortical compartment, in addition to SF-1, our data 
suggest that their upregulation and subsequent increases in StAR provide the link between the 
PACAP-dependent ACTH release and PACAP-dependent sustained corticosterone secretion 
demonstrated in the present work.  
7.11. Is PACAP released in the PVN? If so, where does it come from, and how 
does it induce excitatory signaling to mediate stress responses?  
Based on the immediate behavioral effects of intracerebroventricular (Agarwal et al., 2005) and 
intra-PVN infusions (Norrholm et al., 2005), as well as the extensive histochemical and 
endocrinological evidence cited earlier, including our own, it has convincingly been 
demonstrated that PACAP’s acute role in stressor-responsive pathways is that of an excitatory 
agent. However, at the central level, it is not known whether this is truly direct, i.e. elicited by 
PACAP via binding to receptors on hypophysiotropic and preautonomic neurons in the PVN, or 
via modulation of other transmitter systems. Also, the regional and cellular sources of PACAP-
dependent effects are not completely known, such that the underlying neurochemistry and 
neurocircuitry have yet to be fully elucidated. Figure 34 is a schematic depiction of known 
PACAPergic pathways impinging on the PVN, as well as subsequent compartments involved in 
the generation of stress responses. Note that only those compartments are represented in 























Figure 34. Schematic of PACAPergic stress-responsive pathways. Abbreviations: CAergic bundle, catecholaminergic 
bundle; IML, intermediolateral column; PVN, paraventricular nucleus of the hypothalamus; VLM, ventrolateral medulla. 
Note that the most likely sources of PACAP release in the PVN are the brain stem and hypothalamus. Question mark 
indicates that there could be multiple additional sources, which are unknown. See text for details and references. 
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PACAP is expressed in several regions of the nervous system that are directly connected with 
the PVN. Neurons in cell groups A1, A2 and C1-C3 of the ventrolateral medulla oblongata 
(VLM) send projections to the PVN via the ventral catecholaminergic bundle. This bundle of 
nerve fibers is activated during stress (Pacak and Palkovits, 2001), and PACAP was recently 
found to be expressed in a subpopulation of catecholaminergic neurons in the VLM (Das et al., 
2007; Farnham et al., 2008). Microdialysis studies have previously shown that PACAP potently 
causes release of norepinephrine (NE) in the PVN (Huang et al., 1996). Furthermore, it is well 
documented that NE participates in stimulation of PVN neurons, mainly by driving an excitatory 
glutamatergic relay system (Herman et al., 2002). Thus, it is possible that PACAP modulates 
NE-mediated signaling, rather than, or in addition to, stimulating neurons in the PVN directly. 
Complicating the issue even further, PACAP-immunoreactive cell bodies and nerve fibers are 
found very abundantly throughout the hypothalamus, including the PVN (Hannibal, 2002), and 
several PACAP-expressing subregions of the hypothalamus project to the PVN (Das et al., 
2007). Given that the microenvironment of the PVN is very complex and involves multi-
directional signaling via multiple systems, including classical transmitters, peptides and 
gaseous substances (Herman et al., 2002), it will be very challenging to dissect the 
mechanisms through which PACAP exerts its prominent effects. Based on the distribution and 
known functions of PACAP in the aforementioned circuits, direct and indirect neurotransmitter 
effects, as well as paracrine/autocrine signaling, are possible sources of PACAP-dependent 
stimulation of the PVN. 
Within the PVN, PACAP has access to the HPA axis and autonomic nervous system 
via hypophysiotropic and preautonomic neurons, respectively (Das et al., 2007; Yi et al., 2010). 
Release of PACAP into the hypophyseal portal blood (Dow et al., 1994) may act in parallel with 
PACAP-dependent CRH to stimulate the anterior pituitary. PACAP-containing neurons of the 
brain stem that project to the intermediolateral column (IML) of the spinal cord (Das et al., 2007; 
Farnham et al., 2008) are sources for PACAP-dependent effects mediated via sympathetic 
nerves (Das et al., 2007; Farnham et al., 2008; Yi et al., 2010). Finally, PACAPergic innervation 
of the adrenal medulla, originating in the IML, has been shown to control responses to insulin-
induced hypoglycemia (Hamelink et al., 2002).  
Taken together, PACAP is found in several relay stations within the neuroendocrine 
circuitry that senses stressor exposure in the periphery, signals to the CNS, and elaborates 
adequate responses. Disruption of the gene encoding PACAP is therefore likely to affect neural 
signaling at multiple levels. Nevertheless, we propose that PACAP, originating from neurons 
either in the brain stem and/or hypothalamus (Das et al., 2007; Farnham et al., 2008; Hannibal, 
2002), is released in the PVN to directly affect CRH production and activation of 
hypophysiotropic (and perhaps preautonomic) cell groups. We further argue that the PACAP-
dependent expression of CRH, Nur77 and Nor1 mRNA in response to restraint, described in 
the present experiments, could serve as an index of this mechanism. This argument is based 
on the expression pattern of the PACAP-specific PAC1 receptor in the PVN, whose mRNA 
overlaps largely with mRNA encoding CRH (Nomura et al., 1996), and our finding that Nr4a 
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factors are rapidly induced by PACAP in a neuroendocrine cell line expressing PAC1 (Eiden et 
al., 2008). 
7.12. PACAP mouse models and mental health – what is the “state of the art”? 
Mice with mutations in the genes encoding PACAP or PAC1 have been shown to display 
abnormalities in prepulse inhibition, social behaviors, learning, fear and locomotion. This has 
led to the suggestion that they might be useful models for a whole range of psychiatric 
conditions, including schizophrenia, anxiety, depression, and attention deficit hyperactivity 
disorder (ADHD) (Girard et al., 2006; Hashimoto et al., 2009; Hashimoto et al., 2001; Ishihama 
et al., 2010; Nicot et al., 2004; Otto et al., 2001a; Otto et al., 2001b; Shintani et al., 2006; 
Tanaka et al., 2006). Human association studies of the genes encoding PACAP and PAC1 
appeared to strengthen the view that PACAP signaling is involved in neurobiological 
mechanisms underlying schizophrenia and major depressive disorder (Hashimoto et al., 2007; 
Hashimoto et al., 2010). However, other studies suggested that genetic susceptibility to 
schizophrenia is unlikely to be substantially affected by single-nucleotide polymorphisms in the 
gene encoding PACAP (Ishiguro et al., 2001; Koga et al., 2010). PACAP was also proposed to 
mediate therapeutic effects of lithium in bipolar disorder (Brandish et al., 2005), but genetic 
association studies in humans yielded negative results (Ishiguro et al., 2001; Lohoff et al., 
2008). Thus, it is clear that there is still a gap between our understanding of the molecular and 
cellular mechanisms of PACAP signaling, animal models of altered PACAP signaling function, 
and the human psychiatric disease states in which PACAP is potentially implicated. Despite the 
limitations in translation of experimental findings from mice to humans, animal models will 
continue to be critical in dissecting the biology of mental health (Berton and Nestler, 2006; 
Crawley et al., 1997; Kalueff et al., 2007).  
7.13. PACAP, chronic stress, anxiety and depression – problems and 
perspectives 
Glucocorticoids are highly pleiotropic molecules that have important effects on virtually every 
physiological system in the body. Thus, the consequences of elevated glucocorticoid 
concentrations during stress are very complex, entailing both positive and negative aspects 
(Sapolsky et al., 2000). Nevertheless, it is quite clear that chronic stress and chronic 
hypersecretion of glucocorticoids, acting in concert with genetic predispositions and 
environmental determinants, are risk factors for many illnesses. These include neurological and 
psychiatric diseases, such as anxiety disorders and depression [reviewed in (Chrousos, 2009; 
Cohen et al., 2007; de Kloet et al., 2005; Herman and Seroogy, 2006)].  
Since we and others have shown that basal corticosterone concentrations are normal 
in PACAP-deficient mice, but circadian fluctuations and responses to stressors are blunted 
[present results, as well as (Hashimoto et al., 2009; Morita et al., 2006; Stroth and Eiden, 
2010)], we predict that PACAP-deficient mice will be less susceptible to the effects of chronic 
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stress, and thus less likely to develop anxiety or depression. In other words, disruption of 
PACAP signaling is expected to diminish or abolish hypersecretion of corticosterone during 
chronic stress, while maintaining glucocorticoid concentrations necessary for survival and 
normal function. Lending preliminary support to this idea, PACAP- and PAC1-deficient mice 
display strongly reduced anxiety-like behavior compared to wild-types (Girard et al., 2006; 
Hashimoto et al., 2001; Otto et al., 2001b), and administration of PACAP into the central 
amygdala has been shown to promote a shift from active to passive coping mechanisms in 
response to electric shock (Legradi et al., 2007). Furthermore, chronic stress causes 
upregulation of PACAP and PAC1 in the bed nucleus of the stria terminalis (BNST), and 
infusion of PACAP into this area elicits a long-lasting anxiogenic response (Hammack et al., 
2009). These findings provide evidence for the notion that PACAP is an anxiogenic factor in 
vivo, and thus potentially represents a target for psychiatric conditions such as anxiety and 
depression. However, PACAP-deficient mice have also been reported to display increased 
depression-like behavior compared to wild-types (Hashimoto et al., 2009), an observation that 
does not fit with the aforementioned decrease in anxiety-like behaviors. One of the challenges 
in this context is the absence of unequivocal distinctions between anxiety and depression, both 
in humans and in rodent models (Berton and Nestler, 2006), an issue that is further 
complicated by numerous problems associated with the use of animal models for stress-
triggered psychiatric diseases (Kalueff et al., 2007).  
The phenotype of PACAP-deficient mice in chronic stress paradigms has not yet been 
investigated, and this is an interesting future direction. As a behavioral model for stress-induced 
anxiety and depression, the usefulness of this approach might be hampered by the fact that 
mice with a disrupted PACAP-PAC1 signaling system already display strongly reduced anxiety 
in the absence of challenge, as mentioned above (Girard et al., 2006; Hashimoto et al., 2001; 
Otto et al., 2001b). In general, it would be preferable to have a strain in which behavioral 
differences between genetically altered and wild-type mice only manifest after stressor 
exposure, as this would be required for etiological validity of the model (Berton and Nestler, 
2006). For example, mice with a 50% reduction in GR expression levels show depression-like 
behavior only after stress, thus mimicking the human situation more closely (Chourbaji et al., 
2008). Nevertheless, it will be worthwhile to determine whether PACAP-deficient mice display 
exacerbated or diminished endocrine and neurochemical symptoms of chronic stress, and what 










7.14. Concluding remarks and future directions 
Our experiments have provided solid evidence for the notion that PACAP is a major player in 
orchestrating acute stress responses in vivo. As shown by Hamelink and others, PACAP’s 
neurotransmitter role at the sympathoadrenal synapse is a matter of life and death, controlling 
synthesis and secretion of catecholamines from adrenomedullary chromaffin cells during 
hypoglycemia-induced stress (Hamelink et al., 2002). As shown by the present results, this is 
paralleled by PACAP-dependent induction of catecholaminergic enzyme synthesis, as well as 
release-modulating neuropeptides. Furthermore, we have identified endogenous PACAP as a 
crucial regulator of CRH-expressing neurons in the hypothalamic PVN, the central integrator of 
all stress responses (Herman and Cullinan, 1997). Thus, by controlling the HPA axis far 
upstream, PACAP is required for the acute response to stressors such as restraint, as shown 
by significantly blunted hormone secretion in PACAP-deficient mice. Our results also suggest 
that this entails a PACAP-dependent wave of stimulus-transcription coupling throughout the 
HPA axis, possibly involving Nr4a orphan nuclear receptors at all levels, which is triggered by 
PACAP-dependent stimulation of the PVN.  
Future experiments will determine how PACAP affects responses to chronic stressors 
on the endocrine and cellular levels. In addition, and perhaps most importantly, they will 
address the mechanisms underlying PACAP-mediated central control at the level of the 
hypothalamus. Is PACAP directly affecting neurons in the PVN by binding to PAC1? Or does 
PACAP modulate signaling via the classical transmitters, such as glutamate, GABA and 
norepinephrine? Experimental systems such as primary cultures or acute tissue preparations 
are possible tools to address these questions. By understanding PACAP-induced signaling in 
more detail, we hope to discover potential molecular targets for therapeutic intervention, such 
as during chronic stress-induced mental illness. As mentioned earlier, PACAP appears to be a 
reasonable candidate, based on the fact that its genetic disruption allows basal function of the 
HPA axis to proceed normally, while most likely dampening excessive glucocorticoid secretion 
during persistent and chronic stimulation. Thus, there are still many exciting questions 
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ACh  acetylcholine 
ACTH  adrenocorticotropic hormone 
ADHD  attention deficit hyperactivity disorder 
ANOVA  analysis of variance 
ANS  autonomic nervous system 
ATP  adenosine-5'-triphosphate 
BLAST  basic local alignment search tool 
bp  base pair 
cAMP  cyclic adenosine monophosphate 
cDNA  complementary DNA  
CREB  cAMP responsive element binding protein 
CRH  corticotropin-releasing hormone 
CTP  cytidine-5'-triphosphate 
DEPC  diethylpyrocarbonate 
DNA   deoxyribonucleic acid 
DNase  deoxyribonuclease 
dNTP  deoxyribonucleoside triphosphate 
dpi  dots per inch 
dpm  decays per minute 
DTT  dithiothreitol 
EDTA  ethylene-diamine-tetraacetic acid  
EIA  enzyme immunoassay 
ELISA  enzyme-linked immunosorbent assay 
GPCR  G protein-coupled receptor 
GR  glucocorticoid receptor 
GTP  guanosine-5'-triphosphate 
HCl  hydrochloric acid 
hnRNA  heterogenous nuclear RNA 
HPA axis  hypothalamic-pituitary-adrenocortical axis 
i.c.v.  intracerebroventricular 
i.p.  intraperitoneal 
IML  intermediolateral column of the spinal cord 
IPTG  isopropyl-ß-D-thiogalactopyranoside 
ISH  in situ hybridization histochemistry 
ITF  inducible transcription factor(s) 
IVT  in vitro transcription 
kb  kilobases 
KO  knock-out 
LOWESS  locally weighted scatterplot smoothing 
MgCl2   magnesium chloride 
mRNA  messenger RNA 
NaCl  sodium chloride 
NBRE  NGFI-B responsive element 
NE  norepinephrine 
NGFI-B  nerve growth factor-induced clone B 
NHGRI  National Human Genome Research Institute 
NIH  National Institutes of Health 
NIMH  National Institute of Mental Health 
NINDS  National Institute of Neurological Disorders and Stroke 
NurRE  Nur response element 
O.C.T.  optimal cutting temperature 
PACAP  pituitary adenylate cyclase-activating polypeptide 
PBS  phosphate-buffered saline 
PCR   polymerase chain reaction  
PTSD  posttraumatic stress disorder  
PVN  paraventricular nucleus of the hypothalamus 
qPCR  quantitative PCR 
qRT-PCR  quantitative reverse transcription PCR 
RIA   radioimmunoassay 
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RNA  ribonucleic acid 
RNase  ribonuclease 
rpm  rotations per minute 
RT  reverse transcription; reverse transcriptase 
RT-PCR  reverse transcription PCR 
SDS  sodium dodecyl sulfate 
SEM  standard error of the mean 
SSC  saline-sodium citrate 
TAE  tris-acetate-EDTA 
TEA  triethanolamine 
tRNA  transfer RNA 
U  units 
URL  uniform resource locator 
UTP  uridine-5'-triphosphate 
VLM  ventrolateral medulla oblongata 
WT  wild-type 




Common physical abbreviations: 
 
˚C  degree Celsius 
Ci  Curie 
g  gram(s) 
h  hour 
l  liter 
m  meter 
M  mol per liter 
%  percent 
V  volts 





k  kilo (103) 
m  milli (10-3) 
µ  micro (10-6) 
n  nano (10-9) 
















10.1. Tabular summary of microarray expression analyses 
All microarray analyses were performed with tissue samples from male mice, unless otherwise 




Table 3a Basal adrenal transcriptome -- PACAP-dependent transcripts   
Mean ratio WT/KO Gene symbol Description GeneID 
2.13 Akap11 PREDICTED: A kinase (PRKA) anchor protein 11 219181 
3.70 Alb albumin 11657 
3.23 Apoa1 apolipoprotein A-I 11806 
2.86 Avil advillin 11567 
2.17 Bmi1 Bmi1 polycomb ring finger oncogene 12151 
2.27 ENSMUSG00000047334 ENSMUST00000051733  
2.04 Entpd4 ectonucleoside triphosphate diphosphohydrolase 4 67464 
3.45 Gap43 growth associated protein 43 14432 
2.63 Lep leptin 16846 
2.13 LOC56304 Recombinant antineuraminidase single chain Ig VH and VL domains 56304 
2.63 Ly6k lymphocyte antigen 6 complex, locus K 76486 
3.70 Nefl neurofilament, light polypeptide 18039 
2.08 Ngfr nerve growth factor receptor (TNFR superfamily, member 16) 18053 
2.00 Phf20l1 PHD finger protein 20-like 1 239510 
2.00 Ppfia2 protein tyrosine phosphatase, receptor type, f polypeptide, interacting protein, alpha 2 327814 
3.13 Prph peripherin 19132 
 
Table 3b Basal adrenal transcriptome -- PACAP-repressed transcripts   
Mean ratio WT/KO Gene symbol Description GeneID 
0.49 1700041B20Rik PREDICTED: RIKEN cDNA 1700041B20 gene, transcript variant 1 73338 
0.41 2400009B08Rik RIKEN cDNA 2400009B08 gene 68234 
0.36 9530008L14Rik RIKEN cDNA 9530008L14 gene 109254 
0.47 A530050D06Rik RIKEN cDNA A530050D06 gene 104816 
0.46 A530053G22Rik PREDICTED: RIKEN cDNA A530053G22 gene 208079 
0.42 Acaa1b acetyl-Coenzyme A acyltransferase 1B 235674 
0.45 Acot1 acyl-CoA thioesterase 1 26897 
0.47 Akr1c20 Aldo-keto reductase family 1, member C20 116852 
0.37 Apoc1 apolipoprotein C-I, transcript variant 1 11812 
0.50 AU018778 expressed sequence AU018778 234564 
0.48 BC054059 cDNA sequence BC054059 246747 
0.43 Cd47 CD47 antigen (Rh-related antigen, integrin-associated signal transducer) 16423 
0.44 Cox8b cytochrome c oxidase, subunit VIIIb, nuclear gene encoding mitochondrial protein 12869 
0.42 Cpne5 copine V 240058 
0.47 Cpt1b carnitine palmitoyltransferase 1b, muscle 12895 
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0.49 Egln3 EGL nine homolog 3 (C. elegans) 112407 
0.49 Ehhadh enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase 74147 
0.27 Elovl3 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 12686 
0.34 ENSMUSG00000038882 ENSMUST00000046268  
0.43 Fbp2 fructose bisphosphatase 2 14120 
0.44 Gmpr guanosine monophosphate reductase 66355 
0.49 Gyk glycerol kinase, transcript variant 1 14933 
0.47 Gys2 glycogen synthase 2 232493 
0.43 Ifi27 interferon, alpha-inducible protein 27 76933 
0.50 Impa2 inositol (myo)-1(or 4)-monophosphatase 2 114663 
0.49 Irx6 Iroquois related homeobox 6 (Drosophila) 64379 
0.48 LOC100044592 PREDICTED: similar to cytochrome c 100044592 
0.50 LOC100045837 PREDICTED: similar to cytochrome c 100045837 
0.50 LOC100045925 PREDICTED: similar to cytochrome c 100045925 
0.45 Otop1 otopetrin 1 21906 
0.47 Poln DNA polymerase N 272158 
0.37 Ppara peroxisome proliferator activated receptor alpha 19013 
0.45 Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha 19017 
0.46 Sgsm2 small G protein signaling modulator 2 97761 
0.40 Slc14a2 solute carrier family 14 (urea transporter), member 2, transcript variant 1 27411 
0.41 Slc27a2 solute carrier family 27 (fatty acid transporter), member 2 26458 
0.48 Slc36a2 solute carrier family 36 (proton/amino acid symporter), member 2 246049 
0.33 Slc4a4 solute carrier family 4 (anion exchanger), member 4 54403 
0.40 Tectb tectorin beta 21684 
0.49 Zfhx3 zinc finger homeobox 3 11906 
 
 
Table 3. Genes differentially expressed in adrenal glands from untreated wild-type (WT) versus PACAP knock-out (KO) mice. 
Microarray hybridization was carried out using RNA samples obtained from saline-treated animals (male mice; age range: 4.8-6.4 
months). RNA samples from six individual KO mice were hybridized with fractions of a pool generated from six WT samples. Data 
derived from microarray hybridizations were extracted, normalized (LOWESS correction), quality-filtered (Ratio Quality Measure >= 0.8) 
and statistically evaluated in mAdb (http://nciarray.nci.nih.gov). False discovery rate was set to ~1%. Data were subsequently exported 
to Microsoft Excel and only those transcripts with 2-fold or greater difference in abundance between the two genotypes were retained. 
Furthermore, genes with spurious self-self ratios (greater than 1.5 or smaller than 0.66, respectively) were removed. Multiple 
oligonucleotide targets representing a single Entrez GeneID were collapsed by calculating the average of the respective mean 












Table 4 Basal cerebrocortical transcriptome -- PACAP-dependent transcripts   
Mean ratio WT/KO Gene symbol Description GeneID 
2.04 Rtf1 PREDICTED: Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) 76246 
2.13 Cdkl3 cyclin-dependent kinase-like 3 213084 
2.17 ENSMUSG00000029652 HIGH MOBILITY GROUP PROTEIN 1 (HMG-1) (AMPHOTERIN)   
2.17 Gria3 glutamate receptor, ionotropic, AMPA3 (alpha 3) 53623 
2.22 Gabra2 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 2 14395 
2.22 Rasgrp1 RAS guanyl releasing protein 1 19419 
2.22 Lancl2 LanC (bacterial lantibiotic synthetase component C)-like 2 71835 
2.38 Scn2a1 sodium channel, voltage-gated, type II, alpha 1  110876 
 
 
Table 4. Genes differentially expressed in cerebral cortex from untreated wild-type (WT) versus PACAP knock-out (KO) mice. 
Microarray hybridization was carried out using RNA samples obtained from male mice (average age: 3 months). RNA samples from six 
individual mice were pooled per genotype, and fractions of these two pools were hybridized in triplicate. This “pool versus pool” design 
was carried out twice, and results were subsequently combined. Data were extracted, normalized (LOWESS correction), quality-filtered 
(Ratio Quality Measure >= 0.7) and statistically evaluated in mAdb (http://nciarray.nci.nih.gov). False discovery rate was set to ~1%. 
Data were subsequently exported to Microsoft Excel and only those transcripts with 2-fold or greater difference in abundance between 
the two genotypes were retained. Furthermore, genes with spurious self-self ratios (greater than 1.5 or smaller than 0.66, respectively) 
were removed. Multiple oligonucleotide targets representing a single Entrez GeneID were collapsed by calculating the average of the 




Table 5a Adrenal transcriptome after hypoglycemia -- PACAP-dependent transcripts (females) 
Mean ratio WT/KO Gene Description GeneID 
3.06 1190005F20Rik RIKEN cDNA 1190005F20 gene  98685 
2.41 1810035L17Rik RIKEN cDNA 1810035L17 gene 380773 
2.77 2310040C09Rik RIKEN cDNA 2310040C09 gene  69640 
2.04 2410018M08Rik RIKEN cDNA 2410018M08 gene  71970 
2.15 2810021J22Rik RIKEN cDNA 2810021J22 gene  69944 
2.03 3321401G04Rik RIKEN cDNA 3321401G04 gene 77574 
2.24 5630401D24Rik RIKEN cDNA 5630401D24 gene  71449 
3.64 6720475J19Rik PREDICTED: RIKEN cDNA 6720475J19 gene  68157 
2.09 Acta1 actin, alpha 1, skeletal muscle 11459 
2.29 Areg amphiregulin  11839 
2.23 Arntl aryl hydrocarbon receptor nuclear translocator-like  11865 
2.25 AW146020 expressed sequence AW146020  330361 
2.13 BC029127 PREDICTED: cDNA sequence BC029127 214368 
2.13 Ccnt2 cyclin T2  72949 
2.13 Chchd8 coiled-coil-helix-coiled-coil-helix domain containing 8  68185 
2.59 D4Wsu53e DNA segment, Chr 4, Wayne State University 53, expressed 27981 
2.05 Dbc1 deleted in bladder cancer 1  56710 
2.04 Dtwd1 DTW domain containing 1  69185 
3.00 Ecel1 endothelin converting enzyme-like 1  13599 
2.06 EG245174 PREDICTED: predicted gene, EG245174 245174 
3.91 EG433016 predicted gene, EG433016 433016 
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2.98 ENSMUSG00000035484 ZINC FINGER PROTEIN BC027407. [Source:RefSeq;Acc:NM_153063]  
2.08 ENSMUSG00000050032 ENSMUST00000051128  
2.18 Fam60a family with sequence similarity 60, member A 56306 
2.29 Fst follistatin  14313 
2.28 Gal galanin  14419 
2.03 Hhip Hedgehog-interacting protein  15245 
2.05 Hlx H2.0-like homeobox  15284 
2.07 Ifi203 interferon activated gene 203, transcript variant 1. 15950 
2.18 Klhl8 kelch-like 8  246293 
2.47 Lmo1 LIM domain only 1  109594 
2.00 LOC100044458 PREDICTED: hypothetical protein LOC100044458  100044458 
3.43 LOC545175 PREDICTED: similar to LOC635138 protein  545175 
2.44 Madd MAP-kinase activating death domain 228355 
2.29 Metapl1 Methionine aminopeptidase-like 1 66559 
2.25 Mitd1 MIT, microtubule interacting and transport, domain containing 1 69028 
2.62 Nptx1 neuronal pentraxin 1  18164 
4.44 Nr0b2 nuclear receptor subfamily 0, group B, member 2 23957 
2.35 Parp16 poly (ADP-ribose) polymerase family, member 16 214424 
3.03 Ppcs phosphopantothenoylcysteine synthetase  106564 
2.03 Prdm5 PR domain containing 5  70779 
2.59 Prl7b1 prolactin family 7, subfamily b, member 1 75596 
2.25 Rab40c Rab40c, member RAS oncogene family 224624 
2.52 Rhebl1 Ras homolog enriched in brain like 1  69159 
2.40 Sfrs17b splicing factor, arginine/serine-rich 17b 338351 
2.07 Shpk sedoheptulokinase  74637 
2.02 Smek2 SMEK homolog 2, suppressor of mek1 (Dictyostelium) 104570 
2.34 Srd5a2 steroid 5 alpha-reductase 2  94224 
2.14 St6galnac1 GalNAc alpha-2,6-sialyltransferase I 20445 
4.45 Tac1 tachykinin 1  21333 
2.31 Tgds TDP-glucose 4,6-dehydratase 76355 
2.06 Traf2 Tnf receptor-associated factor 2  22030 
2.04 Ttc30a1 tetratricopeptide repeat domain 30A1  78802 
2.10 Zc3h6 zinc finger CCCH type containing 6  78751 
1.98 Zfp273 zinc finger protein 273  212569 
2.59 Zfp354a zinc finger protein 354A  21408 
2.78 Zfp455 zinc finger protein 455  218311 
2.15 Zfp61 zinc finger protein 61  22719 
2.00 Zfp790 zinc finger protein 790  233056 
2.36 Zmym1 zinc finger, MYM domain containing 1 68310 
2.06  Transcribed locus (UniGene cluster Mm.416451)  







Table 5b Adrenal transcriptome after hypoglycemia -- PACAP-repressed transcripts  (females) 
Mean ratio WT/KO Gene Description GeneID 
0.46 1700086L19Rik PREDICTED: RIKEN cDNA 1700086L19 gene 74284 
0.49 4931408A02Rik RIKEN cDNA 4931408A02 gene 70967 
0.44 8430408G22Rik RIKEN cDNA 8430408G22 gene 213393 
0.42 9430023L20Rik RIKEN cDNA 9430023L20 gene 68118 
0.46 Abtb2 ankyrin repeat and BTB (POZ) domain containing 2 99382 
0.48 Akap2 A kinase (PRKA) anchor protein 2, transcript variant 3 11641 
0.37 Ampd1 adenosine monophosphate deaminase 1 (isoform M) 229665 
0.34 Arl5b ADP-ribosylation factor-like 5B 75869 
0.48 AU018778 expressed sequence AU018778 234564 
0.38 Axud1 AXIN1 up-regulated 1 215418 
0.49 Btg2 B-cell translocation gene 2, anti-proliferative 12227 
0.29 Cabyr calcium-binding tyrosine-(Y)-phosphorylation regulated, transcript variant 4 71132 
0.43 Cbx4 chromobox homolog 4 (Drosophila Pc class) 12418 
0.49 Ccdc57 coiled-coil domain containing 57 71276 
0.43 Ccl12 chemokine (C-C motif) ligand 12 20293 
0.27 Ccl7 chemokine (C-C motif) ligand 7 20306 
0.45 Chka Choline kinase alpha 12660 
0.49 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 13072 
0.28 Cyr61 cysteine rich protein 61 16007 
0.31 D16Ertd472e DNA segment, Chr 16, ERATO Doi 472, expressed 67102 
0.32 Dgat1 Diacylglycerol O-acyltransferase 1 13350 
0.46 Dusp1 dual specificity phosphatase 1 19252 
0.43 Dusp10 dual specificity phosphatase 10 63953 
0.42 Egr1 early growth response 1 13653 
0.45 Elf2 E74-like factor 2 69257 
0.46 Ell2 elongation factor RNA polymerase II 2 192657 
0.37 ENSMUSG00000034313 UNIDENTIFIED READING FRAME. [Source:SPTREMBL;Acc:Q62573]  
0.43 Faim3 Fas apoptotic inhibitory molecule 3 69169 
0.48 Fbxo34 F-box protein 34 78938 
0.35 Fem1b feminization 1 homolog b (C. elegans) 14155 
0.49 Fem1c fem-1 homolog c (C.elegans) 240263 
0.46 Fosl1 fos-like antigen 1 14283 
0.50 Gem GTP binding protein (gene overexpressed in skeletal muscle) 14579 
0.31 Gm889 gene model 889, (NCBI) 380755 
0.50 Hist1h3b histone cluster 1, H3b 319150 
0.48 Hist2h3b histone cluster 2, H3b 319154 
0.50 Homer1 Homer homolog 1 (Drosophila) 26556 
0.28 Ibrdc1 PREDICTED: IBR domain containing 1 268291 
0.47 Ier3 immediate early response 3 15937 
0.43 Kcnk2 potassium channel, subfamily K, member 2 16526 
0.23 Klf4 Kruppel-like factor 4 (gut) 16600 
0.47 Lgr5 leucine rich repeat containing G protein coupled receptor 5 14160 
0.39 Ltf lactotransferrin 17002 
0.49 Mafk v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) 17135 
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0.25 Metrnl meteorin, glial cell differentiation regulator-like 210029 
0.38 Mt1 Metallothionein 1 17748 
0.32 Nr1d1 nuclear receptor subfamily 1, group D, member 1 217166 
0.30 Nr4a1 nuclear receptor subfamily 4, group A, member 1 15370 
0.14 Nr4a2 nuclear receptor subfamily 4, group A, member 2 18227 
0.50 Nr4a3 nuclear receptor subfamily 4, group A, member 3 18124 
0.32 Orm1 orosomucoid 1 18405 
0.45 Phlda1 pleckstrin homology-like domain, family A, member 1 21664 
0.46 Pim3 proviral integration site 3 223775 
0.42 Rassf8 Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 71323 
0.27 Rchy1 Ring finger and CHY zinc finger domain containing 1 68098 
0.47 Rdx radixin, transcript variant 3 19684 
0.33 S100a8 S100 calcium binding protein A8 (calgranulin A) 20201 
0.32 S100a9 S100 calcium binding protein A9 (calgranulin B) 20202 
0.34 Slc25a25 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 227731 
0.20 Snf1lk SNF1-like kinase 17691 
0.45 Taok2 TAO kinase 2 381921 
0.43 Tiparp TCDD-inducible poly(ADP-ribose) polymerase 99929 
0.46 Usp2 ubiquitin specific peptidase 2, transcript variant 2 53376 
0.42 Usp53 Ubiquitin specific peptidase 53 99526 
0.44 Zbtb24 zinc finger and BTB domain containing 24 268294 
0.49  Transcribed locus, similar to cAMP responsive element binding protein 5 isoform beta  
 
 
Table 5. Genes differentially expressed in wild-type (WT) versus PACAP knock-out (KO) adrenal glands 3h after insulin-induced 
hypoglycemia.  Microarray hybridization was carried out using RNA samples obtained from animals treated with 2 U/kg insulin (female 
mice; age range: 12-17 months). Samples from six insulin-treated WT mice were pooled, and fractions of this pool were hybridized with 
samples from six individual insulin-treated KO mice. Duplicates of these six hybridizations were carried out as a “dye-swap” control 
(labeling of WT/KO with Cy3/Cy5 reversed), such that a total of 12 microarray slides were used, each slide representing KO /WT .insulin insulin  
Data were extracted, normalized (LOWESS correction), quality-filtered (Ratio Quality Measure >= 0.8) and statistically evaluated in 
mAdb (http://nciarray.nci.nih.gov). False discovery rate was set to ~1%. Data were subsequently exported to Microsoft Excel and only 
those transcripts with 2-fold or greater difference in abundance between the two genotypes were retained. Multiple oligonucleotide 
targets representing a single Entrez GeneID were collapsed by calculating the average of the respective mean expression ratios. Table 














Table 6a Adrenal glands after hypoglycemia – transcripts upregulated in PACAP-/- mice (“fold increase” values in parentheses reflect changes in adrenal glands from PACAP+/+ mice)   
fold increase Gene symbol Description GeneID 
3.04 2010002N04Rik RIKEN cDNA 2010002N04 gene 106878 
2.42  (2.11) 2010003K11Rik RIKEN cDNA 2010003K11 gene 69861 
5.38 2010109I03Rik RIKEN cDNA 2010109I03 gene 67038 
2.18 2900027M19Rik RIKEN cDNA 2900027M19 gene  
3.90  (2.54) 4930430E16Rik RIKEN cDNA 4930430E16 gene 73873 
2.69 4931408A02Rik RIKEN cDNA 4931408A02 gene 70967 
3.27 4933407C03Rik PREDICTED: RIKEN cDNA 4933407C03 gene, transcript variant 6 74440 
2.04 6530403A03Rik RIKEN cDNA 6530403A03 gene 67797 
4.75 9430023L20Rik RIKEN cDNA 9430023L20 gene 68118 
2.37 9430076C15Rik RIKEN cDNA 9430076C15 gene 320189 
3.56 9830163H01Rik RIKEN cDNA 9830163H01 gene 414109 
2.13 Acvr1 activin A receptor, type 1, transcript variant 2 11477 
3.95 Adarb1 adenosine deaminase, RNA-specific, B1, transcript variant 1 110532 
2.72 Agrp agouti related protein 11604 
3.55 Akap2 A kinase (PRKA) anchor protein 2, transcript variant 3 11641 
2.02 Ankhd1 Ankyrin repeat and KH domain containing 1 108857 
2.40  (2.41) Areg amphiregulin 11839 
2.34 Atp13a2 ATPase type 13A2 74772 
2.16 Atp7a ATPase, Cu++ transporting, alpha polypeptide, transcript variant 2 11977 
2.81 Axud1 AXIN1 up-regulated 1 215418 
2.08 Bag3 Bcl2-associated athanogene 3 29810 
2.15 BC011487 cDNA sequence BC011487 232748 
3.22 BC023892 PREDICTED: cDNA sequence BC023892, transcript variant 1 212943 
3.92 BC056923 cDNA sequence BC056923 227358 
2.30 Bdkrb1 bradykinin receptor, beta 1 12061 
2.10 Bean PREDICTED: brain expressed, associated with Nedd4, transcript variant 3 65115 
2.05 Bhlhb2 basic helix-loop-helix domain containing, class B2 20893 
2.13 Bin1 bridging integrator 1, transcript variant 2 30948 
2.54 Btg2 B-cell translocation gene 2, anti-proliferative 12227 
2.03 Bzw1 basic leucine zipper and W2 domains 1 66882 
2.39  (2.06) C630004H02Rik RIKEN cDNA C630004H02 gene 217310 
2.23 C79267 expressed sequence C79267 212632 
5.20 Cabyr calcium-binding tyrosine-(Y)-phosphorylation regulated, transcript variant 4 71132 
2.47 Cacna2d1 calcium channel, voltage-dependent, alpha2/delta subunit 1, transcript variant e 12293 
2.17 Cald1 Caldesmon 1 109624 
2.15 Camk2d calcium/calmodulin-dependent protein kinase II, delta, transcript variant 3 108058 
2.23 Camk2n2 Calcium/calmodulin-dependent protein kinase II inhibitor 2 73047 
2.37  (2.06) Cbr4 carbonyl reductase 4 234309 
2.04 Cbx4 chromobox homolog 4 (Drosophila Pc class) 12418 
3.06 Ccdc64 Coiled-coil domain containing 64 75665 
3.01 Ccl2 chemokine (C-C motif) ligand 2 20296 
4.53 Ccl7 chemokine (C-C motif) ligand 7 20306 
2.30 Ccne1 cyclin E1 12447 
2.02 Ccnl1 cyclin L1 56706 
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2.31 Cdkn1a cyclin-dependent kinase inhibitor 1A (P21), transcript variant 1 12575 
2.59 Chd7 chromodomain helicase DNA binding protein 7 320790 
2.25 Chka Choline kinase alpha 12660 
2.28 Chst11 carbohydrate sulfotransferase 11 58250 
2.08 Chst8 carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 68947 
2.17 Clasp2 CLIP associating protein 2, transcript variant 1 76499 
2.26 Coq10b coenzyme Q10 homolog B (S. cerevisiae), transcript variant 1 67876 
5.95  (2.56) Crem CAMP-RESPONSIVE ELEMENT MODULATOR. [Source:SWISSPROT;Acc:P27699] 12916 
2.19 Cryba4 crystallin, beta A4 12959 
2.04 Csnk1d casein kinase 1, delta, transcript variant 2 104318 
2.03 Csnk2a1 Casein kinase 2, alpha 1 polypeptide 12995 
2.17 Cxcl1 chemokine (C-X-C motif) ligand 1 14825 
2.84 Cyp2t4 cytochrome P450, family 2, subfamily t, polypeptide 4 384724 
2.68  (2.10) Cyp4v3 cytochrome P450, family 4, subfamily v, polypeptide 3 102294 
2.01 Dbc1 deleted in bladder cancer 1 (human) 56710 
2.14 Ddit4 DNA-damage-inducible transcript 4 74747 
2.28 Ddx3x DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked 13205 
2.42 Ddx5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 13207 
3.65 Dnajc5b DnaJ (Hsp40) homolog, subfamily C, member 5 beta 66326 
2.83 Dos downstream of Stk11 216164 
2.08 Dpysl3 dihydropyrimidinase-like 3 22240 
2.37 Dusp1 dual specificity phosphatase 1 19252 
2.22 Dusp10 dual specificity phosphatase 10 63953 
2.41 Dusp14 dual specificity phosphatase 14 56405 
3.46 Dusp5 dual specificity phosphatase 5 240672 
3.25 EG639787 PREDICTED: predicted gene, EG639787 639787 
3.65 Egr1 early growth response 1 13653 
2.32 Eid2 EP300 interacting inhibitor of differentiation 2 386655 
2.19 Eif1a eukaryotic translation initiation factor 1A 13664 
2.53 Eif5 eukaryotic translation initiation factor 5, transcript variant 2 217869 
2.17 Ell2 elongation factor RNA polymerase II 2 192657 
2.16 Emd emerin 13726 
2.04 Eml5 Echinoderm microtubule associated protein like 5 319670 
3.45 ENSMUSG00000020666 ENSMUST00000020995  
2.14 ENSMUSG00000021314 SIMILAR TO AMPHIPHYSIN (FRAGMENT). [Source:SPTREMBL;Acc:Q8R1C4]  
3.78 ENSMUSG00000031759 ENSMUST00000034209  
2.74 ENSMUSG00000033588 ENSMUST00000039706  
2.55 ENSMUSG00000034735 ENSMUST00000058019  
2.11 ENSMUSG00000036248 ENSMUST00000042684  
2.21 ENSMUSG00000042088 ENSMUST00000040304  
2.05 ENSMUSG00000042865 ENSMUST00000052242  
2.36 ENSMUSG00000043566 ENSMUST00000049510  
2.36 ENSMUSG00000045357 ENSMUST00000062053  
3.42 ENSMUSG00000047796 ENSMUST00000055149  
2.09 ENSMUSG00000049727 ENSMUST00000054572  
2.46 ENSMUSG00000051075 ENSMUST00000057179  
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4.66  (2.47) Eprs glutamyl-prolyl-tRNA synthetase 107508 
2.79 Errfi1 ERBB receptor feedback inhibitor 1 74155 
2.17 Fbxl10 F-box and leucine-rich repeat protein 10, transcript variant 3 30841 
4.35 Fem1b feminization 1 homolog b (C. elegans) 14155 
2.28 Fgfr2 fibroblast growth factor receptor 2, transcript variant 2 14183 
2.02 Fndc3b Fibronectin type III domain containing 3B 72007 
2.17 Fndc4 fibronectin type III domain containing 4 64339 
2.70 Fos FBJ osteosarcoma oncogene 14281 
7.84  (2.12) Fosl1 fos-like antigen 1 14283 
2.20 Frmd6 FERM domain containing 6 319710 
2.13 Fst follistatin 14313 
2.53 Gadd45b growth arrest and DNA-damage-inducible 45 beta 17873 
2.84  (2.31) Gclc glutamate-cysteine ligase, catalytic subunit 14629 
2.57 Gdf9 growth differentiation factor 9 14566 
5.77 Gem GTP binding protein (gene overexpressed in skeletal muscle) 14579 
2.74 Gpr98 G protein-coupled receptor 98 110789 
2.85 Gramd1b GRAM domain containing 1B 235283 
3.00 Hdc histidine decarboxylase  15186 
2.47 Herc4 hect domain and RLD 4 67345 
2.35 Hist1h3b histone cluster 1, H3b 319150 
2.36 Hist2h3b histone cluster 2, H3b 319154 
2.60 Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase 15357 
2.00 Hnrpdl heterogeneous nuclear ribonucleoprotein D-like 50926 
2.02 Hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 15490 
2.00 Hspb8 heat shock protein 8 80888 
2.26 Ibrdc1 PREDICTED: IBR domain containing 1 268291 
2.21 Id1 inhibitor of DNA binding 1 15901 
3.89 Ier3 immediate early response 3 15937 
2.19 Ifrd1 interferon-related developmental regulator 1 15982 
2.73 Il6 interleukin 6 16193 
2.40 Impdh2 inosine 5'-phosphate dehydrogenase 2 23918 
2.23 Irf2bp2 PREDICTED: interferon regulatory factor 2 binding protein 2, transcript variant 1 270110 
2.41 Isy1 ISY1 splicing factor homolog (S. cerevisiae) 57905 
2.95  (2.13) Kiss1 KiSS-1 metastasis-suppressor 280287 
2.27 Klf13 Kruppel-like factor 13 50794 
3.86 Klf4 Kruppel-like factor 4 16600 
2.52  (2.51) Ldlr low density lipoprotein receptor 16835 
2.33 LOC100047762 PREDICTED: similar to Aspartate aminotransferase, cytoplasmic (Transaminase A) 100047762 
2.88 LOC100047937 PREDICTED: similar to Aldehyde dehydrogenase 1 family, member L1 100047937 
2.32  (2.07) LOC218501 PREDICTED: similar to calponin 3, acidic 218501 
2.54  (2.04) LOC432554 PREDICTED: similar to Ddx5 protein 432554 
2.07 LOC623115 PREDICTED: similar to heterogeneous nuclear ribonucleoprotein D-like 623115 
2.56  (2.04) LOC667737 PREDICTED: similar to basic leucine zipper and W2 domains 1 667737 
2.02 Luc7l Luc7 homolog (S. cerevisiae)-like 66978 
4.12  (2.19) Maff v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) 17133 
2.79 Map3k6 mitogen-activated protein kinase kinase kinase 6 53608 
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2.03 March7 membrane-associated ring finger (C3HC4) 7 57438 
3.63 Mat2a methionine adenosyltransferase II, alpha 232087 
2.44 Mbnl2 muscleblind-like 2, transcript variant 2 105559 
2.62 Mcl1 myeloid cell leukemia sequence 1 17210 
5.13 Mcm10 minichromosome maintenance deficient 10 (S. cerevisiae) 70024 
2.39 Mef2d myocyte enhancer factor 2D 17261 
2.23 Metrnl meteorin, glial cell differentiation regulator-like 210029 
4.11  (2.37) Mrap melanocortin 2 receptor accessory protein 77037 
8.15  (2.29) Mt1 Metallothionein 1 17748 
2.69 Mt2 metallothionein 2 17750 
2.67 Mycn v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) 18109 
2.98 Myd116 myeloid differentiation primary response gene 116 17872 
4.53 Nek1 NIMA (never in mitosis gene a)-related expressed kinase 1 18004 
2.13 Nfkbia nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha 18035 
2.35 Nfkbiz nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta 80859 
2.74 Nol5 nucleolar protein 5 55989 
2.80  (2.21) Npal1 NIPA-like domain containing 1 70701 
2.24 Nr1d1 nuclear receptor subfamily 1, group D, member 1 217166 
2.75 Nr4a1 nuclear receptor subfamily 4, group A, member 1 15370 
3.73 Nr4a2 nuclear receptor subfamily 4, group A, member 2 18227 
2.07 Nucks1 nuclear casein kinase and cyclin-dependent kinase substrate 1 98415 
2.87  (2.08) Odc1 ornithine decarboxylase, structural 1 18263 
2.72 Olfr1403 olfactory receptor 1403 258645 
2.66 Olfr1510 olfactory receptor 1510 258423 
2.54 Olfr854 olfactory receptor 854 258515 
2.39 Osbpl7 oxysterol binding protein-like 7 71240 
3.20 Pag1 phosphoprotein associated with glycosphingolipid microdomains 1 94212 
2.47 Pde4b phosphodiesterase 4B, cAMP specific 18578 
2.00 Pim1 proviral integration site 1 18712 
2.31 Pip5k1a phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha 18720 
2.06 Plat plasminogen activator, tissue 18791 
2.27 Plcb4 phospholipase C, beta 4 18798 
2.00 Ppap2b phosphatidic acid phosphatase type 2B 67916 
2.10 Prl8a2 prolactin family 8, subfamily a, member 2 13529 
2.26 Prnd prion protein dublet 26434 
4.61  (2.16) Procr Protein C receptor, endothelial 19124 
2.13 Pthlh Parathyroid hormone-like peptide 19227 
2.16 Pvr poliovirus receptor 52118 
2.02 Rab6 RAB6, member RAS oncogene family 19346 
2.19 Rbm25 RNA binding motif protein 25 67039 
4.21 Rchy1 Ring finger and CHY zinc finger domain containing 1 68098 
2.69 Rdx radixin, transcript variant 1 19684 
2.07 Reg3d regenerating islet-derived 3 delta 30053 
3.08 Rgs1 regulator of G-protein signaling 1 50778 
3.07 Rgs4 regulator of G-protein signaling 4 19736 
2.06 Rnf125 ring finger protein 125 67664 
 127
2.07 Scarb1 scavenger receptor class B, member 1 20778 
11.08  (4.32) Serpine1 Serine (or cysteine) peptidase inhibitor, clade E, member 1 18787 
3.18 Sfrs10 Splicing factor, arginine/serine-rich 10 (transformer 2 homolog, Drosophila) 20462 
2.58  (2.16) Sfrs5 splicing factor, arginine/serine-rich 5 (SRp40, HRS), transcript variant 3 20384 
2.17 Sfrs7 splicing factor, arginine/serine-rich 7 225027 
2.11 Sgk1 serum/glucocorticoid regulated kinase 1 20393 
2.02 Sgtb small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta 218544 
4.42  (2.77) Sh3rf1 SH3 domain containing ring finger 1 59009 
2.59  (2.19) Slc10a6 solute carrier family 10 (sodium/bile acid cotransporter family), member 6 75750 
2.40 Slc23a2 solute carrier family 23 (nucleobase transporters), member 2 54338 
4.26  (2.14) Slc25a25 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 227731 
2.16 Slc41a3 solute carrier family 41, member 3, transcript variant 2 71699 
3.66 Slc6a5 solute carrier family 6 (neurotransmitter transporter, glycine), member 5 104245 
4.34 Snf1lk SNF1-like kinase 17691 
5.51  (3.44) Srxn1 sulfiredoxin 1 homolog (S. cerevisiae) 76650 
3.81 Stat3 signal transducer and activator of transcription 3, transcript variant 3 20848 
2.42 Syt4 synaptotagmin IV 20983 
2.47 Taar4 trace amine-associated receptor 4 209513 
2.69  (2.58) Tac1 tachykinin 1 21333 
2.47 Taok2 TAO kinase 2 381921 
2.43 Tiparp TCDD-inducible poly(ADP-ribose) polymerase 99929 
3.73  (2.12) Tm4sf4 transmembrane 4 superfamily member 4 229302 
2.00 Tmem144 transmembrane protein 144 70652 
2.99 Tnfrsf12a tumor necrosis factor receptor superfamily, member 12a 27279 
4.22  (2.23) Trp53inp1 transformation related protein 53 inducible nuclear protein 1 60599 
2.22 Tubb2a tubulin, beta 2a 22151 
2.88 Tubb6 tubulin, beta 6 67951 
2.07 Txndc11 thioredoxin domain containing 11, transcript variant 2 106200 
2.04 Ubr2 ubiquitin protein ligase E3 component n-recognin 2 224826 
2.26 Usp53 Ubiquitin specific peptidase 53 99526 
2.43 Vdr vitamin D receptor 22337 
2.30 Wdr43 PREDICTED: WD repeat domain 43, transcript variant 9 72515 
2.23 Zan zonadhesin 22635 
2.27 Zbtb24 zinc finger and BTB domain containing 24 268294 
2.24 Zfand5 zinc finger, AN1-type domain 5 22682 
3.13 Zfhx3 zinc finger homeobox 3 11906 
2.87 Zfp113 zinc finger protein 113 56314 
2.29 Zfp192 zinc finger protein 192 93681 
2.74 Zfp36 zinc finger protein 36 22695 
















 Table 6b Adrenal glands after hypoglycemia – transcripts upregulated only in PACAP+/+ mice (PACAP-dependent transcripts)   
fold increase Gene symbol Description GeneID 
2.31 Cyp51 Cytochrome P450, family 51               13121 
2.59 ENSMUSG00000020666   
2.18 ENSMUSG00000033588   
2.08 ENSMUSG00000046206   
2.42 ENSMUSG00000047796   
2.06 ENSMUSG00000050648   
2.17 Hhip Hedgehog-interacting protein          15245 
2.17 Lep Leptin 16846 
2.16 Optn Optineurin 71648 
 
 
Table 6. Transcripts upregulated in adrenal glands 3h after hypoglycemia-induced stress.  Microarray hybridization was carried out 
using RNA samples obtained from animals treated with 2 U/kg insulin or saline (male mice; age range 4.8-6.4 months). Samples from 
six saline-treated mice were pooled, and fractions of this pool were hybridized with samples from six individual insulin-treated mice. 
Expression levels (fold increase) as measured by microarray thus represent WT /WT  and KO /KO . No dye-swap was 
performed. 
insulin saline insulin saline
Data were extracted, normalized (LOWESS correction), quality-filtered (Ratio Quality Measure >= 0.8) and statistically 
evaluated in mAdb (http://nciarray.nci.nih.gov). False discovery rate was set to <1%. Data were subsequently exported to Microsoft 
Excel and only those transcripts showing 2-fold or greater induction were retained. Genes with spurious self-self ratios (greater than 1.5 
or smaller than 0.66, respectively) were removed. Multiple oligonucleotide targets representing a single Entrez GeneID were collapsed 
by calculating the average of the respective mean expression ratios. Table 6a, transcripts induced in KO mice. Transcripts also induced 
in WT are noted in parentheses. Table 6b, PACAP-dependently upregulated transcripts (induced only in WT). Note that most transcripts 






















Overlap of PACAP-repressed transcripts from microarray Experiments 1 and 2 Table 7 
Experiment 1 Experiment 2    
KO ins/WT ins KO ins/KO sal Gene Description GeneID 
2.05 2.37 9430076C15Rik RIKEN cDNA 9430076C15 gene 320189 
2.03 2.69 4931408A02Rik RIKEN cDNA 4931408A02 gene 70967 
2.38 4.75 9430023L20Rik RIKEN cDNA 9430023L20 gene 68118 
2.09 3.55 Akap2 A kinase (PRKA) anchor protein 2, transcript variant 3 11641 
2.62 2.81 Axud1 AXIN1 up-regulated 1, mRNA. 215418 
2.06 2.54 Btg2 B-cell translocation gene 2, anti-proliferative, mRNA. 12227 
3.49 5.20 Cabyr calcium-binding tyrosine-(Y)-phosphorylation regulated (fibrousheathin 2) 71132 
2.30 2.04 Cbx4 chromobox homolog 4 (Drosophila Pc class), mRNA. 12418 
3.74 4.53 Ccl7 chemokine (C-C motif) ligand 7, mRNA. 20306 
2.21 2.25 Chka Choline kinase alpha 12660 
2.15 2.84 Cyp2t4 cytochrome P450, family 2, subfamily t, polypeptide 4, mRNA. 384724 
2.15 2.37 Dusp1 dual specificity phosphatase 1, mRNA. 19252 
2.31 2.22 Dusp10 dual specificity phosphatase 10, mRNA. 63953 
2.36 3.65 Egr1 early growth response 1, mRNA. 13653 
2.18 2.17 Ell2 elongation factor RNA polymerase II 2, mRNA. 192657 
2.85 4.35 Fem1b feminization 1 homolog b (C. elegans), mRNA. 14155 
2.17 7.84 Fosl1 fos-like antigen 1 14283 
2.00 5.77 Gem GTP binding protein (gene overexpressed in skeletal muscle), mRNA. 14579 
2.00 2.35 Hist1h3b histone cluster 1, H3b, mRNA. 319150 
2.08 2.36 Hist2h3b histone cluster 2, H3b, mRNA. 319154 
3.81 2.26 Ibrdc1 PREDICTED: IBR domain containing 1, mRNA. 268291 
2.11 3.89 Ier3 immediate early response 3, mRNA. 15937 
4.39 3.86 Klf4 Kruppel-like factor 4 (gut) 16600 
4.04 2.23 Metrnl meteorin, glial cell differentiation regulator-like, mRNA. 210029 
2.65 8.15 Mt1 Metallothionein 1 17748 
3.14 2.24 Nr1d1 nuclear receptor subfamily 1, group D, member 1, mRNA. 217166 
3.35 2.75 Nr4a1 nuclear receptor subfamily 4, group A, member 1, mRNA. 15370 
6.96 3.73 Nr4a2 nuclear receptor subfamily 4, group A, member 2, mRNA. 18227 
3.66 4.21 Rchy1 Ring finger and CHY zinc finger domain containing 1 68098 
2.13 3.56 Rdx RIKEN cDNA 9830163H01 gene 414109 
2.91 4.26 Slc25a25 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 227731 
4.96 4.34 Snf1lk SNF1-like kinase 17691 
2.21 2.47 Taok2 TAO kinase 2 381921 
2.31 2.43 Tiparp TCDD-inducible poly(ADP-ribose) polymerase 99929 
2.41 2.26 Usp53 Ubiquitin specific peptidase 53 99526 
2.30 2.27 Zbtb24 zinc finger and BTB domain containing 24 268294 
 
 
Table 7. Overlap of PACAP-repressed transcripts from Experiments 1 and 2, i.e. transcripts more abundant in KO adrenals compared to 
WT adrenals 3h after insulin (Experiment 1), and upregulated only or more strongly in KO adrenals 3h after insulin (Experiment 2).     
See legends to tables 5 and 6 for details. 
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